Document:

EX-4.1

 Exhibit 4.1 
 EXECUTION VERSION 
  

 
  

WOLVERINE HEALTHCARE ANALYTICS, INC., 
 AS ISSUER 
 VCPH HOLDING CORP., 

AS GUARANTOR 

AND 
 THE
BANK OF NEW YORK MELLON TRUST COMPANY, N.A., 
 AS TRUSTEE 

10.625% Senior Notes due 2020 
  

 
 INDENTURE

 Dated as of June 6, 2012 
  

 
  

 
  

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE	  	 	1	  
			
	SECTION 1.1.	 	 Definitions
	  	 	1	  
	SECTION 1.2.	 	 Other Definitions
	  	 	35	  
	SECTION 1.3.	 	 Incorporation by Reference of Trust Indenture Act
	  	 	38	  
	SECTION 1.4.	 	 Rules of Construction
	  	 	38	  
		
	ARTICLE II THE NOTES	  	 	39	  
			
	SECTION 2.1.	 	 Form, Dating and Terms
	  	 	39	  
	SECTION 2.2.	 	 Execution and Authentication
	  	 	48	  
	SECTION 2.3.	 	 Registrar and Paying Agent
	  	 	49	  
	SECTION 2.4.	 	 Paying Agent to Hold Money in Trust
	  	 	49	  
	SECTION 2.5.	 	 Holder Lists
	  	 	50	  
	SECTION 2.6.	 	 Transfer and Exchange
	  	 	50	  
	SECTION 2.7.	 	 Form of Certificate to be Delivered upon Termination of Restricted Period
	  	 	54	  
	SECTION 2.8.	 	 Form of Certificate to be Delivered in Connection with Transfers to Institutional Accredited Investors
	  	 	55	  
	SECTION 2.9.	 	 Form of Certificate to be Delivered in Connection with Transfers Pursuant to Regulation S
	  	 	57	  
	SECTION 2.10.	 	 Mutilated, Destroyed, Lost or Stolen Notes
	  	 	58	  
	SECTION 2.11.	 	 Outstanding Notes
	  	 	59	  
	SECTION 2.12.	 	 Temporary Notes
	  	 	60	  
	SECTION 2.13.	 	 Cancellation
	  	 	60	  
	SECTION 2.14.	 	 Payment of Interest; Defaulted Interest
	  	 	61	  
	SECTION 2.15.	 	 CUSIP, Common Code and ISIN Numbers
	  	 	62	  
		
	ARTICLE III COVENANTS	  	 	62	  
			
	SECTION 3.1.	 	 Payment of Notes
	  	 	62	  
	SECTION 3.2.	 	 Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock
	  	 	63	  
	SECTION 3.3.	 	 Limitation on Restricted Payments
	  	 	69	  
	SECTION 3.4.	 	 Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries
	  	 	79	  
	SECTION 3.5.	 	 Limitation on Asset Sales
	  	 	81	  
	SECTION 3.6.	 	 Liens
	  	 	84	  
	SECTION 3.7.	 	 Limitation on Guarantees of Indebtedness by Restricted Subsidiaries
	  	 	84	  
	SECTION 3.8.	 	 Transactions with Affiliates
	  	 	85	  
	SECTION 3.9.	 	 Limitation on Activities of Parent
	  	 	88	  
	SECTION 3.10.	 	 Change of Control
	  	 	89	  
	SECTION 3.11.	 	 Reports and Other Information
	  	 	91	  

  
 i 

							
	 	 	 	  	Page	 
	SECTION 3.12.	 	 Maintenance of Office or Agency
	  	 	93	  
	SECTION 3.13.	 	 Corporate Existence
	  	 	93	  
	SECTION 3.14.	 	 Payment of Taxes
	  	 	93	  
	SECTION 3.15.	 	 Payments for Consent
	  	 	94	  
	SECTION 3.16.	 	 Compliance Certificate
	  	 	94	  
	SECTION 3.17.	 	 Further Instruments and Acts
	  	 	94	  
	SECTION 3.18.	 	 [RESERVED]
	  	 	94	  
	SECTION 3.19.	 	 Statement by Officer as to Default
	  	 	94	  
	SECTION 3.20.	 	 Suspension of Certain Covenants
	  	 	94	  
		
	ARTICLE IV SUCCESSOR COMPANY	  	 	96	  
			
	SECTION 4.1.	 	 Merger, Consolidation or Sale of All or Substantially All Assets
	  	 	96	  
		
	ARTICLE V REDEMPTION OF SECURITIES	  	 	98	  
			
	SECTION 5.1.	 	 Notices to Trustee
	  	 	98	  
	SECTION 5.2.	 	 Selection of Notes to Be Redeemed or Purchased
	  	 	98	  
	SECTION 5.3.	 	 Notice of Redemption
	  	 	98	  
	SECTION 5.4.	 	 Effect of Notice of Redemption
	  	 	99	  
	SECTION 5.5.	 	 Deposit of Redemption or Purchase Price
	  	 	99	  
	SECTION 5.6.	 	 Notes Redeemed or Purchased in Part
	  	 	100	  
	SECTION 5.7.	 	 Optional Redemption
	  	 	100	  
	SECTION 5.8.	 	 Mandatory Redemption
	  	 	101	  
		
	ARTICLE VI DEFAULTS AND REMEDIES	  	 	101	  
			
	SECTION 6.1.	 	 Events of Default
	  	 	101	  
	SECTION 6.2.	 	 Acceleration
	  	 	103	  
	SECTION 6.3.	 	 Other Remedies
	  	 	104	  
	SECTION 6.4.	 	 Waiver of Past Defaults
	  	 	104	  
	SECTION 6.5.	 	 Control by Majority
	  	 	105	  
	SECTION 6.6.	 	 Limitation on Suits
	  	 	105	  
	SECTION 6.7.	 	 Rights of Holders to Receive Payment
	  	 	105	  
	SECTION 6.8.	 	 Collection Suit by Trustee
	  	 	105	  
	SECTION 6.9.	 	 Trustee May File Proofs of Claim
	  	 	106	  
	SECTION 6.10.	 	 Priorities
	  	 	106	  
	SECTION 6.11.	 	 Undertaking for Costs
	  	 	106	  
		
	ARTICLE VII TRUSTEE	  	 	107	  
			
	SECTION 7.1.	 	 Duties of Trustee
	  	 	107	  
	SECTION 7.2.	 	 Rights of Trustee
	  	 	108	  
	SECTION 7.3.	 	 Individual Rights of Trustee
	  	 	110	  
	SECTION 7.4.	 	 Trustee’s Disclaimer
	  	 	110	  
	SECTION 7.5.	 	 Notice of Defaults
	  	 	110	  
	SECTION 7.6.	 	 Reports by Trustee to Holders
	  	 	110	  

  
 ii 

							
	 	  	 	  	Page	 
	SECTION 7.7.	  	 Compensation and Indemnity
	  	 	110	  
	SECTION 7.8.	  	 Replacement of Trustee
	  	 	111	  
	SECTION 7.9.	  	 Successor Trustee by Merger
	  	 	112	  
	SECTION 7.10.	  	 Eligibility; Disqualification
	  	 	112	  
	SECTION 7.11.	  	 Preferential Collection of Claims Against the Issuer
	  	 	113	  
	SECTION 7.12.	  	 Trustee’s Application for Instruction from the Issuer
	  	 	113	  
		
	ARTICLE VIII LEGAL DEFEASANCE AND COVENANT DEFEASANCE	  	 	113	  
			
	SECTION 8.1.	  	 Option to Effect Legal Defeasance or Covenant Defeasance; Defeasance
	  	 	113	  
	SECTION 8.2.	  	 Legal Defeasance and Discharge
	  	 	113	  
	SECTION 8.3.	  	 Covenant Defeasance
	  	 	114	  
	SECTION 8.4.	  	 Conditions to Legal or Covenant Defeasance
	  	 	114	  
	SECTION 8.5.	  	 Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions
	  	 	116	  
	SECTION 8.6.	  	 Repayment to the Issuer
	  	 	116	  
	SECTION 8.7.	  	 Reinstatement
	  	 	117	  
		
	ARTICLE IX AMENDMENTS	  	 	117	  
			
	SECTION 9.1.	  	 Without Consent of Holders
	  	 	117	  
	SECTION 9.2.	  	 With Consent of Holders
	  	 	118	  
	SECTION 9.3.	  	 Compliance with Trust Indenture Act
	  	 	120	  
	SECTION 9.4.	  	 Revocation and Effect of Consents and Waivers
	  	 	120	  
	SECTION 9.5.	  	 Notation on or Exchange of Notes
	  	 	120	  
	SECTION 9.6.	  	 Trustee to Sign Amendments
	  	 	121	  
		
	ARTICLE X GUARANTEE	  	 	121	  
			
	SECTION 10.1.	  	 Guarantee
	  	 	121	  
	SECTION 10.2.	  	 Limitation on Liability; Termination, Release and Discharge
	  	 	123	  
	SECTION 10.3.	  	 Right of Contribution
	  	 	125	  
	SECTION 10.4.	  	 No Subrogation
	  	 	125	  
			
	ARTICLE XI	  		  	 	126	  
		
	SATISFACTION AND DISCHARGE	  	 	126	  
			
	SECTION 11.1.	  	 Satisfaction and Discharge
	  	 	126	  
	SECTION 11.2.	  	 Application of Trust Money
	  	 	127	  
		
	ARTICLE XII MISCELLANEOUS	  	 	127	  
			
	SECTION 12.1.	  	 Trust Indenture Act Controls
	  	 	127	  
	SECTION 12.2.	  	 Notices
	  	 	127	  
	SECTION 12.3.	  	 Communication by Holders with other Holders
	  	 	129	  
	SECTION 12.4.	  	 Certificate and Opinion as to Conditions Precedent
	  	 	129	  

  
 iii

							
	 	 	 	  	Page	 
	SECTION 12.5.	 	 Statements Required in Certificate or Opinion
	  	 	129	  
	SECTION 12.6.	 	 When Notes Disregarded
	  	 	130	  
	SECTION 12.7.	 	 Rules by Trustee, Paying Agent and Registrar
	  	 	130	  
	SECTION 12.8.	 	 Legal Holidays
	  	 	130	  
	SECTION 12.9.	 	 GOVERNING LAW
	  	 	130	  
	SECTION 12.10.	 	 USA Patriot Act
	  	 	130	  
	SECTION 12.11.	 	 No Recourse Against Others
	  	 	130	  
	SECTION 12.12.	 	 Successors
	  	 	131	  
	SECTION 12.13.	 	 Multiple Originals
	  	 	131	  
	SECTION 12.14.	 	 Qualification of Indenture
	  	 	131	  
	SECTION 12.15.	 	 Table of Contents; Headings
	  	 	131	  
	SECTION 12.16.	 	 WAIVERS OF JURY TRIAL
	  	 	131	  
	SECTION 12.17.	 	 Force Majeure
	  	 	131	  

  

			
	EXHIBIT A	  	Form of Series A Note
	EXHIBIT B	  	Form of Series B Note
	EXHIBIT C	  	Form of Indenture Supplement for Joinder of Thomson Reuters (Healthcare) Inc.
	EXHIBIT D	  	Form of Indenture Supplement to Add Future Guarantors

  
 iv 

 CROSS-REFERENCE TABLE* 

 

					
	 TIA Section
	 	 	  	 Indenture Section

	 310(a)(1)
	 		  	7.10
	  (a)(2)
	 		  	7.10
	  (a)(3)
	 		  	N.A.
	  (a)(4)
	 		  	N.A.
	  (a)(5)
	 		  	7.10
	  (b)
	 		  	7.3;7.8; 7.10
	  (c)
	 		  	7.10
	 311(a)
	 		  	7.11
	  (b)
	 		  	7.11
	  (c)
	 		  	N.A.
	 312(a)
	 		  	2.5
	  (b)
	 		  	12.3
	  (c)
	 		  	12.3
	 313(a)
	 		  	7.6
	  (b)(1)
	 		  	7.6;12.2
	  (b)(2)
	 		  	7.6;12.2
	  (c)
	 		  	7.6;12.2
	  (d)
	 		  	7.6
	 314(a)
	 		  	3.11;3.16; 12.5
	  (b)
	 		  	N.A.
	  (c)(1)
	 		  	12.4
	  (c)(2)
	 		  	12.4
	  (c)(3)
	 		  	N.A.
	  (d)
	 		  	N.A.
	  (e)
	 		  	12.5
	 315(a)
	 		  	7.1
	  (b)
	 		  	7.5;12.2
	  (c)
	 		  	7.1
	  (d)
	 		  	7.1
	  (e)
	 		  	6.11
	 316(a)(last sentence)
	 		  	12.6
	  (a)(1)(A)
	 		  	6.5
	  (a)(1)(B)
	 		  	6.4
	  (a)(2)
	 		  	N.A.
	  (b)
	 		  	6.7
	  (c)
	 		  	9.4
	 317(a)(1)
	 		  	6.8
	  (a)(2)
	 		  	6.9
	  (b)
	 		  	2.4
	 318(a)
	 		  	12.1

 N.A. means Not Applicable. 
  

	*	Note: This Cross-Reference Table shall not, for any purpose, be deemed to be part of this Indenture. 

  
 v 

 INDENTURE dated as of June 6, 2012, among WOLVERINE HEALTHCARE ANALYTICS, INC., a
Delaware corporation (the “Issuer”), VCPH HOLDING CORP., a Delaware corporation, as guarantor (the “Parent”), and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (the “Trustee”), as Trustee.

 WHEREAS, all things have been done to make this Indenture and the Notes (as defined below) legal, valid and binding
obligations of the Issuer and Parent. 
 Each party agrees as follows for the benefit of the other parties and for the equal and
ratable benefit of the Holders of (i) the Issuer’s 10.625% Senior Notes, Series A, due 2020, issued on the date hereof (the “Initial Notes”), (ii) if and when issued, an unlimited principal amount of additional
10.625% Senior Notes, Series A, due 2020 in a non-registered offering or 10.625% Senior Notes, Series B, due 2020 in a registered offering that may be offered from time to time subsequent to the Issue Date, in each case subject to
Section 2.1 (the “Additional Notes”) as provided in Section 2.1(a) and (iii) if and when issued, the Issuer’s 10.625% Senior Notes, Series B, due 2020 that may be issued from time to time in
exchange for Initial Notes or any Additional Notes in an offer registered under the Securities Act as provided in the Registration Rights Agreement, as hereinafter defined, (the “Exchange Notes” and, together with the Initial Notes
and Additional Notes, the “Notes”): 
 ARTICLE I  

DEFINITIONS AND INCORPORATION BY REFERENCE 

SECTION 1.1. Definitions. 

“Acquired Indebtedness” means, with respect to any specified Person, 

(1) Indebtedness of any other Person existing at the time such other Person is merged with or into or became a Restricted
Subsidiary of such specified Person, including Indebtedness incurred in connection with, or in contemplation of, such other Person merging with or into or becoming a Restricted Subsidiary of such specified Person; and 

(2) Indebtedness secured by a Lien encumbering any asset acquired by such specified Person. 

“Acquisition” means the transactions contemplated by the Purchase Agreement. 

“Additional Interest” means all additional interest then owing pursuant to the Registration Rights Agreement.

 “Additional Notes” has the meaning ascribed to it in the second introductory paragraph of this Indenture.

 “Affiliate” of any specified Person means any other Person directly or indirectly controlling or controlled
by or under direct or indirect common control with such specified Person. For purposes of this definition, “control” (including, with correlative meanings, the terms 

 
“controlling,” “controlled by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power
to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise. 
 “Applicable Premium” means, with respect to any Note on any Redemption Date, the greater of: 
 (1) 1.0% of the principal amount of such Note; and 
 (2) the excess, if any, of:
(a) the present value at such Redemption Date of (i) the redemption price of such Note at June 1, 2016 (such redemption price being set forth in the table appearing in Section 5.7(d)), plus (ii) all required interest
payments due on such Note through June 1, 2016 (excluding accrued but unpaid interest to the Redemption Date), computed using a discount rate equal to the Treasury Rate as of such Redemption Date plus 50 basis points, over (b) the
principal amount of such Note. 
 The Issuer shall calculate the Applicable Premium. 

“Asset Sale” means: 
 (1) the sale, conveyance, transfer or other disposition, whether in a single transaction or a series of related transactions, of property or assets (including by way of a Sale and Lease-Back Transaction)
of the Issuer (other than Equity Interests of the Issuer) or any of its Restricted Subsidiaries (each referred to in this definition as a “disposition”); or 
 (2) the issuance or sale of Equity Interests of any Restricted Subsidiary (other than Preferred Stock of Restricted Subsidiaries issued in compliance with Section 3.2 or directors’
qualifying shares and shares issued to foreign nationals as required under applicable law), whether in a single transaction or a series of related transactions in each case, other than: 

(a) any disposition of Cash Equivalents or Investment Grade Securities or obsolete, damaged or worn out equipment in the ordinary course
of business or any disposition of inventory or goods (or other assets) held for sale or no longer used in the ordinary course of business of the Issuer and its Restricted Subsidiaries; 

(b) the disposition of all or substantially all of the assets of the Issuer in a manner permitted pursuant to Section 4.1 or
any disposition that constitutes a Change of Control pursuant to the Indenture; 
 (c) the making of any Restricted Payment that
is permitted to be made, and is made, under Section 3.3 and the making of any Permitted Investments; 
 (d) any
disposition of assets or issuance or sale of Equity Interests of any Restricted Subsidiary in any transaction or series of transactions with an aggregate fair market value of less than $5.0 million; 

  
 2 

 (e) any disposition of property or assets or issuance of securities by a Restricted
Subsidiary of the Issuer to the Issuer or by the Issuer or a Restricted Subsidiary of the Issuer to another Restricted Subsidiary of the Issuer; 
 (f) to the extent allowable under Section 1031 of the Code on a tax-free basis, any exchange of like property (excluding any boot thereon) for use in a Similar Business; 

(g) the lease, assignment, sub-lease, license or sublicense of any real or personal property in the ordinary course of business;

 (h) any issuance or sale of Equity Interests in, or Indebtedness or other securities of, an Unrestricted Subsidiary;

 (i) foreclosures, condemnation or any similar action on assets; 

(j) any disposition of Securitization Assets, or participations therein, in connection with any Qualified Securitization Financing, or
the disposition of an account receivable or note receivable in connection with the collection or compromise thereof in the ordinary course of business; 
 (k) the granting of a Lien that is permitted by Section 3.6; 
 (l) the
sale or issuance by a Restricted Subsidiary of Preferred Stock or Disqualified Stock that is permitted by Section 3.2; 
 (m) any financing transaction with respect to property constructed, acquired, replaced, repaired or improved (including any reconstruction, refurbishment, renovation and/or development of real property)
by the Issuer or any Restricted Subsidiary after the Issue Date, including Sale and Lease-Back Transactions and asset securitizations, permitted by the Indenture; 
 (n) any surrender or waiver of contractual rights or the settlement, release or surrender of contractual rights or other litigation claims in the ordinary course of business; and 

(o) the abandonment of intellectual property rights in the ordinary course of business, which in the good faith determination of the
Issuer are not material to the conduct of the business of the Issuer and its Restricted Subsidiaries taken as a whole. 

“Bankruptcy Code” means Title 11 of the United States Code, as amended. 

“Bankruptcy Law” means the Bankruptcy Code and any similar federal, state or foreign law for the relief of debtors.

 “Board Resolution” means a copy of a resolution certified by the Secretary or an Assistant Secretary of a
Person to have been duly adopted by the board of directors of such Person and to be in full force and effect on the date of such certification, and delivered to the Trustee. 
 “Business Day” means each day which is not a Legal Holiday. If a payment date is a Legal Holiday at a place of payment, payment may be made at that place on the next succeeding day that
is not a Legal Holiday, and no interest shall accrue on such payment for the intervening period. 

  
 3 

 “Capital Stock” means: 

(1) in the case of a corporation, corporate stock; 

(2) in the case of an association or business entity, any and all shares, interests, participations, rights or other
equivalents (however designated) of capital stock; 
 (3) in the case of a partnership or limited liability
company, partnership or membership interests (whether general or limited); and 
 (4) any other interest or
participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person. 
 “Capitalized Lease Obligation” means, at the time any determination thereof is to be made, the amount of the liability in respect of a capital lease that would at such time be required to
be capitalized and reflected as a liability on a balance sheet (excluding the footnotes thereto) in accordance with GAAP. 
 “Cash Equivalents” means: 
 (1) U.S. dollars or,
in the case of a Foreign Subsidiary, any other foreign currency held by the Issuer and the Restricted Subsidiaries in the ordinary course of business; 
 (2) securities issued or directly and fully and unconditionally guaranteed or insured by the U.S. government or any agency or instrumentality thereof the securities of which are unconditionally guaranteed
as a full faith and credit obligation of such government with maturities of 24 months or less from the date of acquisition; 
 (3) certificates of deposit, time deposits and eurodollar time deposits with maturities of one year or less from the date of acquisition, bankers’ acceptances with maturities not exceeding one year
and overnight bank deposits, in each case with any commercial bank having capital and surplus of not less than $500.0 million in the case of U.S. banks and $100.0 million (or the U.S. dollar equivalent as of the date of determination) in the case of
non-U.S. banks, and in each case in a currency permitted under clause (1) above; 
 (4) repurchase
obligations for underlying securities of the types described in clauses (2) and (3) entered into with any financial institution meeting the qualifications specified in clause (3) above, and in each case in a currency permitted under
clause (1) above; 
 (5) commercial paper rated at least P-2 by Moody’s or at least A-2 by S&P and
in each case maturing within 24 months after the date of creation thereof, and in each case in a currency permitted under clause (1) above; 

  
 4 

 (6) marketable short-term money market and similar securities having a
rating of at least P-2 or A-2 from either Moody’s or S&P, respectively (or, if at any time neither Moody’s nor S&P shall be rating such obligations, an equivalent rating from another Rating Agency) and in each case maturing within
24 months after the date of creation thereof and in a currency permitted under clause (1) above; 
 (7)
investment funds investing 95% of their assets in securities of the types described in clauses (1) through (6) above; 
 (8) readily marketable direct obligations issued by any state, commonwealth or territory of the United States or any political subdivision or taxing authority thereof having an Investment Grade Rating
from either Moody’s or S&P with maturities of 24 months or less from the date of acquisition; 
 (9)
Indebtedness or Preferred Stock issued by Persons with a rating of “A” or higher from S&P or “A2” or higher from Moody’s with maturities of 24 months or less from the date of acquisition and in each case in a currency
permitted under clause (1) above; 
 (10) Investments with average maturities of 12 months or less from the
date of acquisition in money market funds rated AAA- (or the equivalent thereof) or better by S&P or Aaa3 (or the equivalent thereof) or better by Moody’s and in each case in a currency permitted under clause (1) above; and 

(11) credit card receivables and debit card receivables so long as such are considered cash equivalents under GAAP and are
so reflected on the Issuer’s balance sheet. 
 Notwithstanding the foregoing, Cash Equivalents shall include amounts denominated in
currencies other than those set forth in clause (1) above, provided that such amounts are converted into any currency listed in clause (1) as promptly as practicable and in any event within ten Business Days following the receipt of
such amounts. 
 “Cash Management Services” means any of the following to the extent not constituting a line of
credit (other than an overnight overdraft facility that is not in default): ACH transactions, treasury and/or cash management services, including, without limitation, controlled disbursement services, overdraft facilities, foreign exchange
facilities, deposit and other accounts and merchant services. 
 “Change of Control” means the
occurrence of any of the following: 
 (1) the sale, lease or transfer, in one or a series of related
transactions (other than by way of merger or consolidation), of all or substantially all of the assets of the Issuer and its Subsidiaries or Parent, taken as a whole, to any Person other than to (i) one or more Permitted Holders or
(ii) any Subsidiary Guarantor; 

  
 5 

 (2) the Issuer becomes aware of (by way of a report or any other filing
pursuant to Section 13(d) of the Exchange Act, proxy, vote, written notice or otherwise) the acquisition by any Person or group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act, or any successor
provision), including any group acting for the purpose of acquiring, holding or disposing of securities (within the meaning of Rule 13d-5(b)(1) under the Exchange Act), other than one or more Permitted Holders, in a single transaction or in a
related series of transactions, by way of merger, consolidation or other business combination or purchase of beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act, or any successor provision) of 50% or more of the total
voting power of the Voting Stock of the Issuer or any of its direct or indirect parent companies holding directly or indirectly 100% of the total voting power of the Voting Stock of the Issuer; or 

(3) the Issuer ceases to be a Wholly-Owned Subsidiary of Parent (except in a transaction consummated in accordance with
the covenant described under Section 4.1). 
 “Code” means the Internal Revenue Code of 1986, as amended,
or any successor thereto. 
 “Consolidated Depreciation and Amortization Expense” means, with respect to any
Person for any period, the total amount of depreciation and amortization expense, including the amortization of deferred financing fees, of such Person and its Restricted Subsidiaries for such period on a consolidated basis and otherwise determined
in accordance with GAAP. 
 “Consolidated Interest Expense” means, with respect to any Person for any period,
without duplication, the sum of: 
  

	 	(1)	consolidated interest expense of such Person and its Restricted Subsidiaries for such period, to the extent such expense was deducted (and not added back) in computing
Consolidated Net Income (including (a) amortization of original issue discount resulting from the issuance of Indebtedness at less than par, (b) all commissions, discounts and other fees and charges owed with respect to letters of credit
or bankers’ acceptances, (c) non-cash interest payments (but excluding any non-cash interest expense attributable to the movement in the mark-to-market valuation of Hedging Obligations or other derivative instruments pursuant to GAAP),
(d) the interest component of Capitalized Lease Obligations and (e) net payments, if any, pursuant to interest rate Hedging Obligations with respect to Indebtedness, and excluding (u) annual agency fees paid to the administrative
agents and collateral agents under any Debt Facilities, (v) penalties and interest related to taxes, (w) any Additional Interest with respect to the Notes, (x) amortization of deferred financing fees, debt issuance costs, discounted
liabilities, commissions, fees and expenses, (y) any expensing of bridge, commitment and other financing fees and (z) commissions, discounts, yield and other fees and charges (including any interest expense) related to any Securitization
Facility); plus 

  

	 	(2)	consolidated capitalized interest of such Person and its Restricted Subsidiaries for such period, whether paid or accrued; less 

 

	 	(3)	interest income for such period. 

  
 6 

 For purposes of this definition, interest on a Capitalized Lease Obligation shall be deemed
to accrue at an interest rate reasonably determined by such Person to be the rate of interest implicit in such Capitalized Lease Obligation in accordance with GAAP. 
 “Consolidated Net Income” means, with respect to any Person for any period, the aggregate of the Net Income, of such Person and its Restricted Subsidiaries for such period, on a
consolidated basis, and otherwise determined in accordance with GAAP; provided, however, that, without duplication, 
 (1) the Net Income for such period shall not include the cumulative effect of a change in accounting principles during such period; 

(2) any net after-tax effect of income (loss) from disposed, abandoned or discontinued operations and any net after-tax
gains or losses on disposal of disposed, abandoned or discontinued operations shall be excluded; 
 (3) any net
after-tax effect of gains or losses (less all fees and expenses relating thereto) attributable to asset dispositions (including sales or other dispositions of assets under a Securitization Facility) other than in the ordinary course of business, as
determined in Good Faith by the Issuer, shall be excluded; 
 (4) the Net Income for such period of any Person
that is not a Subsidiary, or is an Unrestricted Subsidiary, or that is accounted for by the equity method of accounting, shall be excluded; provided that Consolidated Net Income of the Issuer shall be increased by the amount of dividends or
distributions or other payments that are actually paid in cash or Cash Equivalents (or to the extent converted into cash or Cash Equivalents) to the referent Person or a Restricted Subsidiary thereof in respect of such period (without duplication
for purposes of Section 3.3 of any amounts included in Section 3.3(a)(C)(iv)(a)); 
 (5)
solely for the purpose of determining the amount available for Restricted Payments under Section 3.3(a)(C)(i), the Net Income for such period of any Restricted Subsidiary (other than any Subsidiary Guarantor) shall be excluded to the
extent the declaration or payment of dividends or similar distributions by that Restricted Subsidiary of its Net Income is not at the date of determination permitted without any prior governmental approval (which has not been obtained) or, directly
or indirectly, is otherwise restricted by the operation of the terms of its charter or any agreement, instrument, judgment, decree, order, statute, rule, or governmental regulation applicable to that Restricted Subsidiary or its stockholders, unless
such restriction with respect to the payment of dividends or similar distributions has been legally waived; provided that Consolidated Net Income of the Issuer shall be increased by the amount of dividends or other distributions or other
payments actually paid in cash (or to the extent converted into cash) to the Issuer or a Restricted Subsidiary thereof in respect of such period, to the extent not already included therein; 

  
 7 

 (6) effects of adjustments (including the effects of such adjustments pushed
down to the Issuer and its Restricted Subsidiaries) in such Person’s consolidated financial statements, including adjustments to the inventory, property and equipment, software and other intangible assets (including favorable and unfavorable
leases and contracts), deferred revenue and debt line items in such Person’s consolidated financial statements pursuant to GAAP resulting from the application of purchase accounting in relation to the Transactions or any consummated acquisition
or the amortization or write-off or write-down of any amounts thereof, net of taxes, shall be excluded; 
 (7)
any after-tax effect of income (loss) from the early extinguishment or cancellation of Indebtedness or Hedging Obligations or other derivative instruments shall be excluded; 

(8) any impairment charge, asset write-off or write-down, in each case pursuant to GAAP and the amortization of
intangibles and other assets arising pursuant to GAAP shall be excluded; 
 (9) any (i) non-cash
compensation charge or expense recorded from grants of stock appreciation or similar rights, stock options, restricted stock or other rights and (ii) income (loss) attributable to deferred compensation plans or trusts shall be excluded;

 (10) any fees and expenses incurred during such period, or any amortization thereof for such period, in
connection with any acquisition, Investment, Asset Sale, issuance or repayment of Indebtedness, issuance of Equity Interests, refinancing transaction or amendment or modification of any debt instrument (in each case, including any such transaction
consummated prior to the Issue Date and any such transaction undertaken but not completed) and any charges or non-recurring costs incurred during such period as a result of any such transaction shall be excluded; 

(11) accruals and reserves that are established within twelve months after the Issue Date that are so required to be
established as a result of the Transactions or the other transactions required by the Senior Credit Facility in accordance with GAAP, shall be excluded; 
 (12) any net unrealized gain or loss resulting from currency translation and gains or losses related to currency remeasurements of Indebtedness (including any unrealized net loss or gain resulting from
hedge agreements for currency exchange risk) shall be excluded; 
 (13) any net unrealized gains and losses
resulting from Hedging Obligations or embedded derivatives that require similar accounting treatment and the application of Accounting Standards Codification Topic 815 (“ASC 815”) and related pronouncements shall be excluded; and

 (14) any net after-tax effect of extraordinary gains or losses during such period in accordance with GAAP
shall be excluded. 

  
 8 

 In addition, to the extent not already included in the Net Income of such Person and its
Restricted Subsidiaries, notwithstanding anything to the contrary in the foregoing, Consolidated Net Income shall include the amount of proceeds received from business interruption insurance and reimbursements of any expenses and charges that are
covered by indemnification or other reimbursement provisions in connection with any Permitted Investment or any sale, conveyance, transfer or other disposition of assets permitted under the Indenture. 

Notwithstanding the foregoing, for the purpose of Section 3.3 only (other than Section 3.3(a)(C)(iv)), there
shall be excluded from Consolidated Net Income any income arising from any sale or other disposition of Restricted Investments made by the Issuer and its Restricted Subsidiaries, any repurchases and redemptions of Restricted Investments from the
Issuer and its Restricted Subsidiaries, any repayments of loans and advances which constitute Restricted Investments by the Issuer or any of its Restricted Subsidiaries, any sale of the stock of an Unrestricted Subsidiary or any distribution or
dividend from an Unrestricted Subsidiary, in each case only to the extent such amounts increase the amount of Restricted Payments permitted under Section 3.3(a)(C)(iv). 

“Consolidated Secured Debt Ratio” means, as of any date of determination, the ratio of (1) Consolidated Total
Indebtedness of the Issuer and its Restricted Subsidiaries that is secured by Liens as of the end of the most recent fiscal quarterly period for which internal financial statements are available immediately preceding the date on which such event for
which such calculation is being made shall occur to (2) the Issuer’s EBITDA for the most recently ended four full fiscal quarters for which internal financial statements are available immediately preceding the date on which such event for
which such calculation is being made shall occur, in each case with such pro forma adjustments to Consolidated Total Indebtedness and EBITDA as are appropriate and consistent with the pro forma adjustment provisions set forth in the definition of
Fixed Charge Coverage Ratio. 
 “Consolidated Total Indebtedness” means, as at any date of determination, an
amount equal to the sum of (1) the aggregate amount of all outstanding Indebtedness of the Issuer and its Restricted Subsidiaries on a consolidated basis consisting of Indebtedness for borrowed money, Obligations in respect of Capitalized Lease
Obligations and debt obligations evidenced by promissory notes and similar instruments, as determined in accordance with GAAP (excluding for the avoidance of doubt all undrawn amounts under revolving credit facilities and letters of credit and all
obligations relating to Qualified Securitization Financings) and (2) the aggregate amount of all outstanding Disqualified Stock of the Issuer and all Disqualified Stock and Preferred Stock of its Restricted Subsidiaries on a consolidated basis,
with the amount of such Disqualified Stock and Preferred Stock equal to the greater of their respective voluntary or involuntary liquidation preferences and maximum fixed repurchase prices, in each case determined on a consolidated basis in
accordance with GAAP (excluding the impact on Indebtedness resulting from the application of purchase accounting in connection with the Transactions or any acquisition). For purposes hereof, the “maximum fixed repurchase price” of any
Disqualified Stock or Preferred Stock that does not have a fixed repurchase price shall be calculated in accordance with the terms of such Disqualified Stock or Preferred Stock as if such Disqualified Stock or Preferred Stock were purchased on any
date on which Consolidated Total Indebtedness shall be required to be determined pursuant to the Indenture, and if such price is based upon, or measured by, the fair market value of such Disqualified Stock or Preferred Stock, such fair market value
shall be 

  
 9 

 
determined reasonably and in Good Faith by the Issuer. Consolidated Total Indebtedness shall be calculated net of all cash and Cash Equivalents of the Company and its Restricted Subsidiaries to
the extent that (i) the use of such cash and Cash Equivalents for application to payment of the obligations under the Notes is not prohibited by any contract or requirement of law and (ii) such cash and Cash Equivalents are free and clear
of all Liens (other than Liens in favor of the Notes and Liens permitted by clauses (2), (3), (23) and (33) of the definition of Permitted Liens); provided that the amount of such cash and Cash Equivalents shall not exceed $25.0
million. 
 “Contingent Obligations” means, with respect to any Person, any obligation of such Person
guaranteeing any leases, dividends or other obligations that do not constitute Indebtedness (“primary obligations”) of any other Person (the “primary obligor”) in any manner, whether directly or indirectly,
including, without limitation, any obligation of such Person, whether or not contingent, 
  

	 	(1)	to purchase any such primary obligation or any property constituting direct or indirect security therefor, 

 

	 	(2)	to advance or supply funds 

  

	 	(a)	for the purchase or payment of any such primary obligation, or 

  

	 	(b)	to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, or

  

	 	(3)	to purchase property, securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to
make payment of such primary obligation against loss in respect thereof. 

 “Corporate Trust
Office” means the office of the Trustee at which at any particular time its corporate trust business in relation to this Indenture shall be principally administered, which office at the date of execution of this Indenture is located at The
Bank of New York Mellon Trust Company, N.A., 2 N. LaSalle Street, Suite 1020, Chicago, IL 60602, Attn: Corporate Trust Administration, and for purposes of Section 2.3 such office shall also mean the office or agency of the Trustee located at 2
N. LaSalle St., Suite 1020, Chicago, IL 60602, Attn: Corporate Trust Administration or such other address as the Trustee may designate from time to time by notice to the Holders and the Issuer. 

“Custodian” means the Trustee, as custodian with respect to the Notes in global form, or any successor entity thereto.

 “Debt Facilities” means, with respect to the Issuer or any of its Restricted Subsidiaries, one or more debt
facilities, including the Senior Credit Facility, or other financing arrangements (including, without limitation, commercial paper facilities or indentures) providing for revolving credit loans, term loans, letters of credit or other indebtedness,
including any notes, mortgages, guarantees, collateral documents, instruments and agreements executed in connection therewith, and any amendments, supplements, modifications, extensions, renewals, restatements or refunding thereof and any indentures
or credit facilities or commercial paper facilities that 

  
 10 

 replace, refund or refinance any part of the loans, notes, other credit facilities or commitments
thereunder, including any such replacement, refunding or refinancing facility or indenture that increases the amount permitted to be borrowed thereunder or alters the maturity thereof (provided that such increase in borrowings is permitted
under Section 3.2) or adds Restricted Subsidiaries as additional borrowers or guarantors thereunder and whether by the same or any other agent, lender or investor or group of lenders or investors. 

“Default” means any event that is, or with the passage of time or the giving of notice or both would be, an Event of
Default; provided that any Default that results solely from the taking of an action that would have been permitted but for the continuation of a previous Default shall be deemed to be cured if such previous Default is cured prior to becoming
an Event of Default. 
 “Definitive Notes” means certificated Notes for which DTC is not the Holder.

 “Designated Non-cash Consideration” means the fair market value of non-cash consideration received by the
Issuer or a Restricted Subsidiary in connection with an Asset Sale that is so designated as Designated Non-cash Consideration pursuant to an Officer’s Certificate, setting forth the basis of such valuation, executed by the principal financial
officer of the Issuer, less the amount of cash or Cash Equivalents received in connection with a subsequent sale of or collection on such Designated Non-cash Consideration. 
 “Designated Preferred Stock” means Preferred Stock of the Issuer or any parent company thereof (in each case other than Disqualified Stock) that is issued for cash (other than to a
Restricted Subsidiary or an employee stock ownership plan or trust established by the Issuer or any of its Subsidiaries) and is so designated as Designated Preferred Stock, pursuant to an Officer’s Certificate executed by the principal
financial officer of the Issuer or the applicable parent company thereof, as the case may be, on the issuance date thereof, the cash proceeds of which are excluded from the calculation set forth in Section 3.3(a)(iv)(C). 

“Disqualified Stock” means, with respect to any Person, any Capital Stock of such Person which, by its terms, or by the
terms of any security into which it is convertible or for which it is putable or exchangeable, or upon the happening of any event, matures or is mandatorily redeemable (other than solely as a result of a change of control or asset sale) pursuant to
a sinking fund obligation or otherwise, or is redeemable at the option of the holder thereof (other than solely as a result of a change of control or asset sale), in whole or in part, in each case prior to the date 91 days after the earlier of the
maturity date of the Notes or the date the Notes are no longer outstanding; provided, however, that if such Capital Stock is issued to any plan for the benefit of employees of the Issuer or its Subsidiaries or by any such plan to such
employees, such Capital Stock shall not constitute Disqualified Stock solely because it may be required to be repurchased by the Issuer or its Subsidiaries in order to satisfy applicable statutory or regulatory obligations. 

“DTC” means The Depository Trust Company, its nominees and their respective successors and assigns, or such other
depository institution hereinafter appointed by the Issuer. 
 “EBITDA” means, with respect to any Person for
any period, the Consolidated Net Income of such Person for such period 

  
 11 

	 	(1)	increased (without duplication) by: 

  

	 	(a)	provision for taxes based on income, profits or capital, including, without limitation, state, local, franchise and similar taxes and foreign withholding taxes of such
Person paid or accrued during such period deducted (and not added back) in computing Consolidated Net Income; plus 

  

	 	(b)	Fixed Charges of such Person for such period (including costs of surety bonds in connection with financing activities), plus amounts excluded from the definition of
“Consolidated Interest Expense” pursuant to clauses (1)(u) through (1)(z) thereof, to the extent the same were deducted (and not added back) in calculating such Consolidated Net Income; plus 

 

	 	(c)	Consolidated Depreciation and Amortization Expense of such Person for such period to the extent the same were deducted (and not added back) in computing Consolidated
Net Income; plus 

  

	 	(d)	any expenses or charges (other than depreciation or amortization expense) related to any Equity Offering, Permitted Investment, acquisition, disposition,
recapitalization, restructuring, reorganization or the incurrence of Indebtedness permitted to be incurred by the Indenture (including a refinancing thereof) (whether or not successful), including 

(i) such fees, expenses or charges related to the Transactions and any Securitization Fees, and 

(ii) any amendment or other modification of the Notes, the Senior Credit Facility and any Securitization Fees, in each case, deducted
(and not added back) in computing Consolidated Net Income; plus 
  

	 	(e)	any other non-cash charges, expenses or losses reducing Consolidated Net Income for such period or any such charges, expenses or losses related to the Transactions,
excluding any such charge that represents an accrual or reserve for a cash expenditure for a future period; plus 

  

	 	(f)	the amount of management, monitoring, consulting and advisory fees (including termination fees) and related indemnities and expenses paid or accrued in such period to
the Sponsor to the extent otherwise permitted under Section 3.8; plus 

  

	 	(g)	 the amount of “run-rate” cost savings and synergies projected by the Issuer in good faith and certified by the chief financial officer of the
Issuer to be realized as a result of (I) specified actions taken during such period or (II) specified actions to be taken, which have been approved by the board of directors of the Issuer (calculated on a pro forma basis as though such cost
savings and synergies had been realized on the first day of such period), net of the amount of actual benefits realized during such period from such actions; provided that (A) the chief financial officer of the Issuer shall have

  
 12 

	 	certified that (x) such cost savings and synergies are reasonably identifiable, factually supportable and reasonably attributable to the actions specified and
reasonably anticipated to result from such actions and (y) such actions have been or will be taken and the benefits resulting therefrom are anticipated by the Issuer to be realized within 12 months of the Issue Date, (B) no cost savings or
synergies shall be added pursuant to this clause (g) to the extent duplicative of any expenses or charges relating to such cost savings or synergies that are included elsewhere in this definition with respect to such period or duplicative of
any pro forma adjustments made pursuant to the definition of “Fixed Charge Coverage Ratio” and (C) the aggregate amount of cost savings and synergies added pursuant to this clause (g) shall not exceed 12.5% of EBITDA for any
period of four consecutive fiscal quarters; plus 

  

	 	(h)	the amount of loss on sale of Securitization Assets and related assets to the Securitization Subsidiary in connection with a Qualified Securitization Financing; plus

  

	 	(i)	any costs or expense incurred by the Issuer or a Restricted Subsidiary pursuant to any management equity plan or stock option plan or any other management or employee
benefit plan or agreement or any stock subscription or shareholder agreement, to the extent that such cost or expenses are funded with cash proceeds contributed to the capital of the Issuer or net cash proceeds of an issuance of Equity Interest of
the Issuer (other than Disqualified Stock) solely to the extent that such net cash proceeds are excluded from the calculation set forth in Section 3.3(a)(C); plus 

 

	 	(j)	cash receipts (or any netting arrangements resulting in reduced cash expenditures) not representing EBITDA or Net Income in any period to the extent non-cash gains
relating to such income were deducted in the calculation of EBITDA pursuant to clause (2) below for any previous period and not added back; plus 

  

	 	(k)	any net loss included in the consolidated financial statements with respect to noncontrolling interests due to the application of Accounting Standards Codification
Topic 810, Consolidation (“ASC 810”); plus 

  

	 	(l)	rent expense as determined in accordance with GAAP not actually paid in cash during such period (net of rent expense paid in cash during such period over and above rent
expense as determined in accordance with GAAP); plus 

  

	 	(m)	realized foreign exchange losses resulting from the impact of foreign currency changes on the valuation of assets or liabilities on the balance sheet of the Issuer and
its Restricted Subsidiaries; plus 

  
 13 

	 	(n)	net realized losses from Hedging Obligations or embedded derivatives that require similar accounting treatment and the application of ASC 815 and related
pronouncements; plus 

  

	 	(o)	any non-cash impairment charge or asset write-off or write-down, including impairment charges or asset write-offs or write-downs related to intangible assets,
long-lived assets, investments in debt and equity securities or otherwise as a result of a change in law or regulation (including the amortization of the consideration for any non-competition agreements entered into in connection with the
Transactions); 

  

	 	(2)	decreased (without duplication) by: (a) non-cash gains increasing Consolidated Net Income of such Person for such period, excluding any non-cash gains to the
extent they represent the reversal of an accrual or reserve for a potential cash item that reduced EBITDA in any prior period and any non-cash gains with respect to cash actually received in a prior period so long as such cash did not increase
EBITDA in such prior period; plus (b) realized foreign exchange income or gains resulting from the impact of foreign currency changes on the valuation of assets or liabilities on the balance sheet of the Issuer and its Restricted Subsidiaries;
plus (c) any net realized income or gains from Hedging Obligations or embedded derivatives that require similar accounting treatment and the application of ASC 815 and related pronouncements, plus (d) any net income included in the
consolidated financial statements due to the application of ASC 810, plus (e) rent expense actually paid in cash during such period (net of rent expense paid in cash during such period in an amount equal to rent expense determined in accordance
with GAAP); and 

  

	 	(3)	increased or decreased by (without duplication), as applicable: (a) any adjustments resulting from the application of Accounting Standards Codification Topic 460
or any comparable regulation; (b) any net after-tax effect of non-recurring or unusual gains or losses, costs, charges or expenses (less all fees and expenses relating thereto) (including any such amounts relating to the Transactions to the
extent incurred on or prior to the date that is the one year anniversary of the Issue Date), severance, relocation costs and curtailments or modifications to pension and post-retirement employee benefit plans; and (c) any gains or losses
attributable to the extinguishment of any (1) Indebtedness or (2) Hedging Obligations or other derivative instruments of the Issuer or any Restricted Subsidiary. 

For the avoidance of doubt, EBITDA shall be calculated without regard to effects of adjustments pursuant to GAAP resulting from the
application of purchase accounting in relation to the Transactions or any acquisition permitted under the Indenture, including, without limitation, write-offs of acquired in-process research and development, amortization of inventory write-ups and
amortization of acquisition-related intangibles, write-offs of deferred revenue, any gain or loss attributable to the extinguishment of any (1) Indebtedness or (2) Hedging Obligations or other derivative instruments of the Issuer or any
Restricted Subsidiary. 

  
 14 

 “Equity Interests” means Capital Stock and all warrants, options or other
rights to acquire Capital Stock, but excluding any debt security that is convertible into, or exchangeable for, Capital Stock. 

“Equity Offering” means any public or private sale of common stock or Preferred Stock of the Issuer or any of its direct
or indirect parent companies (excluding Disqualified Stock), other than: 
 (1) public offerings with respect to the
Issuer’s or any direct or indirect parent company’s common stock registered on Form S-4 or Form S-8; 
 (2) issuances
to any Subsidiary of the Issuer; and 
 (3) any such public or private sale that constitutes an Excluded Contribution.

 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the
SEC promulgated thereunder. 
 “Exchange Notes” means any notes issued in exchange for Notes pursuant to the
Registration Rights Agreement or similar agreement. 
 “Excluded Contribution” means net cash proceeds,
marketable securities or Qualified Proceeds received by the Issuer from 
  

	 	(1)	contributions to its common equity capital, and 

  

	 	(2)	the sale (other than to a Subsidiary of the Issuer or to any management equity plan or stock option plan or any other management or employee benefit plan or agreement
of the Issuer) of Capital Stock (other than Disqualified Stock and Designated Preferred Stock) of the Issuer, 

 in each case
designated as Excluded Contributions pursuant to an Officer’s Certificate executed by the principal financial officer of the Issuer on the date such capital contributions are made or the date such Equity Interests are sold, as the case may be,
which are excluded from the calculation set forth in Section 3.3(a)(iv)(C). 
 “Fiscal Year” means
the fiscal year of the Issuer ending on December 31 of each year or such other date as the board of directors of the Issuer may approve. 
 “Fixed Charge Coverage Ratio” means, with respect to any Person for any period, the ratio of EBITDA of such Person for such period to the Fixed Charges of such Person for such period. In
the event that the Issuer or any Restricted Subsidiary incurs, assumes, guarantees, redeems, retires or extinguishes any Indebtedness (other than Indebtedness incurred under any revolving credit facility unless such indebtedness has been permanently
repaid and has not been replaced) or issues or redeems Disqualified Stock or Preferred Stock subsequent to the 

  
 15 

 commencement of the period for which the Fixed Charge Coverage Ratio is being calculated but prior to or
simultaneously with the event for which the calculation of the Fixed Charge Coverage Ratio is made (the “Fixed Charge Coverage Ratio Calculation Date”), then the Fixed Charge Coverage Ratio shall be calculated giving pro forma
effect to such incurrence, assumption, guarantee, redemption, retirement or extinguishment of Indebtedness, or such issuance or redemption of Disqualified Stock or Preferred Stock, as if the same had occurred at the beginning of the applicable
four-quarter period. 
 For purposes of making the computation referred to above, Investments, acquisitions, dispositions,
mergers, consolidations and discontinued operations (as determined in accordance with GAAP) that have been made by the Issuer or any of its Restricted Subsidiaries during the four-quarter reference period or subsequent to such reference period and
on or prior to or simultaneously with the Fixed Charge Coverage Ratio Calculation Date shall be calculated on a pro forma basis assuming that all such Investments, acquisitions, dispositions, mergers, consolidations and discontinued operations (and
the change in any associated fixed charge obligations and the change in EBITDA resulting therefrom) had occurred on the first day of the four-quarter reference period. If since the beginning of such period any Person that subsequently became a
Restricted Subsidiary or was merged with or into the Issuer or any of its Restricted Subsidiaries since the beginning of such period shall have made any Investment, acquisition, disposition, merger, consolidation or discontinued operations that
would have required adjustment pursuant to this definition, then the Fixed Charge Coverage Ratio shall be calculated giving pro forma effect thereto for such period as if such Investment, acquisition, disposition, merger, consolidation or
discontinued operations had occurred at the beginning of the applicable four-quarter period. 
 For purposes of this definition,
whenever pro forma effect is to be given to a transaction, the pro forma calculations shall be (x) made in good faith by the chief financial officer of the Issuer (and may include, for the avoidance of doubt, cost savings and operating expense
reductions resulting from such Investment, acquisition, merger or consolidation (including the Transactions) or discontinued operations which is being given pro forma effect that have been or are expected to be realized or (y) determined in
accordance with Regulation S-X. If any Indebtedness bears a floating rate of interest and is being given pro forma effect, the interest on such Indebtedness shall be calculated as if the rate in effect on the Fixed Charge Coverage Ratio Calculation
Date had been the applicable rate for the entire period (taking into account any Hedging Obligations applicable to such Indebtedness). Interest on a Capitalized Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by
a responsible financial or accounting officer of the Issuer to be the rate of interest implicit in such Capitalized Lease Obligation in accordance with GAAP. For purposes of making the computation referred to above, interest on any Indebtedness
under a revolving credit facility computed on a pro forma basis shall be computed based upon the average daily balance of such Indebtedness during the applicable period except as set forth in the first paragraph of this definition. Interest on
Indebtedness that may optionally be determined at an interest rate based upon a factor of a prime or similar rate, a eurocurrency interbank offered rate, or other rate, shall be deemed to have been based upon the rate actually chosen, or, if none,
then based upon such optional rate chosen as the Issuer may designate. 

  
 16 

 “Fixed Charges” means, with respect to any Person for any period, the sum
of: 
  

	 	(1)	Consolidated Interest Expense of such Person for such period; 

  

	 	(2)	all cash dividends or other distributions paid (excluding items eliminated in consolidation) on any series of Preferred Stock of Non-Guarantor Subsidiaries during such
period; and 

  

	 	(3)	all cash dividends or other distributions paid (excluding items eliminated in consolidation) on any series of Disqualified Stock during such period.

 “Foreign Subsidiary” means, with respect to any Person, any Restricted Subsidiary of such
Person that is not organized or existing under the laws of the United States, any state thereof, the District of Columbia, or any territory thereof and any Restricted Subsidiary of such Foreign Subsidiary. 

“GAAP” means generally accepted accounting principles in the United States which are in effect on the Issue Date.

 “Good Faith by the Issuer” means the decision in good faith by a responsible financial officer of the
Issuer; provided that (a) if such decision involves a determination of fair market value in excess of $2.0 million, the decision is made in good faith by the Senior Management of the Issuer and (b) if such decision involves a
determination of fair market value in excess of $15.0 million, the decision is made in good faith by the board of directors of the Issuer. 
 “Government Securities” means securities that are: 
  

	 	(1)	direct obligations of the United States of America for the timely payment of which its full faith and credit is pledged; or 

 

	 	(2)	obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of America the timely payment of which is
unconditionally guaranteed as a full faith and credit obligation by the United States of America, 

 which, in either case, are
not callable or redeemable at the option of the issuers thereof, and shall also include a depository receipt issued by a bank (as defined in Section 3(a)(2) of the Securities Act), as custodian with respect to any such Government Securities or
a specific payment of principal of or interest on any such Government Securities held by such custodian for the account of the holder of such depository receipt; provided that (except as required by law) such custodian is not authorized to
make any deduction from the amount payable to the holder of such depository receipt from any amount received by the custodian in respect of the Government Securities or the specific payment of principal of or interest on the Government Securities
evidenced by such depository receipt. 
 “guarantee” means a guarantee (other than by endorsement of negotiable
instruments for collection in the ordinary course of business), direct or indirect, in any manner (including letters of credit and reimbursement agreements in respect thereof), of all or any part of any Indebtedness or other obligations. 

  
 17 

 “Guarantee” means the guarantee by any Guarantor of the Issuer’s
Obligations under this Indenture and the Notes. 
 “Guarantor” means Parent and each Restricted Subsidiary that
provides a Guarantee of the Notes. 
 “Hedging Obligations” means, with respect to any Person, the obligations
of such Person under any interest rate swap agreement, interest rate cap agreement, interest rate collar agreement, commodity swap agreement, commodity cap agreement, commodity collar agreement, foreign exchange contract, currency swap agreement or
similar agreement providing for the transfer or mitigation of interest rate, commodity price or currency risks either generally or under specific contingencies. 
 “Holder” means the Person in whose name a Note is registered on the registrar’s books. 
 “IAI” means an institutional “accredited investor” as described in Rule 501(a)(1), (2), (3) or (7) under the Securities Act. 

“Indebtedness” means, with respect to any Person, without duplication: 

 

	 	(1)	any indebtedness (including principal and premium) of such Person, whether or not contingent: 

(a) in respect of borrowed money; 
 (b) evidenced by bonds, notes, debentures or similar instruments or letters of credit or bankers’ acceptances (or, without duplication, reimbursement agreements in respect thereof); 

(c) representing the balance of the deferred and unpaid purchase price of any property (including Capitalized Lease
Obligations), except (i) any such balance that constitutes an obligation in respect of a commercial letter of credit, a trade payable or similar obligation to a trade creditor, in each case accrued in the ordinary course of business (and with
respect to commercial letters of credit repaid in a timely manner) and (ii) any earn-out obligations until such obligation becomes a liability on the balance sheet of such Person in accordance with GAAP and is not paid after becoming due and
payable; or 
 (d) representing any net obligations under Hedging Obligations; 

if and to the extent that any of the foregoing Indebtedness (other than letters of credit and Hedging Obligations) would
appear as a liability upon a balance sheet (excluding the footnotes thereto) of such Person prepared in accordance with GAAP; 
  

	 	(2)	 to the extent not otherwise included, any obligation by such Person to be liable for, or to pay, as obligor, guarantor or otherwise, on the obligations
of the type referred to in clause (1) of a third Person (whether or not such items 

  
 18 

	 	would appear upon the balance sheet of such obligor or guarantor), other than by endorsement of negotiable instruments for collection in the ordinary course of
business; and 

  

	 	(3)	to the extent not otherwise included, the obligations of the type referred to in clause (1) of a third Person secured by a Lien on any asset owned by such first
Person, whether or not such Indebtedness is assumed by such first Person; 

 provided, however, that notwithstanding
the foregoing, Indebtedness shall be deemed not to include Contingent Obligations incurred in the ordinary course of business. For the avoidance of doubt, Indebtedness does not include Cash Management Services. 

“Indenture” means this Indenture, as amended or supplemented from time to time. 

“Independent Financial Advisor” means an independent accounting, appraisal, investment banking firm or consultant to
Persons engaged in Similar Businesses of nationally recognized standing that is, in the good faith judgment of the Issuer, qualified to perform the task for which it has been engaged. 

“Initial Notes” has the meaning ascribed to it in the second introductory paragraph of this Indenture. 

“Initial Purchasers” means J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated,
Morgan Stanley & Co. LLC and UBS Securities LLC. 
 “Interest Payment Date” means June 1 and
December 1 of each year to the Stated Maturity of the Notes. 
 “Investment Grade Rating” means a rating
equal to or higher than Baa3 (or the equivalent) by Moody’s and BBB- (or the equivalent) by S&P, or, in either case, an equivalent rating by any other Rating Agency. 
 “Investment Grade Securities” means: 
  

	 	(1)	securities issued or directly and fully guaranteed or insured by the United States government or any agency or instrumentality thereof (other than Cash Equivalents);

  

	 	(2)	debt securities or debt instruments with an Investment Grade Rating, but excluding any debt securities or instruments constituting loans or advances among the Issuer
and its Subsidiaries; 

  

	 	(3)	investments in any fund that invests exclusively in investments of the type described in clauses (1) and (2) which fund may also hold immaterial amounts of
cash pending investment or distribution; and 

  

	 	(4)	corresponding instruments in countries other than the United States customarily utilized for high quality investments. 

  
 19 

 “Investments” means, with respect to any Person, all investments by such
Person in other Persons (including Affiliates) in the form of loans (including guarantees), advances or capital contributions (excluding accounts receivable, credit card and debit card receivables, trade credit, advances to customers, commission,
travel and similar advances to officers and employees, in each case made in the ordinary course of business), purchases or other acquisitions for consideration of Indebtedness, Equity Interests or other securities issued by any other Person and
investments that are required by GAAP to be classified on the balance sheet (excluding the footnotes) of the Issuer in the same manner as the other investments included in this definition to the extent such transactions involve the transfer of cash
or other property. For purposes of the definition of “Unrestricted Subsidiary” and Section 3.3, 
 (1) “Investments” shall include the portion (proportionate to the Issuer’s equity interest in such Subsidiary) of the fair market value of the net assets of a Subsidiary of the Issuer at
the time that such Subsidiary is designated an Unrestricted Subsidiary; provided, however, that upon a redesignation of such Subsidiary as a Restricted Subsidiary, the Issuer shall be deemed to continue to have a permanent
“Investment” in an Unrestricted Subsidiary in an amount (if positive) equal to: 
  

	 	(a)	the Issuer’s “Investment” in such Subsidiary at the time of such redesignation; less 

 

	 	(b)	the portion (proportionate to the Issuer’s equity interest in such Subsidiary) of the fair market value of the net assets of such Subsidiary at the time of such
redesignation; and 

 (2) any property transferred to or from an Unrestricted Subsidiary shall be
valued at its fair market value at the time of such transfer, in each case as determined in Good Faith by the Issuer. 

“Issue Date” means June 6, 2012. 
 “Issuer” means Wolverine Healthcare Analytics, Inc. (and not any of its Subsidiaries) and its permitted successors. 

“Legal Holiday” means a Saturday, a Sunday or a day on which commercial banking institutions are not required to be open
in the State of New York. 
 “Lien” means, with respect to any asset, any mortgage, lien (statutory or
otherwise), pledge, hypothecation, charge, security interest, preference, priority or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law, including any conditional sale or
other title retention agreement, any lease in the nature thereof, any option or other agreement to sell or give a security interest in and any filing of or agreement to give any financing statement under the Uniform Commercial Code (or equivalent
statutes) of any jurisdiction; provided that in no event shall an operating lease be deemed to constitute a Lien. 

  
 20 

 “Moody’s” means Moody’s Investors Service, Inc. and any successor
to its rating agency business. 
 “Net Income” means, with respect to any Person, the net income (loss) of such
Person, determined in accordance with GAAP and before any reduction in respect of Preferred Stock dividends. 
 “Net
Proceeds” means the aggregate cash proceeds received by the Issuer or any of its Restricted Subsidiaries in respect of any Asset Sale, including any cash received upon the sale or other disposition of any Designated Non-cash Consideration
received in any Asset Sale, net of the direct costs relating to such Asset Sale and the sale or disposition of such Designated Non-cash Consideration, including legal, accounting and investment banking fees, and brokerage and sales commissions, any
relocation expenses incurred as a result thereof; taxes paid or payable as a result thereof (after taking into account any available tax credits or deductions and any tax sharing arrangements), amounts required to be applied to the repayment of
principal, premium, if any, and interest on Senior Indebtedness secured by a Lien on the assets disposed of required (other than required by Section 3.5(b)(1)) to be paid as a result of such transaction and any deduction of appropriate
amounts to be provided by the Issuer or any of its Restricted Subsidiaries as a reserve in accordance with GAAP against any liabilities associated with the asset disposed of in such transaction and retained by the Issuer or any of its Restricted
Subsidiaries after such sale or other disposition thereof, including pension and other post-employment benefit liabilities and liabilities related to environmental matters or against any indemnification obligations associated with such transaction.

 “Non-Guarantor Subsidiary” means any Restricted Subsidiary that is not a Guarantor. 

“Non-U.S. Person” means a Person who is not a U.S. Person (as defined in Regulation S). 

“Notes” has the meaning ascribed to it in the second introductory paragraph of this Indenture. 

“Notes Custodian” means the custodian with respect to the Global Notes (as appointed by DTC), or any successor Person
thereto and shall initially be the Trustee. 
 “Obligations” means any principal, interest (including any
interest accruing subsequent to the filing of a petition in bankruptcy, reorganization or similar proceeding at the rate provided for in the documentation with respect thereto, whether or not such interest is an allowed claim under applicable state,
federal or foreign law), premium, penalties, fees, indemnifications, reimbursements (including reimbursement obligations with respect to letters of credit and bankers’ acceptances), damages and other liabilities, and guarantees of payment of
such principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities, payable under the documentation governing any Indebtedness. 
 “Offering Memorandum” means the final offering memorandum dated May 24, 2012 relating to the offering by the Issuer of $327.15 million aggregate principal amount of Notes and any
future offering memorandum relating to Additional Notes. 

  
 21 

 “Officer” means the Chairman of the Board, the Chief Executive Officer, the
President, any Executive Vice President, Senior Vice President or Vice President, the Treasurer or the Secretary of the Issuer or any other Person, as the case may be. 
 “Officer’s Certificate” means a certificate signed on behalf of the Issuer by an Officer of the Issuer or on behalf of any other Person, as the case may be, who must be the principal
executive officer, the principal financial officer, the treasurer or the principal accounting officer of the Issuer or such other Person, that meets the requirements set forth in the Indenture. 

“Opinion of Counsel” means a written opinion from legal counsel who is reasonably acceptable to the Trustee and that
meets the requirements set forth in this Indenture. The counsel may be an employee of or counsel to the Issuer. 

“Parent” has the meaning ascribed to it in the first introductory paragraph of this Indenture. 

“Permitted Asset Swap” means the concurrent purchase and sale or exchange of Related Business Assets or a combination of
Related Business Assets and cash or Cash Equivalents between the Issuer or any of its Restricted Subsidiaries and another Person; provided that any cash or Cash Equivalent received must be applied in accordance with Section 3.5.

 “Permitted Holders” means the Sponsor and members of management of the Issuer (or its direct parent) who are
holders of Equity Interests of the Issuer (or any of its direct or indirect parent companies) on the Issue Date and any group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act or any successor provision) of
which any of the foregoing are members; provided that, in the case of such group and without giving effect to the existence of such group or any other group, the Sponsor and such members of management, collectively, have beneficial ownership
of more than 50% of the total voting power of the Voting Stock of the Issuer or any of its direct or indirect parent companies held by such group. Any Person or group whose acquisition of beneficial ownership constitutes a Change of Control in
respect of which a Change of Control Offer is made in accordance with the requirements of the Indenture shall thereafter, together with its Affiliates, constitute an additional Permitted Holder. 

“Permitted Investments” means 
  

	 	(1)	any Investment in the Issuer or any of its Restricted Subsidiaries; 

  

	 	(2)	any Investment in cash and Cash Equivalents or Investment Grade Securities; 

 

	 	(3)	any Investment by the Issuer or any of its Restricted Subsidiaries in a Person that is engaged in a Similar Business if as a result of such Investment:

 (a) such Person becomes a Restricted Subsidiary; or 

  
 22 

 (b) such Person, in one transaction or a series of related transactions, is
merged or consolidated with or into, or transfers or conveys substantially all of its assets to, or is liquidated into, the Issuer or a Restricted Subsidiary, 
 and, in each case, any Investment held by such Person; provided that such Investment was not acquired by such Person in contemplation of such acquisition, merger, consolidation or transfer;

  

	 	(4)	any Investment in securities or other assets not constituting cash, Cash Equivalents or Investment Grade Securities and received in connection with an Asset Sale made
pursuant to the provisions of Section 3.5 or any other disposition of assets not constituting an Asset Sale; 

  

	 	(5)	any Investment existing on the Issue Date and any extension, modification, replacement or renewal of any such Investments existing on the Issue Date, but only to the
extent not involving additional advances, contributions or other Investments of cash or other assets or other increases thereof other than as a result of the accrual or accretion of interest or original issue discount or the issuance of pay-in-kind
securities, in each case, pursuant to the terms of such Investment as in effect on the Issue Date (or as subsequently amended or otherwise modified in a manner not disadvantageous to the Holders of the Notes in any material respect);

  

	 	(6)	any Investment acquired by the Issuer or any of its Restricted Subsidiaries: 

(a) in exchange for any other Investment or accounts receivable held by the Issuer or any such Restricted Subsidiary in
connection with or as a result of a bankruptcy, workout, reorganization or recapitalization of the issuer of such other Investment or accounts receivable; or 
 (b) as a result of a foreclosure by the Issuer or any of its Restricted Subsidiaries with respect to any secured Investment or other transfer of title with respect to any secured Investment in default;

  

	 	(7)	Hedging Obligations permitted under Section 3.2(b)(10); 

  

	 	(8)	Investments the payment for which consists of Equity Interests (exclusive of Disqualified Stock) of the Issuer, or any of its direct or indirect parent companies;
provided, however, that such Equity Interests shall not increase the amount available for Restricted Payments under Section 3.3(a)(C); 

  

	 	(9)	guarantees of Indebtedness permitted under Section 3.2; 

  

	 	(10)	any transaction to the extent it constitutes an Investment that is permitted and made in accordance with Section 3.8(b) (except transactions permitted by
clauses (2), (5), (9), (11) and (15) of Section 3.8(b)); 

  
 23 

	 	(11)	Investments consisting of purchases, acquisitions or licensing of inventory, supplies, material, software, intellectual property or equipment; 

 

	 	(12)	additional Investments having an aggregate fair market value, taken together with all other Investments made pursuant to this clause (13) that are at that time
outstanding (without giving effect to the sale of an Unrestricted Subsidiary to the extent the proceeds of such sale do not consist of cash or marketable securities), not to exceed the greater of (x) $25.0 million and (y) 1.50% of Total
Assets at the time of such Investment (with the fair market value of each Investment being measured at the time made and without giving effect to subsequent changes in value); 

 

	 	(13)	Investments relating to a Securitization Subsidiary that, in the good faith determination of the Issuer are necessary or advisable to effect any Qualified
Securitization Financing; 

  

	 	(14)	advances to, or guarantees of Indebtedness of, officers, directors and employees not in excess of $6.0 million outstanding at any one time, in the aggregate;

  

	 	(15)	loans and advances to officers, directors and employees for business-related travel expenses, moving expenses and other similar expenses, in each case incurred in the
ordinary course of business or consistent with past practices or to fund such Person’s purchase of Equity Interests of the Issuer or any direct or indirect parent company thereof; 

 

	 	(16)	Investments consisting of licensing of intellectual property pursuant to joint marketing arrangements with other Persons; 

 

	 	(17)	contributions to a “rabbi” trust for the benefit of employees within the meaning of Revenue Procedure 92-64 or other grantor trust subject to the claims of
creditors in the case of a bankruptcy of the Issuer; 

  

	 	(18)	Investments in securities of trade creditors or customers received pursuant to any plan of reorganization or similar arrangement upon the bankruptcy or insolvency of
such trade creditor or customer; and 

  

	 	(19)	stock, obligations or securities received in settlement of debts created in the ordinary course of business and owing to the Issuer or any Restricted Subsidiary or in
satisfaction of judgments. 

 “Permitted Liens” means, with respect to any Person: 

(1) pledges or deposits by such Person under workmen’s compensation laws, unemployment insurance laws or similar
legislation, or good faith deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness) or leases to which such Person is a party, or deposits to secure public or statutory obligations of such Person or deposits
of cash or U.S. government bonds to secure surety or appeal bonds to which such Person is a party, or deposits as security for contested taxes or import duties or for the payment of rent, in each case incurred in the ordinary course of business;

  
 24 

 (2) Liens imposed by law, such as carriers’, warehousemen’s,
materialmen’s, repairmen’s and mechanics’ Liens, in each case for sums not yet overdue for a period of more than 60 days or being contested in good faith by appropriate proceedings or other Liens arising out of judgments or awards
against such Person with respect to which such Person shall then be proceeding with an appeal or other proceedings for review if adequate reserves with respect thereto are maintained on the books of such Person in accordance with GAAP; 

(3) Liens for taxes, assessments or other governmental charges not yet overdue for a period of more than 30 days or which
are being contested in good faith by appropriate proceedings diligently conducted, if adequate reserves with respect thereto are maintained on the books of such Person in accordance with GAAP, or for property taxes on property that the Issuer or one
of its Subsidiaries has determined to abandon if the sole recourse for such tax, assessment, charge, levy or claims is to such property; 
 (4) Liens in favor of issuers of performance, surety, bid, indemnity, warranty, release, appeal or similar bonds or with respect to other regulatory requirements or letters of credit or bankers’
acceptances issued, and completion guarantees provided for, in each case pursuant to the request of and for the account of such Person in the ordinary course of its business; 

(5) minor survey exceptions, minor encumbrances, ground leases, easements or reservations of, or rights of others for,
licenses, rights-of-way, servitudes, sewers, electric lines, drains, telegraph and telephone and cable television lines, gas and oil pipelines and other similar purposes, or zoning, building codes or other restrictions (including, without
limitation, minor defects or irregularities in title and similar encumbrances) as to the use of real properties or Liens incidental, to the conduct of the business of such Person or to the ownership of its properties which were not incurred in
connection with Indebtedness and which do not in the aggregate materially impair their use in the operation of the business of such Person; 
 (6) Liens securing Indebtedness permitted to be incurred pursuant to Section 3.2(b)(4) or Section 3.2(b)(21); provided that Liens securing Indebtedness permitted to be
incurred pursuant to Section 3.2(b)(21) extend only to the assets of Foreign Subsidiaries; 
 (7)
Liens existing on the Issue Date (with the exception of Liens securing the Senior Credit Facility, on the Issue Date, which shall be deemed incurred pursuant to clause (33) of this definition); 

(8) Liens on property or shares of stock of a Person at the time such Person becomes a Subsidiary; provided, however,
such Liens are not created or incurred in connection with, or in contemplation of, such other Person becoming such a Subsidiary; provided, further, however, that such Liens may not extend to any other property owned by the Issuer or any
of its Restricted Subsidiaries; 

  
 25 

 (9) Liens on property at the time the Issuer or a Restricted Subsidiary
acquired the property, including any acquisition by means of a merger or consolidation with or into the Issuer or any of its Restricted Subsidiaries; provided, however, that such Liens are not created or incurred in connection with, or in
contemplation of, such acquisition, merger or consolidation; provided, further, however, that the Liens may not extend to any other property owned by the Issuer or any of its Restricted Subsidiaries; 

(10) Liens securing Indebtedness or other obligations of a Restricted Subsidiary owing to the Issuer or another Restricted
Subsidiary permitted to be incurred in accordance with Section 3.2; 
 (11) Liens securing Hedging
Obligations and Cash Management Services so long as related Indebtedness is, and is permitted to be under the Indenture, secured by a Lien on the same property securing such Hedging Obligations; 

(12) Liens on specific items of inventory or other goods and proceeds of any Person securing such Person’s
obligations in respect of bankers’ acceptances issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods; 

(13) leases, subleases, licenses or sublicenses granted to others in the ordinary course of business which do not
materially interfere with the ordinary conduct of the business of the Issuer or any of its Restricted Subsidiaries and do not secure any Indebtedness; 
 (14) Liens arising from Uniform Commercial Code financing statement filings regarding operating leases or consignments entered into by the Issuer and its Restricted Subsidiaries in the ordinary course of
business; 
 (15) Liens in favor of the Issuer or any Subsidiary Guarantor; 

(16) Liens on equipment of the Issuer or any of its Restricted Subsidiaries granted in the ordinary course of business to
the Issuer’s clients; 
 (17) Liens on Securitization Assets and related assets incurred in connection with
a Qualified Securitization Financing; 
 (18) Liens to secure any refinancing, refunding, extension, renewal or
replacement (or successive refinancing, refunding, extensions, renewals or replacements) as a whole, or in part, of any Indebtedness secured by any Lien referred to in the foregoing clauses (7), (8) and (9); provided, however,
that (a) such new Lien shall be limited to all or part of the same property that secured the original Lien (plus improvements on such property), and (b) the Indebtedness secured by such Lien at such time is not increased to any amount
greater than the sum of (i) the outstanding principal amount or, if greater, committed amount of the Indebtedness described under clauses (7), (8) and (9) at the time the original Lien became a Permitted Lien under the Indenture, and
(ii) an amount necessary to pay any fees and expenses, including premiums, related to such refinancing, refunding, extension, renewal or replacement; 

  
 26 

 (19) deposits made or other security provided to secure liabilities to
insurance carriers under insurance or self-insurance arrangements in the ordinary course of business; 
 (20)
other Liens securing obligations incurred in the ordinary course of business which obligations do not exceed $15.0 million at any one time outstanding; 
 (21) Liens securing judgments for the payment of money not constituting an Event of Default under Section 6.1(5) so long as such Liens are adequately bonded and any appropriate legal
proceedings that may have been duly initiated for the review of such judgment have not been finally terminated or the period within which such proceedings may be initiated has not expired; 

(22) Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in
connection with the importation of goods in the ordinary course of business; 
 (23) Liens (i) of a
collection bank arising under Section 4-210 of the Uniform Commercial Code on items in the course of collection, (ii) attaching to commodity trading accounts or other commodity brokerage accounts incurred in the ordinary course of
business, and (iii) in favor of banking institutions arising as a matter of law encumbering deposits (including the right of set-off) and which are within the general parameters customary in the banking industry; 

(24) Liens deemed to exist in connection with Investments in repurchase agreements permitted under
Section 3.2; provided that such Liens do not extend to any assets other than those that are the subject of such repurchase agreement; 
 (25) Liens encumbering reasonable customary initial deposits and margin deposits and similar Liens attaching to commodity trading accounts or other brokerage accounts incurred in the ordinary course of
business and not for speculative purposes; 
 (26) Liens that are contractual rights of setoff (i) relating
to the establishment of depository relations with banks not given in connection with the issuance of Indebtedness, (ii) relating to pooled deposit or sweep accounts of the Issuer or any of its Restricted Subsidiaries to permit satisfaction of
overdraft or similar obligations incurred in the ordinary course of business of the Issuer and its Restricted Subsidiaries or (iii) relating to purchase orders and other agreements entered into with customers of the Issuer or any of its
Restricted Subsidiaries in the ordinary course of business; 
 (27) Liens solely on any cash earnest money
deposits made by the Issuer or any of its Restricted Subsidiaries in connection with any letter of intent or purchase agreement permitted under the Indenture; 
 (28) the rights reserved or vested in any Person by the terms of any lease, license, franchise, grant or permit held by the Issuer or any of its Restricted Subsidiaries or by a statutory provision, to
terminate any such lease, license, franchise, grant or permit, or to require annual or periodic payments as a condition to the continuance thereof; 

  
 27 

 (29) restrictive covenants affecting the use to which real property may be
put; provided, however, that the covenants are complied with; 
 (30) security given to a public utility
or any municipality or governmental authority when required by such utility or authority in connection with the operations of that Person in the ordinary course of business; 

(31) zoning by-laws and other land use restrictions, including, without limitation, site plan agreements, development
agreements and contract zoning agreements; 
 (32) Liens arising out of conditional sale, title retention,
consignment or similar arrangements for sale of goods entered into by the Issuer or any Restricted Subsidiary in the ordinary course of business; and 
 (33) Liens securing Indebtedness permitted to be incurred under Debt Facilities, including any letter of credit facility relating thereto, that was permitted by the terms of the Indenture to be incurred
pursuant to Section 3.2(b)(1). 
 For purposes of this definition, the term “Indebtedness” shall be deemed to include
interest on such Indebtedness. 
 “Person” means any individual, corporation, limited liability company,
partnership, joint venture, association, joint stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. 

“Predecessor Note” of any particular Note means every previous Note evidencing all or a portion of the same debt as that
evidenced by such particular Note; and, for the purposes of this definition, any Note authenticated and delivered under Section 2.10 in exchange for or in lieu of a mutilated, destroyed, lost or stolen Note shall be deemed to evidence
the same debt as the mutilated, destroyed, lost or stolen Note. 
 “Preferred Stock” means any Equity Interest
with preferential rights of payment of dividends or upon liquidation, dissolution, or winding up. 
 “Purchase
Agreement” means the Stock and Asset Purchase Agreement, dated as of April 23, 2012, among Thomson Reuters U.S. Inc., Thomson Reuters Global Resources and VCPH Holding Corp., as the same may be amended prior to the Issue Date.

 “Qualified Proceeds” means assets that are used or useful in, or Capital Stock of any Person engaged in, a
Similar Business; provided that the fair market value of any such assets or Capital Stock shall be determined in Good Faith by the Issuer 
 “Qualified Securitization Financing” means any Securitization Facility of a Securitization Subsidiary that meets the following conditions: (i) the board of managers or directors of
the Issuer shall have determined in good faith that such Qualified Securitization Financing (including financing terms, covenants, termination events and other provisions) is in the aggregate economically fair and reasonable to the Issuer and its
Restricted Subsidiaries, (ii) all sales of Securitization Assets and related assets by the Issuer or any Restricted Subsidiary to the 

  
 28 

 Securitization Subsidiary or any other Person are made at fair market value (as determined in Good Faith by
the Issuer), (iii) the financing terms, covenants, termination events and other provisions thereof shall be market terms (as determined in good faith by the Issuer) and may include Standard Securitization Undertakings and (iv) the
Obligations under such Securitization Facility are non-recourse (except for customary representations, warranties, covenants and indemnities made in connection with such facilities) to the Issuer or any of its Restricted Subsidiaries (other than a
Securitization Subsidiary). The grant of a security interest in any Securitization Assets of the Issuer or any of its Restricted Subsidiaries (other than a Securitization Subsidiary) to secure Indebtedness under the Senior Credit Facility shall not
be deemed a Qualified Securitization Financing. 
 “QIB” means any “qualified institutional buyer” as
such term is defined in Rule 144A. 
 “Rating Agencies” means Moody’s and S&P or if Moody’s or
S&P or both shall not make a rating on the Notes publicly available, a nationally recognized statistical rating agency or agencies, as the case may be, selected by the Issuer which shall be substituted for Moody’s or S&P or both, as the
case may be. 
 “Registration Rights Agreement” means (i) the Registration Rights Agreement related to the
Notes dated as of the Issue Date, among the Issuer, the Guarantors and the Initial Purchasers, as amended or supplemented, and (ii) any other registration rights agreement entered into in connection with the issuance of Additional Notes in a
private offering by the Issuer after the Issue Date. 
 “Regulation S” means Regulation S under the Securities
Act. 
 “Regulation S-X” means Regulation S-X under the Securities Act. 

“Related Business Assets” means assets (other than cash or Cash Equivalents) used or useful in a Similar Business,
provided that any assets received by the Issuer or a Restricted Subsidiary in exchange for assets transferred by the Issuer or a Restricted Subsidiary shall not be deemed to be Related Business Assets if they consist of securities of a Person,
unless upon receipt of the securities of such Person, such Person would become a Restricted Subsidiary. 
 “Restricted
Investment” means an Investment other than a Permitted Investment. 
 “Restricted Notes” means Initial
Notes and Additional Notes bearing one of the restrictive legends described in Section 2.1(d). 

“Restricted Notes Legend” means the legend set forth in Section 2.1(d)(1) and, in the case of the Temporary
Regulation S Global Note, the legend set forth in Section 2.1(d)(2). 
 “Restricted Subsidiary”
means, at any time, any direct or indirect Subsidiary of the Issuer (including any Foreign Subsidiary) that is not then an Unrestricted Subsidiary; provided, however, that upon the occurrence of an Unrestricted Subsidiary ceasing to be an
Unrestricted Subsidiary, such Subsidiary shall be included in the definition of “Restricted Subsidiary.” 

  
 29 

 “Rule 144A” means Rule 144A under the Securities Act. 

“S&P” means Standard & Poor’s, a division of The McGraw-Hill Companies, Inc., and any successor to its
rating agency business. 
 “Sale and Lease-Back Transaction” means any arrangement providing for the leasing by
the Issuer or any of its Restricted Subsidiaries of any real or tangible personal property, which property has been or is to be sold or transferred by the Issuer or such Restricted Subsidiary to a third Person in contemplation of such leasing.

 “SEC” means the U.S. Securities and Exchange Commission. 

“Secured Indebtedness” means any Indebtedness of the Issuer or any of its Restricted Subsidiaries secured by a Lien.

 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the SEC
promulgated thereunder. 
 “Securitization Asset” means any accounts receivable, real estate asset, mortgage
receivables or related assets, in each case subject to a Securitization Facility. 
 “Securitization Facility”
means any of one or more securitization financing facilities as amended, supplemented, modified, extended, renewed, restated or refunded from time to time, pursuant to which the Issuer or any of its Restricted Subsidiaries sells its Securitization
Assets to either (a) a Person that is not a Restricted Subsidiary or (b) a Securitization Subsidiary that in turn sells Securitization Assets to a Person that is not a Restricted Subsidiary. 

“Securitization Fees” means distributions or payments made directly or by means of discounts with respect to any
Securitization Asset or participation interest therein issued or sold in connection with, and other fees paid to a Person that is not a Restricted Subsidiary in connection with, any Qualified Securitization Financing. 

“Securitization Repurchase Obligation” means any obligation of a seller of Securitization Assets in a Qualified
Securitization Financing to repurchase Securitization Assets arising as a result of a breach of a representation, warranty or covenant or otherwise, including, without limitation, as a result of a receivable or portion thereof becoming subject to
any asserted defense, dispute, off set or counterclaim of any kind as a result of any action taken by, any failure to take action by or any other event relating to the seller. 
 “Securitization Subsidiary” means any Subsidiary in each case formed for the purpose of and that solely engages in one or more Qualified Securitization Financings and other activities
reasonably related thereto. 
 “Senior Credit Facility” means the Debt Facility under the Credit Agreement to
be entered into as of the Issue Date by and among the Issuer, the lenders party thereto in their capacities as lenders thereunder and JPMorgan Chase Bank, N.A., as Administrative Agent, including any guarantees, collateral documents, instruments and
agreements executed in connection therewith, and any amendments, supplements, modifications, extensions, renewals, 

  
 30 

 restatements, refundings or refinancings thereof and any indentures or credit facilities or commercial paper
facilities with banks or other institutional lenders or investors that replace, refund or refinance any part of the loans, notes, other credit facilities or commitments thereunder, including any such replacement, refunding or refinancing facility or
indenture that increases the amount borrowable thereunder or alters the maturity thereof (provided that such increase in borrowings is permitted under Section 3.2). 

“Senior Indebtedness” means: 
  

	 	(1)	all Indebtedness of the Issuer or any Subsidiary Guarantor outstanding under the Senior Credit Facility or the Notes and related Guarantees (including interest accruing
on or after the filing of any petition in bankruptcy or similar proceeding or for reorganization of the Issuer or any Guarantor (at the rate provided for in the documentation with respect thereto, regardless of whether or not a claim for post-filing
interest is allowed in such proceedings)), and any and all other fees, expense reimbursement obligations, indemnification amounts, penalties, and other amounts (whether existing on the Issue Date or thereafter created or incurred) and all
obligations of the Issuer or any Subsidiary Guarantor to reimburse any bank or other Person in respect of amounts paid under letters of credit, acceptances or other similar instruments; 

 

	 	(2)	all Hedging Obligations (and guarantees thereof) owing to a Lender (as defined in the Senior Credit Facility) or any Affiliate of such Lender (or any Person that was a
Lender or an Affiliate of such Lender at the time the applicable agreement giving rise to such Hedging Obligation was entered into); provided that such Hedging Obligations are permitted to be incurred under the terms of the Indenture;

  

	 	(3)	any other Indebtedness of the Issuer or any Subsidiary Guarantor permitted to be incurred under the terms of the Indenture, unless the instrument under which such
Indebtedness is incurred expressly provides that it is subordinated in right of payment to the Notes or any related Guarantee; and 

  

	 	(4)	all Obligations with respect to the items listed in the preceding clause (1), (2) and (3); provided, however, that Senior Indebtedness shall not include:

  

	 	(a)	any obligation of such Person to the Issuer or any of its Subsidiaries; 

  

	 	(b)	any liability for federal, state, local or other taxes owed or owing by such Person; 

 

	 	(c)	any accounts payable or other liability to trade creditors arising in the ordinary course of business; 

 

	 	(d)	any Indebtedness or other Obligation of such Person which is subordinate or junior in any respect to any other Indebtedness or other Obligation of such person; or

  

	 	(e)	that portion of any Indebtedness which at the time of incurrence is incurred in violation of the Indenture. 

  
 31 

 “Senior Management” means the Chief Executive Officer and the Chief
Financial Officer of the Issuer. 
 “Shelf Registration Statement” shall have the meaning set forth in the
Registration Rights Agreement. 
 “Significant Subsidiary” means any Restricted Subsidiary that would be a
“significant subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such regulation is in effect on the Issue Date. 

“Similar Business” means any business conducted or proposed to be conducted by the Issuer and its Restricted
Subsidiaries on the Issue Date or any business that is similar, reasonably related, incidental or ancillary thereto. 

“Sponsor” means The Veritas Capital Fund IV, L.P., and each of its Affiliates but not including, however, any portfolio
companies of any of the foregoing. 
 “Sponsor Management Agreement” means the management agreement between
certain of the management companies associated with the Sponsor and the Issuer. 
 “Standard Securitization
Undertakings” means representations, warranties, covenants and indemnities entered into by the Issuer or any Subsidiary of the Issuer which the Issuer has determined in good faith to be customary in a Securitization Financing, including,
without limitation, those relating to the servicing of the assets of a Securitization Subsidiary, it being understood that any Securitization Repurchase Obligation shall be deemed to be a Standard Securitization Undertaking. 

“Stated Maturity” means, with respect to any Obligation, the date specified in such Obligation as the fixed date on
which the payment of principal of such Obligation is due and payable, including pursuant to any mandatory redemption provision, but shall not include any date on which the payment of principal of such Obligation is due and payable as a result of any
contingent obligations to repay, redeem or repurchase any such principal prior to the date originally scheduled for the payment thereof. 
 “Subordinated Indebtedness” means: 
 (1) any Indebtedness of the
Issuer which is by its terms subordinated in right of payment to the Notes, and 
 (2) any Indebtedness of any Subsidiary
Guarantor which is by its terms subordinated in right of payment to the Guarantee of such entity of the Notes. 

  
 32 

 “Subsidiary” means, with respect to any Person: 

(1) any corporation, association, or other business entity (other than a partnership, joint venture, limited liability
company or similar entity) of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time
of determination owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof or is consolidated under GAAP with such Person at such time; and 

(2) any partnership, joint venture, limited liability company or similar entity of which 

(x) more than 50% of the capital accounts, distribution rights, total equity and voting interests or general or limited partnership
interests, as applicable, are owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof whether in the form of membership, general, special or limited partnership or
otherwise, and 
 (y) such Person or any Restricted Subsidiary of such Person is a controlling general partner or otherwise
controls such entity. 
 “Subsidiary Guarantee” means the guarantee by any Subsidiary Guarantor of the
Issuer’s Obligations under the Indenture and the Notes. 
 “Total Assets” means, as of any date,
the total consolidated assets of the Issuer and its Restricted Subsidiaries on a consolidated basis, as shown on the most recent consolidated balance sheet of the Issuer and its Restricted Subsidiaries, determined on a pro forma basis in a manner
consistent with the pro forma basis contained in the definition of Fixed Charge Coverage Ratio. 

“Transactions” means the Acquisition, the issuance of the Notes and borrowings under the Senior Credit Facility as in
effect on the Issue Date. 
 “Treasury Rate” means, as of any Redemption Date, the yield to maturity as of such
Redemption Date of United States Treasury securities with a constant maturity (as compiled and published in the most recent Federal Reserve Statistical Release H.15 (519) that has become publicly available at least two Business Days prior to
the Redemption Date (or, if such Statistical Release is no longer published, any publicly available source of similar market data)) most nearly equal to the period from the Redemption Date to June 1, 2016; provided, however, that if the
period from the Redemption Date to June 1, 2016 is less than one year, the weekly average yield on actually traded United States Treasury securities adjusted to a constant maturity of one year shall be used. 

“Trust Indenture Act” or “TIA” means the Trust Indenture Act of 1939, as amended (15 U.S.C.
§§ 77aaa-777bbbb). 
 “Trustee” means the party named as such in this Indenture until a successor
replaces it in accordance with the terms of this Indenture and, thereafter, means the successor. 

  
 33 

 “Trust Officer” shall mean, when used with respect to the Trustee, any
corporate trust officer or any other officer or assistant officer of the Trustee customarily performing functions similar to those performed by the persons who at the time shall be such corporate trust officers who shall have direct responsibility
for the administration of this Indenture at the Corporate Trust Office, or any other officer of the Trustee to whom any corporate trust matter is referred because of his or her knowledge of and familiarity with the particular subject and who shall
have direct responsibility for the administration of this Indenture. 
 “Unrestricted Subsidiary” means:

 (1) any Subsidiary of the Issuer, which at the time of determination is an Unrestricted Subsidiary (as
designated by the Issuer, as provided below); and 
 (2) any Subsidiary of an Unrestricted Subsidiary.

 The Issuer may designate any Subsidiary of the Issuer (including any existing Subsidiary and any newly acquired or newly
formed Subsidiary) to be an Unrestricted Subsidiary unless such Subsidiary or any of its Subsidiaries owns any Equity Interests or Indebtedness of, or owns or holds any Lien on, any property of, the Issuer or any Subsidiary of the Issuer (other than
solely any Subsidiary of the Subsidiary to be so designated); provided that 
  

	 	(1)	any Unrestricted Subsidiary must be an entity of which the Equity Interests entitled to cast at least a majority of the votes that may be cast by all Equity Interests
having ordinary voting power for the election of directors or Persons performing a similar function are owned, directly or indirectly, by the Issuer, 

  

	 	(2)	such designation complies with Section 3.3, and 

  

	 	(3)	each of: 

  

	 	(a)	the Subsidiary to be so designated; and 

  

	 	(b)	its Subsidiaries 

 has not at the time of
designation, and does not thereafter, create, incur, issue, assume, guarantee or otherwise become directly or indirectly liable with respect to any Indebtedness pursuant to which the lender has recourse to any of the assets of the Issuer or any
Restricted Subsidiary. 
 The Issuer may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; provided that,
immediately after giving effect to such designation no Default or Event of Default shall have occurred and be continuing and the Issuer or the relevant Restricted Subsidiary would be able to incur such Indebtedness pursuant to
Section 3.2 on a pro forma basis taking into account such designation. 
 Any such designation by the Issuer shall
be notified by the Issuer to the Trustee by promptly filing with the Trustee a copy of the resolution of the board of directors of the Issuer or any committee thereof giving effect to such designation and an Officer’s Certificate certifying
that such designation complied with the foregoing provisions. 

  
 34 

 “Voting Stock” of any Person as of any date means the Capital Stock of such
Person that is at the time entitled to vote in the election of the board of directors of such Person. 
 “Weighted
Average Life to Maturity” means, when applied to any Indebtedness, Disqualified Stock or Preferred Stock, as the case may be, at any date, the quotient obtained by dividing 

(1) the sum of the products of the number of years from the date of determination to the date of each successive scheduled
principal payment of such Indebtedness or redemption or similar payment with respect to such Disqualified Stock or Preferred Stock multiplied by the amount of such payment; by 

(2) the sum of all such payments. 
 “Wholly-Owned Subsidiary” of any Person means a Subsidiary of such Person, 100% of the outstanding Equity Interests of which (other than directors’ qualifying shares) shall at the
time be owned by such Person or by one or more Wholly-Owned Subsidiaries of such Person. 
 SECTION 1.2. Other
Definitions. 
  

					
	 	  	Defined in	 
	 Term
	  	Section	 
	 “Acceptable Commitment”
	  	 	3.5	(b) 
	 “Additional Restricted Notes”
	  	 	2.1	(b) 
	 “Affiliate Transaction”
	  	 	3.8	  
	 “Agent Members”
	  	 	2.1	(e)(iii) 
	 “Application Period”
	  	 	3.5	(b) 
	 “Asset Sale Offer”
	  	 	3.5	(b) 
	 “Authenticating Agent”
	  	 	2.2	  
	 “Automatic Exchange”
	  	 	2.6	(e) 
	 “Automatic Exchange Date”
	  	 	2.6	(e) 
	 “Automatic Exchange Notice”
	  	 	2.6	(e) 
	 “Automatic Exchange Notice Date”
	  	 	2.6	(e) 
	 “Change of Control Offer”
	  	 	3.10	  

  
 35 

					
	 	  	Defined in	 
	 Term
	  	Section	 
	 “Change of Control Payment”
	  	 	3.10	  
	 “Change of Control Payment Date”
	  	 	3.10	(a)(2) 
	 “Clearstream”
	  	 	2.1	(b) 
	 “Covenant Defeasance”
	  	 	8.3	  
	 “Defaulted Interest”
	  	 	2.14	  
	 “Euroclear”
	  	 	2.1	(b) 
	 “Event of Default”
	  	 	6.1	  
	 “Excess Proceeds”
	  	 	3.5	(b) 
	 “Exchange Global Note”
	  	 	2.1	(b) 
	 “Global Notes”
	  	 	2.1	(b) 
	 “Guaranteed Obligations”
	  	 	10.1	  
	 “incur”
	  	 	3.2	(a) 
	 “incurrence”
	  	 	3.2	(a) 
	 “Initial Lien”
	  	 	3.6	  
	 “Institutional Accredited Investor Global Note”
	  	 	2.1	(b) 
	 “Institutional Accredited Investor Notes”
	  	 	2.1	(b) 
	 “Issuer Order”
	  	 	2.2	  
	 “Legal Defeasance”
	  	 	8.2	  
	 “Notes Register”
	  	 	2.3	  
	 “Pari Passu Indebtedness”
	  	 	3.5	(b) 
	 “Paying Agent”
	  	 	2.3	  
	 “Permanent Regulation S Global Note”
	  	 	2.1	(b) 
	 “protected purchaser”
	  	 	2.10	  
	 “Redemption Date”
	  	 	5.7	(a) 

  
 36 

					
	 	  	Defined in	 
	 Term
	  	Section	 
	 “Refinancing Indebtedness”
	  	 	3.2	(b)(13) 
	 “Refunding Capital Stock”
	  	 	3.3	(b)(2) 
	 “Registrar”
	  	 	2.3	  
	 “Regulation S Global Note”
	  	 	2.1	(b) 
	 “Regulation S Notes”
	  	 	2.1	(b) 
	 “Reinstatement Date”
	  	 	3.20	  
	 “Resale Restriction Termination Date”
	  	 	2.6	(b) 
	 “Restricted Global Note”
	  	 	2.6	(e) 
	 “Restricted Payments”
	  	 	3.3	(a) 
	 “Restricted Period”
	  	 	2.1	(b) 
	 “Rule 144A Global Note”
	  	 	2.1	(b) 
	 “Rule 144A Notes”
	  	 	2.1	(b) 
	 “Second Commitment”
	  	 	3.5	(b) 
	 “Special Interest Payment Date”
	  	 	2.14	(a) 
	 “Special Record Date”
	  	 	2.14	(a) 
	 “Successor Company”
	  	 	4.1	(a)(1) 
	 “Successor Person”
	  	 	10.2	(b)(i) 
	 “Suspended Covenants”
	  	 	3.20	  
	 “Suspension Period”
	  	 	3.20	  
	 “Tax Group”
	  	 	3.3	(b)(15)(B) 
	 “Temporary Regulation S Global Note”
	  	 	2.1	(b) 
	 “Transaction Documents”
	  	 	3.9	(c) 
	 “Treasury Capital Stock”
	  	 	3.3	(b)(2) 
	 “Trustee”
	  	 	8.5	  
	 “Unrestricted Global Note”
	  	 	2.6	(e) 

  
 37 

 SECTION 1.3. Incorporation by Reference of Trust Indenture Act. This Indenture is
subject to the mandatory provisions of the TIA which are incorporated by reference in and made a part of this Indenture. The following TIA terms have the following meanings: 
 “Commission” means the SEC. 
 “indenture securities” means the
Notes and Guarantees. 
 “indenture security holder” means a Holder. 

“indenture to be qualified” means this Indenture. 
 “indenture trustee” or “institutional trustee” means the Trustee. 
 “obligor” on the indenture securities means the Issuer, each Guarantor and any other obligor on the indenture securities. 

All other TIA terms used in this Indenture that are defined by the TIA, defined in the TIA by reference to another statute or defined by
SEC rule have the meanings assigned to them by such definitions. 
 SECTION 1.4. Rules of Construction. Unless the
context otherwise requires: 
 (1) a term has the meaning assigned to it; 

(2) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

(3) “or” is not exclusive; 

(4) “including” means including without limitation; 

(5) words in the singular include the plural and words in the plural include the singular; 

(6) the principal amount of any noninterest bearing or other discount security at any date shall be the principal amount
thereof that would be shown on a balance sheet of the issuer dated such date prepared in accordance with GAAP; 

(7) the principal amount of any preferred stock shall be (i) the maximum liquidation value of such preferred stock or
(ii) the maximum mandatory redemption or mandatory repurchase price with respect to such preferred stock, whichever is greater; 

  
 38 

 (8) all amounts expressed in this Indenture or in any of the Notes in terms
of money refer to the lawful currency of the United States of America; 
 (9) the words “herein,”
“hereof” and “hereunder” and other words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision; and 

(10) unless otherwise specifically indicated, the term “consolidated” with respect to any Person refers to such
Person on a consolidated basis in accordance with GAAP, but excluding from such consolidation any Unrestricted Subsidiary as if such Unrestricted Subsidiary were not an Affiliate of such Person. 

ARTICLE II  
 THE NOTES 
 SECTION 2.1. Form, Dating and Terms. 

(a) The aggregate principal amount of Notes that may be authenticated and delivered under this Indenture is unlimited. The Initial Notes
issued on the date hereof shall be in an aggregate principal amount of $327,150,000. In addition, the Issuer may issue, from time to time in accordance with the provisions of this Indenture, Additional Notes (as provided herein) and Exchange Notes.
Furthermore, Notes may be authenticated and delivered upon registration of transfer, exchange or in lieu of, other Notes pursuant to Sections 2.2, 2.6, 2.10, 2.12, 5.6 or 9.5, in connection with an Asset
Sale Offer pursuant to Section 3.5 or in connection with a Change of Control Offer pursuant to Section 3.10. 
 Notwithstanding anything to the contrary contained herein, the Issuer may not issue any Additional Notes, unless such issuance is in compliance with Sections 3.2 and 3.6. 

The Initial Notes shall be known and designated as “10.625% Senior Notes, Series A, due 2020” of the Issuer. Additional Notes
issued as Restricted Notes shall be known and designated as “10.625% Senior Notes, Series A, due 2020” of the Issuer. Additional Notes issued other than as Restricted Notes shall be known and designated as “10.625% Senior Notes,
Series B, due 2020” of the Issuer, and Exchange Notes shall be known and designated as “10.625% Senior Notes, Series B, due 2020” of the Issuer. 
 With respect to any Additional Notes, the Issuer shall set forth in (a) a Board Resolution and (b)(i) an Officer’s Certificate or (ii) one or more indentures supplemental hereto, the
following information: 
 (1) the aggregate principal amount of such Additional Notes to be authenticated and
delivered pursuant to this Indenture; 
 (2) the issue price and the issue date of such Additional Notes,
including the date from which interest shall accrue; and 
 (3) whether such Additional Notes shall be Restricted
Notes issued in the form of Exhibit A hereto and/or shall be issued in the form of Exhibit B hereto. 

  
 39 

 In authenticating and delivering Additional Notes, the Trustee shall be entitled to receive
and shall be fully protected in relying upon, in addition to the Opinion of Counsel and Officer’s Certificate required by Section 12.4, an Opinion of Counsel as to the due authorization, execution, delivery, validity and
enforceability of such Additional Notes. 
 The Initial Notes, the Additional Notes and the Exchange Notes shall be considered
collectively as a single class for all purposes of this Indenture. Holders of the Initial Notes, the Additional Notes and the Exchange Notes shall vote and consent together on all matters to which such Holders are entitled to vote or consent as one
class, and none of the Holders of the Initial Notes, the Additional Notes or the Exchange Notes shall have the right to vote or consent as a separate class on any matter to which such Holders are entitled to vote or consent. 

If any of the terms of any Additional Notes are established by action taken pursuant to Board Resolutions of the Issuer, a copy of an
appropriate record of such action shall be certified by the Secretary or any Assistant Secretary of the Issuer and delivered to the Trustee at or prior to the delivery of the Officer’s Certificate or the indenture supplemental hereto setting
forth the terms of the Additional Notes. 
 (b) The Initial Notes are being offered and sold by the Issuer pursuant to a
Purchase Agreement, dated May 24, 2012, among the Issuer, Parent, J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and the other initial purchasers named therein. The Initial Notes and any Additional Notes
(if issued as Restricted Notes) (the “Additional Restricted Notes”) shall be resold initially only to (A) QIBs in reliance on Rule 144A and (B) Non-U.S. Persons in reliance on Regulation S. Such Initial Notes and
Additional Restricted Notes may thereafter be transferred to, among others, QIBs, purchasers in reliance on Regulation S and IAIs in accordance with Rule 501 of the Securities Act, in each case, in accordance with the procedure described herein.
Additional Notes offered after the date hereof may be offered and sold by the Issuer from time to time pursuant to one or more purchase agreements in accordance with applicable law. 

Initial Notes and Additional Restricted Notes offered and sold to QIBs in the United States of America in reliance on Rule 144A (the
“Rule 144A Notes”) shall be issued in the form of a permanent global Note substantially in the form of Exhibit A, which is hereby incorporated by reference and made a part of this Indenture, including appropriate legends as
set forth in Section 2.1(d) (the “Rule 144A Global Note”), deposited with the Trustee, as custodian for DTC, duly executed by the Issuer and authenticated by the Trustee as hereinafter provided. The Rule 144A Global Note
may be represented by more than one certificate, if so required by DTC’s rules regarding the maximum principal amount to be represented by a single certificate. The aggregate principal amount of the Rule 144A Global Note may from time to time
be increased or decreased by adjustments made on the records of the Trustee, as custodian for DTC or its nominee, as hereinafter provided. 

  
 40 

 Initial Notes and any Additional Restricted Notes offered and sold outside the United States
of America (the “Regulation S Notes”) in reliance on Regulation S shall initially be issued in the form of a temporary global Note (the “Temporary Regulation S Global Note”), without interest coupons. Beneficial
interests in the Temporary Regulation S Global Note shall be exchanged for beneficial interests in a corresponding permanent global Note, without interest coupons, substantially in the form of Exhibit A including appropriate legends as set
forth in Section 2.1(d) (the “Permanent Regulation S Global Note” and, together with the Temporary Regulation S Global Note, each a “Regulation S Global Note”) within a reasonable period after the
expiration of the Restricted Period (as defined below) upon delivery of the certification contemplated by Section 2.7. Each Regulation S Global Note shall be deposited upon issuance with, or on behalf of, the Trustee as custodian for DTC
in the manner described in this Article II for credit to the respective accounts of the purchasers (or to such other accounts as they may direct), including, but not limited to, accounts at Euroclear Bank S.A./N.V.
(“Euroclear”) or Clearstream Banking, société anonyme (“Clearstream”). Prior to the 40th day after the later of the commencement of the offering of the Initial Notes and the Issue Date (such period
through and including such 40th day, the “Restricted Period”), interests in the Temporary Regulation S Global Note may only be transferred to non-U.S. persons pursuant to Regulation S, to QIBs under Rule 144A or IAIs in accordance
with the transfer and certification requirements described herein for exchanges of interests in a Global Note. 
 Investors may
hold their interests in the Regulation S Global Note through organizations other than Euroclear or Clearstream that are participants in DTC’s system or directly through Euroclear or Clearstream, if they are participants in such systems, or
indirectly through organizations which are participants in such systems. If such interests are held through Euroclear or Clearstream, Euroclear and Clearstream shall hold such interests in the applicable Regulation S Global Note on behalf of their
participants through customers’ securities accounts in their respective names on the books of their respective depositaries. Such depositaries, in turn, shall hold such interests in the applicable Regulation S Global Note in customers’
securities accounts in the depositaries’ names on the books of DTC. 
 The Regulation S Global Note may be represented by
more than one certificate, if so required by DTC’s rules regarding the maximum principal amount to be represented by a single certificate. The aggregate principal amount of the Regulation S Global Note may from time to time be increased or
decreased by adjustments made on the records of the Trustee, as custodian for DTC or its nominee, as hereinafter provided. 

Initial Notes and Additional Restricted Notes resold to IAIs (the “Institutional Accredited Investor Notes”) in the
United States of America shall be issued in the form of a permanent global Note substantially in the form of Exhibit A including appropriate legends as set forth in Section 2.1(d) (the “Institutional Accredited Investor
Global Note”) deposited with the Trustee, as custodian for DTC, duly executed by the Issuer and authenticated by the Trustee as hereinafter provided. The Institutional Accredited Investor Global Note may be represented by more than one
certificate, if so required by DTC’s rules regarding the maximum principal amount to be represented by a single certificate. The aggregate principal amount of the Institutional Accredited Investor Global Note may from time to time be increased
or decreased by adjustments made on the records of the Trustee, as custodian for DTC or its nominee, as hereinafter provided. 

  
 41 

 Exchange Notes exchanged for interests in the Rule 144A Notes, the Regulation S Notes and
the Institutional Accredited Investor Notes shall be issued in the form of a permanent global Note, substantially in the form of Exhibit B, which is hereby incorporated by reference and made a part of this Indenture, deposited with the
Trustee as hereinafter provided, including the appropriate legend set forth in Section 2.1(d) (the “Exchange Global Note”). The Exchange Global Note shall be deposited upon issuance with, or on behalf of, the Trustee as
custodian for DTC, duly executed by the Issuer and authenticated by the Trustee as hereinafter provided. The Exchange Global Note may be represented by more than one certificate, if so required by DTC’s rules regarding the maximum principal
amount to be represented by a single certificate. 
 The Rule 144A Global Note, the Regulation S Global Note, the Institutional
Accredited Investor Global Note and the Exchange Global Note are sometimes collectively herein referred to as the “Global Notes.” 
 The principal of (and premium, if any) and interest on the Notes shall be payable at the office or agency of Paying Agent or Registrar designated by the Issuer maintained for such purpose in the United
States or at such other office or agency of the Issuer as may be maintained for such purpose pursuant to Section 2.3 of this Indenture; provided, however, that, at the option of the Issuer, each installment of interest may be paid
by (i) check mailed to addresses of the Persons entitled thereto as such addresses shall appear on the Notes Register or (ii) wire transfer to an account located in the United States maintained by the payee, subject to the last sentence of
this paragraph. Payments in respect of Notes represented by a Global Note (including principal, premium, if any, and interest) shall be made by wire transfer of immediately available funds to the accounts specified by DTC. Payments in respect of
Notes represented by Definitive Notes (including principal, premium, if any, and interest) held by a Holder of at least $1,000,000 aggregate principal amount of Notes represented by Definitive Notes shall be made by wire transfer to a U.S. dollar
account maintained by the payee with a bank in the United States if such Holder elects payment by wire transfer by giving written notice to the Trustee or the Paying Agent to such effect designating such account no later than 15 days immediately
preceding the relevant due date for payment (or such other date as the Trustee may accept in its discretion). 
 The Notes may
have notations, legends or endorsements required by law, stock exchange rule or usage, in addition to those set forth on Exhibit A and Exhibit B and in Section 2.1(d). The Issuer shall approve any notation, endorsement or
legend on the Notes. Each Note shall be dated the date of its authentication. The terms of the Notes set forth in Exhibit A and Exhibit B are part of the terms of this Indenture and, to the extent applicable, the Issuer, the Guarantors
and the Trustee, by their execution and delivery of this Indenture, expressly agree to be bound by such terms. 
 (c)
Denominations. The Notes shall be issuable only in fully registered form, without coupons, and only in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. 

(d) Restrictive Legends. Unless and until (i) an Initial Note or an Additional Note issued as a Restricted Note is sold under
an effective registration statement or (ii) an Initial Note or an Additional Note issued as a Restricted Note is exchanged for an Exchange Note in connection with an effective registration statement, in each case pursuant to the Registration
Rights Agreement or a similar agreement or (iii) the Trustee receives an Opinion of Counsel reasonably satisfactory to the Issuer and the Trustee to the effect that neither such legend nor the related restrictions on transfer are required in
order to maintain compliance with the provisions of the Securities Act: 

  
 42 

 (1) the Rule 144A Global Note, the Regulation S Global Note and the
Institutional Accredited Investor Global Note shall bear the following legend on the face thereof: 
 THIS SECURITY HAS NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED,
TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION. THE HOLDER OF THIS SECURITY, BY ITS ACCEPTANCE HEREOF, AGREES ON ITS OWN
BEHALF AND ON BEHALF OF ANY INVESTOR ACCOUNT FOR WHICH IT HAS PURCHASED SECURITIES, TO OFFER, SELL OR OTHERWISE TRANSFER SUCH SECURITY, PRIOR TO THE DATE (THE “RESALE RESTRICTION TERMINATION DATE”) THAT IS [IN THE CASE OF RULE 144A NOTES:
ONE YEAR AFTER THE LATEST OF THE ORIGINAL ISSUE DATE HEREOF, THE ORIGINAL ISSUE DATE OF THE ISSUANCE OF ANY ADDITIONAL NOTES AND THE LAST DATE ON WHICH THE COMPANY OR ANY AFFILIATE OF THE ISSUER WAS THE OWNER OF THIS SECURITY (OR ANY PREDECESSOR OF
SUCH SECURITY),] [IN THE CASE OF REGULATION S NOTES: 40 DAYS AFTER THE LATER OF THE ORIGINAL ISSUE DATE HEREOF, THE ORIGINAL ISSUE DATE OF THE ISSUANCE OF ANY ADDITIONAL NOTES AND THE DATE ON WHICH THIS SECURITY (OR ANY PREDECESSOR OF SUCH SECURITY)
WAS FIRST OFFERED TO PERSONS OTHER THAN DISTRIBUTORS (AS DEFINED IN RULE 902 OF REGULATION S) IN RELIANCE ON REGULATION S], ONLY (A) TO THE ISSUER OR ANY SUBSIDIARY THEREOF, (B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BEEN DECLARED
EFFECTIVE UNDER THE SECURITIES ACT, (C) FOR SO LONG AS THE SECURITIES ARE ELIGIBLE FOR RESALE PURSUANT TO RULE 144A UNDER THE SECURITIES ACT (“RULE 144A”), TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED INSTITUTIONAL
BUYER” AS DEFINED IN RULE 144A THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, (D) PURSUANT TO OFFERS AND SALES TO
NON-U.S. PERSONS THAT OCCUR OUTSIDE THE UNITED STATES WITHIN THE MEANING OF REGULATION S UNDER THE SECURITIES ACT, (E) TO AN INSTITUTIONAL “ACCREDITED INVESTOR” WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7) UNDER THE
SECURITIES ACT THAT IS NOT A QUALIFIED INSTITUTIONAL BUYER AND THAT IS PURCHASING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF ANOTHER INSTITUTIONAL ACCREDITED INVESTOR, IN EACH CASE IN A MINIMUM PRINCIPAL AMOUNT OF SECURITIES OF $250,000 OR
(F) PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM THE 

  
 43 

 REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, SUBJECT TO THE COMPANY’S AND THE
TRUSTEE’S RIGHT PRIOR TO ANY SUCH OFFER, SALE OR TRANSFER PURSUANT TO CLAUSES (D), (E) OR (F) TO REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATION AND/ OR OTHER INFORMATION SATISFACTORY TO EACH OF THEM. THIS LEGEND WILL BE
REMOVED UPON THE REQUEST OF THE HOLDER AFTER THE RESALE RESTRICTION TERMINATION DATE. [IN THE CASE OF REGULATION S NOTES: BY ITS ACQUISITION HEREOF, THE HOLDER HEREOF REPRESENTS THAT IT IS NOT A U.S. PERSON NOR IS IT PURCHASING FOR THE ACCOUNT OF A
U.S. PERSON AND IS ACQUIRING THIS SECURITY IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH REGULATION S UNDER THE SECURITIES ACT.] 

BY ITS ACQUISITION OF THIS SECURITY THE HOLDER HEREOF WILL BE DEEMED TO HAVE REPRESENTED AND WARRANTED THAT EITHER (1) NO PORTION OF
THE ASSETS USED BY SUCH HOLDER TO ACQUIRE OR HOLD THIS SECURITY CONSTITUTES THE ASSETS OF AN EMPLOYEE BENEFIT PLAN THAT IS SUBJECT TO TITLE I OF THE U.S. EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”), OF A PLAN,
INDIVIDUAL RETIREMENT ACCOUNT OR OTHER ARRANGEMENT THAT IS SUBJECT TO SECTION 4975 OF THE U.S. INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”), OR PROVISIONS UNDER ANY OTHER FEDERAL, STATE, LOCAL, NON-U.S. OR OTHER LAWS OR
REGULATIONS THAT ARE SIMILAR TO SUCH PROVISIONS OF ERISA OR THE CODE (“SIMILAR LAWS”), OR OF AN ENTITY WHOSE UNDERLYING ASSETS ARE CONSIDERED TO INCLUDE “PLAN ASSETS” OF ANY SUCH PLAN, ACCOUNT OR ARRANGEMENT, OR (II) THE
ACQUISITION AND HOLDING OF THIS SECURITY WILL NOT CONSTITUTE A NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION 406 OF ERISA OR SECTION 4975 OF THE CODE OR A SIMILAR VIOLATION UNDER ANY APPLICABLE SIMILAR LAWS. 

(2) the Temporary Regulation S Global Note shall bear the following additional legend on the face thereof: 

THIS SECURITY IS A TEMPORARY GLOBAL NOTE. PRIOR TO THE EXPIRATION OF THE RESTRICTED PERIOD APPLICABLE HERETO, BENEFICIAL INTERESTS HEREIN
MAY NOT BE HELD BY ANY PERSON OTHER THAN (1) A NON-U.S. PERSON OR (2) A U.S. PERSON THAT PURCHASED SUCH INTEREST IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).
BENEFICIAL INTERESTS HEREIN ARE NOT EXCHANGEABLE FOR PHYSICAL NOTES OTHER THAN A PERMANENT GLOBAL NOTE IN ACCORDANCE WITH THE TERMS OF THE INDENTURE. TERMS IN THIS LEGEND ARE USED AS USED IN REGULATION S UNDER THE SECURITIES ACT. 

  
 44 

 (3) Each Global Security, whether or not an Initial Security, shall bear the
following legend on the face thereof: 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY
TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER
NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO DTC, TO NOMINEES OF DTC OR TO A SUCCESSOR
THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 

(4) Each Note issued hereunder that has more than a de minimis amount of original issue discount for U.S. federal income
tax purposes shall bear a legend in substantially the following form: 
 THIS SECURITY IS ISSUED WITH
“ORIGINAL ISSUE DISCOUNT” WITHIN THE MEANING OF SECTION 1273 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED. A HOLDER MAY OBTAIN THE ISSUE PRICE, AMOUNT OF ORIGINAL ISSUE DISCOUNT, ISSUE DATE AND YIELD TO MATURITY FOR SUCH NOTE BY
SUBMITTING A WRITTEN REQUEST FOR SUCH INFORMATION TO: ATTENTION: CHIEF FINANCIAL OFFICER, WOLVERINE HEALTHCARE ANALYTICS, INC., C/O THE VERITAS CAPITAL FUND IV, L.P., 590 MADISON AVENUE, 41ST FLOOR, NEW YORK, NEW YORK 10022, FAX NUMBER (212) 688-9411. 

(e) Book-Entry Provisions. (i) This Section 2.1(e) shall apply only to Global Notes deposited with the Trustee,
as custodian for DTC. 
 (ii) Each Global Note initially shall (x) be registered in the name of DTC or the
nominee of DTC, (y) be delivered to the Trustee as custodian for DTC and (z) bear legends as set forth in Section 2.1(d). Transfers of a Global Note (but not a beneficial interest therein) shall be limited to transfers thereof
in whole, but not in part, to the DTC, its successors or its respective nominees, except as set forth in Section 2.1(e)(v) and 2.1(f). If a beneficial interest in a Global Note is transferred or exchanged for a beneficial interest
in another Global Note, the Trustee shall (x) record a decrease in the principal amount of the Global Note being transferred or exchanged equal to the principal amount of such transfer or exchange and (y) record a like increase in the
principal amount of the other Global Note. Any beneficial interest in one Global Note that is transferred to a 

  
 45 

 
Person who takes delivery in the form of an interest in another Global Note, or exchanged for an interest in another Global Note, shall, upon transfer or exchange, cease to be an interest in such
Global Note and become an interest in the other Global Note and, accordingly, shall thereafter be subject to all transfer and exchange restrictions, if any, and other procedures applicable to beneficial interests in such other Global Note for as
long as it remains such an interest. 
 (iii) Members of, or participants in, DTC (“Agent
Members”) shall have no rights under this Indenture with respect to any Global Note held on their behalf by DTC or by the Trustee as the custodian of DTC or under such Global Note, and DTC may be treated by the Issuer, the Trustee and any
agent of the Issuer or the Trustee as the absolute owner of such Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Issuer, the Trustee or any agent of the Issuer or the Trustee from giving
effect to any written certification, proxy or other authorization furnished by DTC or impair, as between DTC and its Agent Members, the operation of customary practices of DTC governing the exercise of the rights of a Holder of a beneficial interest
in any Global Note. 
 (iv) In connection with any transfer of a portion of the beneficial interest in a Global
Note pursuant to Section 2.1(f) to beneficial owners who are required to hold Definitive Notes, the Notes Custodian shall reflect on its books and records the date and a decrease in the principal amount of such Global Note in an amount
equal to the principal amount of the beneficial interest in the Global Note to be transferred, and the Issuer shall execute, and the Trustee shall authenticate and make available for delivery, one or more Definitive Notes of like tenor and amount.

 (v) In connection with the transfer of an entire Global Note to beneficial owners pursuant to
Section 2.1(f), such Global Note shall be deemed to be surrendered to the Trustee for cancellation, and the Issuer shall execute, and the Trustee shall authenticate and make available for delivery, to each beneficial owner identified by
DTC in exchange for its beneficial interest in such Global Note, an equal aggregate principal amount of Definitive Notes of authorized denominations. 
 (vi) The registered Holder of a Global Note may grant proxies and otherwise authorize any person, including Agent Members and persons that may hold interests through Agent Members, to take any action
which a Holder is entitled to take under this Indenture or the Notes. 
 (vii) Any Holder of a Global Note shall,
by acceptance of such Global Note, agree that transfers of beneficial interests in such Global Note may be effected only through a book-entry system maintained by (a) the Holder of such Global Note (or its agent) or (b) any Holder of a
beneficial interest in such Global Note, and that ownership of a beneficial interest in such Global Note shall be required to be reflected in a book entry. 
 (f) Definitive Notes. (i) Except as provided below, owners of beneficial interests in Global Notes shall not be entitled to receive Definitive Notes. If required to do so pursuant to any
applicable law or regulation, beneficial owners may obtain Definitive Notes in 

  
 46 

 
exchange for their beneficial interests in a Global Note upon written request in accordance with DTC’s and the Registrar’s procedures. In addition, Definitive Notes shall be transferred
to all beneficial owners in exchange for their beneficial interests in a Global Note if (A) DTC notifies the Issuer that it is unwilling or unable to continue as depositary for such Global Note or DTC ceases to be a clearing agency registered
under the Exchange Act, at a time when DTC is required to be so registered in order to act as depositary, and in each case a successor depositary is not appointed by the Issuer within 90 days of such notice or, (B) the Issuer in its sole
discretion executes and delivers to the Trustee and Registrar an Officer’s Certificate stating that such Global Note shall be so exchangeable or (C) an Event of Default has occurred and is continuing and the Registrar has received a
request from DTC. In the event of the occurrence of any of the events specified in the second preceding sentence or in clause (A), (B) or (C) of the preceding sentence, the Issuer shall promptly make available to the Trustee a reasonable
supply of Definitive Notes. 
 (ii) Any Definitive Note delivered in exchange for an interest in a Global Note
pursuant to Section 2.1(e)(iii) or (iv) shall, except as otherwise provided by Section 2.6(d), bear the applicable legend regarding transfer restrictions applicable to the Definitive Note set forth in
Section 2.1(d). 
 (iii) If a Definitive Note is transferred or exchanged for a beneficial interest
in a Global Note, the Trustee shall (x) cancel such Definitive Note, (y) record an increase in the principal amount of such Global Note equal to the principal amount of such transfer or exchange and (z) in the event that such transfer
or exchange involves less than the entire principal amount of the canceled Definitive Note, the Issuer shall execute, and the Trustee shall authenticate and make available for delivery, to the transferring Holder a new Definitive Note representing
the principal amount not so transferred. 
 (iv) If a Definitive Note is transferred or exchanged for another
Definitive Note, (x) the Trustee shall cancel the Definitive Note being transferred or exchanged, (y) the Issuer shall execute, and the Trustee shall authenticate and make available for delivery, one or more new Definitive Notes in
authorized denominations having an aggregate principal amount equal to the principal amount of such transfer or exchange to the transferee (in the case of a transfer) or the Holder of the canceled Definitive Note (in the case of an exchange),
registered in the name of such transferee or Holder, as applicable, and (z) if such transfer or exchange involves less than the entire principal amount of the canceled Definitive Note, the Issuer shall execute, and the Trustee shall
authenticate and make available for delivery to the Holder thereof, one or more Definitive Notes in authorized denominations having an aggregate principal amount equal to the untransferred or unexchanged portion of the canceled Definitive Notes,
registered in the name of the Holder thereof. 
 (v) Notwithstanding anything to the contrary in this Indenture,
in no event shall a Definitive Note be delivered upon exchange or transfer of a beneficial interest in the Temporary Regulation S Global Note prior to the end of the Restricted Period. 

  
 47 

 SECTION 2.2. Execution and Authentication. One Officer shall sign the Notes for the
Issuer by manual or facsimile signature. If the Officer whose signature is on a Note no longer holds that office at the time the Trustee authenticates the Note, the Note shall be valid nevertheless. 

A Note shall not be valid until an authorized officer of the Trustee manually authenticates the Note. The signature of the Trustee on a
security shall be conclusive evidence that such Note has been duly and validly authenticated and issued under this Indenture. A Note shall be dated the date of its authentication. 

At any time and from time to time after the execution and delivery of this Indenture, the Trustee shall authenticate and make available
for delivery: (1) Initial Notes for original issue on the Issue Date in an aggregate principal amount of $327,150,000, (2) subject to the terms of this Indenture, Additional Notes for original issue in an unlimited principal amount,
(3) Exchange Notes for issue only in an exchange offer pursuant to the Registration Rights Agreement or upon resale under an effective Shelf Registration Statement, and only in exchange for Initial Notes or Additional Notes of an equal
principal amount and (4) under the circumstances set forth in Section 2.6(e), Initial Notes in the form of an Unrestricted Global Note, in each case upon a written order of the Issuer signed by one Officer (the “Issuer
Order”). Such Issuer Order shall specify whether the Notes shall be in the form of Definitive Notes or Global Notes, the amount of the Notes to be authenticated and the date on which the original issue of Notes is to be authenticated and
whether the Notes are to be Initial Notes, Additional Notes or Exchange Notes. 
 The Trustee may appoint an agent (the
“Authenticating Agent”) reasonably acceptable to the Issuer to authenticate the Notes. Any such instrument shall be evidenced by an instrument signed by a Trust Officer, a copy of which shall be furnished to the Issuer. Unless
limited by the terms of such appointment, any such Authenticating Agent may authenticate Notes whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by the Authenticating Agent. An
Authenticating Agent has the same rights as any Registrar, Paying Agent or agent for service of notices and demands. 
 In case
the Issuer or any Guarantor, pursuant to Article IV or Section 10.2, as applicable, shall be consolidated or merged with or into any other Person or shall convey, transfer, lease or otherwise dispose of its properties and assets
substantially as an entirety to any Person, and the successor Person resulting from such consolidation, or surviving such merger, or into which the Issuer or any Guarantor shall have been merged, or the Person which shall have received a conveyance,
transfer, lease or other disposition as aforesaid, shall have executed an indenture supplemental hereto with the Trustee pursuant to Article IV or Section 10.2, as applicable, any of the Notes authenticated or delivered prior to
such consolidation, merger, conveyance, transfer, lease or other disposition may (but shall not be required), from time to time, at the request of the successor Person, be exchanged for other Notes executed in the name of the successor Person with
such changes in phraseology and form as may be appropriate, but otherwise in substance of like tenor as the Notes surrendered for such exchange and of like principal amount; and the Trustee, upon the Issuer Order of the successor Person, shall
authenticate and make available for delivery Notes as specified in such order for the purpose of such exchange. If Notes shall at any time be authenticated and delivered in any new name of a successor Person pursuant to this Section 2.2
in exchange or substitution for or upon registration of transfer of any Notes, such successor Person, at the option of the Holders but without expense to them, shall provide for the exchange of all Notes at the time outstanding for Notes
authenticated and delivered in such new name. 

  
 48 

 SECTION 2.3. Registrar and Paying Agent. 

The Issuer shall maintain one or more offices or agencies where Notes may be presented for registration of transfer or for exchange (the
“Registrar”) and an office or agency where Notes may be presented for payment (the “Paying Agent”). The Registrar shall keep a register of the Notes and of their transfer and exchange (the “Notes
Register”). The Issuer may have one or more co-registrars and one or more additional paying agents. The term “Paying Agent” includes any additional paying agent and the term “Registrar” includes any co-registrar.

 The Issuer shall enter into an appropriate agency agreement with any Registrar or Paying Agent not a party to this Indenture,
which shall incorporate the terms of the TIA. The agreement shall implement the provisions of this Indenture that relate to such agent. The Issuer shall notify the Trustee of the name and address of each such agent. If the Issuer fails to maintain a
Registrar or Paying Agent, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to Section 7.7. The Issuer or any Guarantor may act as Paying Agent, Registrar or transfer agent. 

The Issuer initially appoints the Trustee as Registrar and Paying Agent for the Notes. The Issuer may change any Registrar or Paying
Agent without prior notice to the Holders, but upon written notice to such Registrar or Paying Agent and to the Trustee; provided, however, that no such removal shall become effective until (i) acceptance of any appointment by a
successor as evidenced by an appropriate agreement entered into by the Issuer and such successor Registrar or Paying Agent, as the case may be, and delivered to the Trustee or (ii) notification to the Trustee that the Trustee shall serve as
Registrar or Paying Agent until the appointment of a successor in accordance with clause (i) above. The Registrar or Paying Agent may resign at any time upon written notice to the Issuer and the Trustee. 

If Additional Interest is payable on the Notes, the Issuer shall provide an Officer’s Certificate to the Trustee on or before the
record date for each Interest Payment Date such Additional Interest is payable setting forth the amount of such Additional Interest in reasonable detail. The Trustee may provide a copy of such Officer’s Certificate or other notice received from
the Issuer relating to Additional Interest to any Holder upon request. 
 The Issuer will be responsible for making calculations
called for under the Notes, including but not limited to determination of redemption price, premium, if any, and any additional amounts or other amounts payable on the Notes. The Issuer will make the calculations in good faith and, absent manifest
error, its calculations will be final and binding on the Holders. The Issuer will provide a schedule of its calculations to the Trustee when requested by the Trustee, and the Trustee is entitled to rely conclusively on the accuracy of the
Issuer’s calculations without independent verification. 
 SECTION 2.4. Paying Agent to Hold Money in Trust.

 By no later than 11:00 a.m. (New York City time) on the date on which any principal of, premium, if any, or interest on any
Note is due and payable, the Issuer shall deposit with the Paying Agent a sum sufficient in immediately available funds to pay such principal, premium or interest when due. The Issuer shall require each Paying Agent (other than the Trustee)

  
 49 

 
to agree in writing that such Paying Agent shall hold in trust for the benefit of Holders or the Trustee all money held by such Paying Agent for the payment of principal of, premium, if any, or
interest on the Notes (whether such assets have been distributed to it by the Issuer or other obligors on the Notes), shall notify the Trustee in writing of any default by the Issuer or any Guarantor in making any such payment and shall during the
continuance of any default by the Issuer (or any other obligor upon the Notes) in the making of any payment in respect of the Notes, upon the written request of the Trustee, forthwith deliver to the Trustee all sums held in trust by such Paying
Agent for payment in respect of the Notes together with a full accounting thereof. If the Issuer or a Subsidiary of the Issuer acts as Paying Agent, it shall segregate the money held by it as Paying Agent and hold it as a separate trust fund. The
Issuer at any time may require a Paying Agent (other than the Trustee) to pay all money held by it to the Trustee and to account for any funds or assets disbursed by such Paying Agent. Upon complying with this Section 2.4, the Paying
Agent (if other than the Issuer or a Subsidiary of the Issuer) shall have no further liability for the money delivered to the Trustee. Upon any bankruptcy, reorganization or similar proceeding with respect to the Issuer, the Trustee shall serve as
Paying Agent for the Notes. 
 SECTION 2.5. Holder Lists. 

The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and
addresses of Holders and shall otherwise comply with TIA § 312(a). If the Trustee is not the Registrar, or to the extent otherwise required under the TIA, the Issuer, on its own behalf and on behalf of each of the Guarantors, shall furnish or
cause the Registrar to furnish to the Trustee, in writing at least five Business Days before each interest payment date and at such other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may
reasonably require of the names and addresses of Holders and the Issuer shall otherwise comply with TIA § 312(a). 

SECTION 2.6. Transfer and Exchange. 
 (a) A Holder may transfer a Note (or a beneficial interest therein) to another Person or exchange a Note (or a beneficial interest therein) for another Note or Notes of any authorized denomination by
presenting to the Trustee a written request therefor stating the name of the proposed transferee or requesting such an exchange, accompanied by any certification, opinion or other document required by this Section 2.6. The Trustee shall
promptly register any transfer or exchange that meets the requirements of this Section 2.6 by noting the same in the register maintained by the Trustee for the purpose, and no transfer or exchange shall be effective until it is
registered in such register. The transfer or exchange of any Note (or a beneficial interest therein) may only be made in accordance with this Section 2.6 and Sections 2.1(e) and 2.1(f), as applicable, and, in the case of a
Global Note (or a beneficial interest therein), the applicable rules and procedures of DTC, Euroclear and Clearstream. The Trustee shall refuse to register any requested transfer or exchange that does not comply with this paragraph. 

(b) Transfers of Rule 144A Notes and Institutional Accredited Investor Notes. The following provisions shall apply with respect to
any proposed registration of transfer of a Rule 144A Note or an Institutional Accredited Investor Note prior to the date which is one year after the later of the date of its original issue and the last date on which the Issuer or any Affiliate of
the Issuer was the owner of such Notes (or any predecessor thereto) (the “Resale Restriction Termination Date”): 

  
 50 

 (i) a registration of transfer of a Rule 144A Note or an Institutional
Accredited Investor Note or a beneficial interest therein to a QIB shall be made upon the representation of the transferee in the form as set forth on the reverse of the Note that it is purchasing for its own account or an account with respect to
which it exercises sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A, and is aware that the sale to it is being made in reliance on Rule 144A and acknowledges
that it has received such information regarding the Issuer as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware that the transferor is relying upon its foregoing
representations in order to claim the exemption from registration provided by Rule 144A; provided that no such written representation or other written certification shall be required in connection with the transfer of a beneficial interest in
the Rule 144A Global Note to a transferee in the form of a beneficial interest in that Rule 144A Global Note in accordance with this Indenture and the applicable procedures of DTC. 

(ii) a registration of transfer of a Rule 144A Note or an Institutional Accredited Investor Note or a beneficial interest
therein to an IAI shall be made upon receipt by the Trustee or its agent of a certificate substantially in the form set forth in Section 2.8 from the proposed transferee and, if requested by the Issuer, the delivery of an opinion of
counsel, certification and/or other information satisfactory to it; and 
 (iii) a registration of transfer of a
Rule 144A Note or an Institutional Accredited Investor Note or a beneficial interest therein to a Non-U.S. Person shall be made upon receipt by the Trustee or its agent of a certificate substantially in the form set forth in Section 2.9
from the proposed transferee and, if requested by the Issuer, the delivery of an opinion of counsel, certification and/or other information satisfactory to it. 
 (c) Transfers of Regulations S Notes. The following provisions shall apply with respect to any proposed transfer of a Regulation S Note prior to the expiration of the Restricted Period: 

(i) a transfer of a Regulation S Note or a beneficial interest therein to a QIB shall be made upon the representation of
the transferee, in the form of assignment on the reverse of the certificate, that it is purchasing the Note for its own account or an account with respect to which it exercises sole investment discretion and that it and any such account is a
“qualified institutional buyer” within the meaning of Rule 144A, is aware that the sale to it is being made in reliance on Rule 144A and acknowledges that it has received such information regarding the Issuer as the undersigned has
requested pursuant to Rule 144A or has determined not to request such information and that it is aware that the transferor is relying upon its foregoing representations in order to claim the exemption from registration provided by Rule 144A;

  
 51 

 (ii) a transfer of a Regulation S Note or a beneficial interest therein to
an IAI shall be made upon receipt by the Trustee or its agent of a certificate substantially in the form set forth in Section 2.8 from the proposed transferee and, if requested by the Issuer or the Trustee, the delivery of an opinion of
counsel, certification and/or other information satisfactory to each of them; and 
 (iii) a transfer of a
Regulation S Note or a beneficial interest therein to a Non-U.S. Person shall be made upon receipt by the Trustee or its agent of a certificate substantially in the form set forth in Section 2.9 hereof from the proposed transferee and,
if requested by the Issuer, receipt by the Trustee or its agent of an opinion of counsel, certification and/or other information satisfactory to the Issuer. 
 After the expiration of the Restricted Period, interests in the Regulation S Note may be transferred in accordance with applicable law without requiring the certification set forth in
Section 2.8, Section 2.9 or any additional certification. 
 (d) Restricted Notes Legend. Upon
the transfer, exchange or replacement of Notes not bearing a Restricted Notes Legend, the Registrar shall deliver Notes that do not bear a Restricted Notes Legend. Upon the transfer, exchange or replacement of Notes bearing a Restricted Notes
Legend, the Registrar shall deliver only Notes that bear a Restricted Notes Legend unless (i) Initial Notes are being exchanged for Exchange Notes in an exchange offer pursuant to the Registration Rights Agreement, in which case the Exchange
Notes shall not bear a Restricted Notes Legend, (ii) an Initial Note is being transferred pursuant to the Shelf Registration Statement or other effective registration statement, (iii) Initial Notes are being exchanged for Notes that do not
bear the Restricted Notes Legend in accordance with Section 2.6(e) or (iv) there is delivered to the Registrar an Opinion of Counsel reasonably satisfactory to the Issuer and the Trustee to the effect that neither such legend nor
the related restrictions on transfer are required in order to maintain compliance with the provisions of the Securities Act. Any Additional Notes sold in a registered offering shall not be required to bear the Restricted Notes Legend. 

(e) Automatic Exchange from Global Note Bearing Restricted Notes Legend to Global Note Not Bearing Restricted Notes Legend. Upon
the Issuer’s satisfaction that the Restricted Notes Legend shall no longer be required in order to maintain compliance with the Securities Act, beneficial interests in a Global Note bearing the Restricted Notes Legend (a “Restricted
Global Note”) may be automatically exchanged into beneficial interests in a Global Note not bearing the Restricted Notes Legend (an “Unrestricted Global Note”) without any action required by or on behalf of the Holder (the
“Automatic Exchange”) at any time on or after the date that is the 366th calendar day after (A) with respect to the Notes issued on the Issue Date or (B) with respect to Additional Notes, if any, the issue date of such
Additional Notes, or, in each case, if such day is not a Business Day, on the next succeeding Business Day (the “Automatic Exchange Date”). Upon the Issuer’s satisfaction that the Restricted Notes Legend shall no longer be
required in order to maintain compliance with the Securities Act, the Issuer may pursuant to the rules and procedures (i) provide written notice to DTC at least fifteen (15) calendar days prior to the Automatic Exchange Date, instructing
DTC to exchange all of the outstanding beneficial interests in a particular Restricted Global Note to the Unrestricted Global Note, which the Issuer shall have previously otherwise made eligible for exchange with the DTC, (ii) provide prior
written notice (the “Automatic Exchange Notice”) to each Holder at such Holder’s address appearing in the register of Holders at least fifteen (15) calendar days prior to the Automatic Exchange Date (the “Automatic
Exchange Notice Date”), which notice must include (w) the Automatic Exchange 

  
 52 

 
Date, (x) the section of the Indenture pursuant to which the Automatic Exchange shall occur, (y) the “CUSIP” number of the Restricted Global Note from which such Holder’s
beneficial interests shall be transferred and the (z) “CUSIP” number of the Unrestricted Global Note into which such Holder’s beneficial interests shall be transferred, and (iii) on or prior to the Automatic Exchange Date,
deliver to the Trustee for authentication one or more Unrestricted Global Notes, duly executed by the Issuer, in an aggregate principal amount equal to the aggregate principal amount of Restricted Global Notes to be exchanged. At the Issuer’s
request on no less than five (5) calendar days’ notice prior to the Automatic Exchange Notice Date, the Trustee shall deliver, in the Issuer’s name and at its expense, the Automatic Exchange Notice to each Holder at such Holder’s
address appearing in the register of Holders. Notwithstanding anything to the contrary in this Section 2.6(e), during the fifteen (15) day period prior to the Automatic Exchange Date, no transfers or exchanges other than pursuant to
this Section 2.6(e) shall be permitted without the prior written consent of the Issuer. Upon such exchange of beneficial interests pursuant to this Section 2.6(e), the aggregate principal amount of the Global Notes shall be
increased or decreased by adjustments made on the records of the Trustee, as custodian for the Depositary, to reflect the relevant increase or decrease in the principal amount of such Global Note resulting from the applicable exchange. The
Restricted Global Note from which beneficial interests are transferred pursuant to an Automatic Exchange shall be canceled following the Automatic Exchange. 
 (f) Retention of Written Communications. The Registrar shall retain copies of all letters, notices and other written communications received pursuant to Section 2.1 or this
Section 2.6. The Issuer shall have the right to inspect and make copies of all such letters, notices or other written communications at any reasonable time upon the giving of reasonable prior written notice to the Registrar. 

(g) Obligations with Respect to Transfers and Exchanges of Notes. 

(i) To permit registrations of transfers and exchanges, the Issuer shall, subject to the other terms and conditions of
this Article II, execute and the Trustee shall authenticate Definitive Notes and Global Notes at the Registrar’s request. 
 (ii) No service charge shall be made to a Holder for any registration of transfer or exchange, but the Issuer may require the Holder to pay a sum sufficient to cover any transfer tax assessments or
similar governmental charge payable in connection therewith (other than any such transfer taxes, assessments or similar governmental charges payable upon exchange or transfer pursuant to Sections 2.2, 2.6, 2.10, 2.12,
3.5, 3.10, 5.6 or 9.5). 
 (iii) The Issuer (and the Registrar) shall not be required
to register the transfer of or exchange of any Note (A) for a period beginning (1) 15 days before the mailing of a notice of an offer to repurchase or redeem Notes and ending at the close of business on the day of such mailing or
(2) 15 days before an interest payment date and ending on such interest payment date or (B) called for redemption, except the unredeemed portion of any Note being redeemed in part. 

  
 53 

 (iv) Prior to the due presentation for registration of transfer of any Note,
the Issuer, the Trustee, the Paying Agent or the Registrar may deem and treat the person in whose name a Note is registered as the owner of such Note for the purpose of receiving payment of principal of, premium, if any, and (subject to paragraph 2
of the forms of Notes attached hereto as Exhibits A and B) interest on such Note and for all other purposes whatsoever, including without limitation the transfer or exchange of such Note, whether or not such Note is overdue, and none of the
Issuer, the Trustee, the Paying Agent or the Registrar shall be affected by notice to the contrary. 
 (v) Any
Definitive Note delivered in exchange for an interest in a Global Note pursuant to Section 2.1(f) shall, except as otherwise provided by Section 2.6(d), bear the applicable legend regarding transfer restrictions applicable to
the Definitive Note set forth in Section 2.1(d). 
 (vi) All Notes issued upon any transfer or
exchange pursuant to the terms of this Indenture shall evidence the same debt and shall be entitled to the same benefits under this Indenture as the Notes surrendered upon such transfer or exchange. 

(h) No Obligation of the Trustee. (i) The Trustee shall have no responsibility or obligation to any beneficial owner of a
Global Note, a member of, or a participant in, DTC or other Person with respect to the accuracy of the records of DTC or its nominee or of any participant or member thereof, with respect to any ownership interest in the Notes or with respect to the
delivery to any participant, member, beneficial owner or other Person (other than DTC) of any notice (including any notice of redemption or purchase) or the payment of any amount or delivery of any Notes (or other security or property) under or with
respect to such Notes. All notices and communications to be given to the Holders and all payments to be made to Holders in respect of the Notes shall be given or made only to or upon the order of the registered Holders (which shall be DTC or its
nominee in the case of a Global Note). The rights of beneficial owners in any Global Note shall be exercised only through DTC subject to the applicable rules and procedures of DTC. The Trustee may rely and shall be fully protected in relying upon
information furnished by DTC with respect to its members, participants and any beneficial owners. 
 (ii) The
Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable law with respect to any transfer of any interest in any Note (including any
transfers between or among DTC participants, members or beneficial owners in any Global Note) other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly
required by, the terms of this Indenture, and to examine the same to determine substantial compliance as to form with the express requirements hereof. Neither the Trustee nor any of its agents shall have any responsibility for any actions taken or
not taken by DTC. 
 SECTION 2.7. Form of Certificate to be Delivered upon Termination of Restricted Period. 

[Date] 
 Wolverine Healthcare
Analytics, Inc. 
 c/o The Bank of New York Mellon Trust Company, N.A. 
 2 N. LaSalle Street, Suite 1020 
 Chicago, IL 60602 

Attention: Corporate Trust Administration 

  
 54 

	Re:	Wolverine Healthcare Analytics, Inc. (the “Issuer”) 

 10.625% Senior Notes due 2020 (the “Notes”) 
 Ladies and Gentlemen: 

This letter relates to Notes represented by a temporary global Note (the “Temporary Regulation S Global Note”). Pursuant
to Section 2.1 of the Indenture dated as of June 6, 2012 relating to the Notes (as amended or supplemented, the “Indenture”), we hereby certify that the persons who are the beneficial owners of
$[            ] principal amount of Notes represented by the Temporary Regulation S Global Note are persons outside the United States to whom beneficial interests in such Notes could be
transferred in accordance with Rule 904 of Regulation S promulgated under the Securities Act of 1933, as amended. Accordingly, you are hereby requested to issue a Permanent Regulation S Global Note representing the undersigned’s interest in the
principal amount of Notes represented by the Temporary Regulation S Global Note, all in the manner provided by the Indenture. We certify that we [are][are not] an Affiliate of the Issuer. 

You and the Issuer are entitled to rely upon this letter and are irrevocably authorized to produce this letter or a copy hereof to any
interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby. Terms used in this letter have the meanings set forth in Regulation S. 

Very truly yours, 
 [Name of Transferor] 

By:                      
                                         
                                   

 

			
	                             
                                         
                                         
              	 	

                       
 Authorized Signature                                 

SECTION 2.8. Form of Certificate to be Delivered in Connection with Transfers to Institutional Accredited Investors. 

[Date] 
 Wolverine Healthcare
Analytics, Inc. 
 c/o The Bank of New York Mellon Trust Company, N.A. 
 2 N. LaSalle Street, Suite 1020 
 Chicago, IL 1020 

Attention: Corporate Trust Administration 

  
 55 

 Ladies and Gentlemen: 
 This certificate is delivered to request a transfer of $[            ] principal amount of the 10.625% Senior Notes due 2020 (the
“Notes”) of Wolverine Healthcare Analytics, Inc. (the “Issuer”). 
 Upon transfer, the Notes
would be registered in the name of the new beneficial owner as follows: 
  

	
	
Name:                          
                                         
                  

	
	
Address:                          
                                         
              

	
	 Taxpayer ID
Number:                                        
                     

 The undersigned represents and warrants to you that: 

1. We are an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities
Act of 1933, as amended (the “Securities Act”)) purchasing for our own account or for the account of such an institutional “accredited investor” at least $250,000 principal amount of the Notes, and we are acquiring the
Notes not with a view to, or for offer or sale in connection with, any distribution in violation of the Securities Act. We have such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risk of our
investment in the Notes and we invest in or purchase securities similar to the Notes in the normal course of our business. We and any accounts for which we are acting are each able to bear the economic risk of our or its investment. 

2. We understand that the Notes have not been registered under the Securities Act and, unless so registered, may not be sold except as
permitted in the following sentence. We agree on our own behalf and on behalf of any investor account for which we are purchasing Notes to offer, sell or otherwise transfer such Notes prior to the date that is one year after the later of the date of
original issue and the last date on which the Issuer or any affiliate of the Issuer was the owner of such Notes (or any predecessor thereto) (the “Resale Restriction Termination Date”) only (a) to the Issuer or any Subsidiary
thereof, (b) pursuant to an effective registration statement under the Securities Act, (c) in a transaction complying with the requirements of Rule 144A under the Securities Act, to a person we reasonably believe is a “qualified
institutional buyer” under Rule 144A of the Securities Act (a “QIB”) that is purchasing for its own account or for the account of a QIB and to whom notice is given that the transfer is being made in reliance on Rule 144A,
(d) pursuant to offers and sales to non-U.S. persons that occur outside the United States within the meaning of Regulation S under the Securities Act, (e) to an institutional “accredited investor” within the meaning of Rule
501(a)(1), (2), (3) or (7) under the Securities Act that is purchasing for its own account or for the account of such an institutional “accredited investor,” in each case in a minimum principal amount of Notes of $250,000 for
investment purposes and not with a view to or for offer or sale in connection with any distribution in violation of the Securities Act or (f) pursuant to any other available exemption from the registration requirements of the Securities Act,
subject in each of the foregoing cases to any requirement of law that the disposition of our property or the property of such investor account or accounts be at all times within our or their control and in compliance with any applicable state
securities laws. The foregoing restrictions on 

  
 56 

 
resale shall not apply subsequent to the Resale Restriction Termination Date. If any resale or other transfer of the Notes is proposed to be made pursuant to clause (e) above prior to the
Resale Restriction Termination Date, the transferor shall deliver a letter from the transferee substantially in the form of this letter to the Issuer and the Trustee, which shall provide, among other things, that the transferee is an institutional
“accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act) and that it is acquiring such Notes for investment purposes and not for distribution in violation of the Securities Act. Each
purchaser acknowledges that the Issuer and the Trustee reserve the right prior to any offer, sale or other transfer prior to the Resale Termination Date of the Notes pursuant to clauses (d), (e) or (f) above to require the delivery of an
opinion of counsel, certifications and/or other information satisfactory to the Issuer and the Trustee. 
 3. We [are][are not]
an Affiliate of the Issuer. 
  

			
		  	TRANSFEREE:                           
                                         
 
		
		  	BY:                             
                                         
                   

 SECTION 2.9. Form of Certificate to be Delivered in Connection with Transfers Pursuant to Regulation
S. 
 [Date] 

Wolverine Healthcare Analytics, Inc. 
 c/o The
Bank of New York Mellon Trust Company, N.A. 
 2 N. LaSalle Street, Suite 1020 
 Chicago, IL 60602 
 Attention: Corporate Trust Administration 

 

	 	Re:	Wolverine Healthcare Analytics, Inc. (the “Issuer”) 

10.625% Senior Notes due 2020 (the “Notes”) 
 Ladies and Gentlemen: 
 In connection with our proposed sale of
$[            ] aggregate principal amount of the Notes, we confirm that such sale has been effected pursuant to and in accordance with Regulation S under the United States Securities Act
of 1933, as amended (the “Securities Act”), and, accordingly, we represent that: 
 (a) the
offer of the Notes was not made to a person in the United States; 

  
 57 

 (b) either (i) at the time the buy order was originated, the transferee
was outside the United States or we and any person acting on our behalf reasonably believed that the transferee was outside the United States or (ii) the transaction was executed in, on or through the facilities of a designated off-shore
securities market and neither we nor any person acting on our behalf knows that the transaction has been pre-arranged with a buyer in the United States; 
 (c) no directed selling efforts have been made in the United States in contravention of the requirements of Rule 903(a)(2) or Rule 904(a)(2) of Regulation S, as applicable; and 

(d) the transaction is not part of a plan or scheme to evade the registration requirements of the Securities Act.

 In addition, if the sale is made during a restricted period and the provisions of Rule 903(b)(2), Rule 903(b)(3) or Rule
904(b)(1) of Regulation S are applicable thereto, we confirm that such sale has been made in accordance with the applicable provisions of Rule 903(b)(2), Rule 903(b)(3) or Rule 904(b)(1), as the case may be. 

We also hereby certify that we [are][are not] an Affiliate of the Issuer and, to our knowledge, the transferee of the Notes [is][is not]
an Affiliate of the Issuer. 
 You and the Issuer are entitled to rely upon this letter and are irrevocably authorized to
produce this letter or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby. Terms used in this certificate have the meanings set forth in Regulation S.

 Very truly yours, 
 [Name of Transferor] 

By:                      
                                         
                                   

 

			
	                             
                                         
                                         
              	 	

                       
 Authorized Signature                                 

SECTION 2.10. Mutilated, Destroyed, Lost or Stolen Notes. 

If a mutilated Note is surrendered to the Registrar or if the Holder of a Note claims that the Note has been lost, destroyed or
wrongfully taken, the Issuer shall issue and the Trustee shall authenticate a replacement Note if the requirements of Section 8-405 of the Uniform Commercial Code are met, such that the Holder (a) satisfies the Issuer or the Trustee that
such Note has been lost, destroyed or wrongfully taken within a reasonable time after such Holder has notice of such loss, destruction or wrongful taking and the Registrar has not registered a transfer prior to receiving such notification,
(b) makes such request to the Issuer or Trustee prior to the Note being acquired by a protected purchaser as defined in Section 8-303 of the Uniform Commercial Code (a “protected purchaser”) and (c) satisfies any
other reasonable requirements of 

  
 58 

 
the Trustee; provided, however, if after the delivery of such replacement Note, a protected purchaser of the Note for which such replacement Note was issued presents for payment or
registration such replaced Note, the Trustee or the Issuer shall be entitled to recover such replacement Note from the Person to whom it was issued and delivered or any Person taking therefrom, except a protected purchaser, and shall be entitled to
recover upon the security or indemnity provided therefor to the extent of any loss, damage, cost or expense incurred by the Issuer or the Trustee in connection therewith. If required by the Trustee or the Issuer, such Holder shall furnish an
indemnity bond sufficient in the judgment of the Issuer and the Trustee to protect the Issuer, the Trustee, the Paying Agent and the Registrar from any loss which any of them may suffer if a Note is replaced, and, in the absence of notice to the
Issuer, any Guarantor or the Trustee that such Note has been acquired by a protected purchaser, the Issuer shall execute, and upon receipt of an Issuer Order, the Trustee shall authenticate and make available for delivery, in exchange for any such
mutilated Note or in lieu of any such destroyed, lost or stolen Note, a new Note of like tenor and principal amount, bearing a number not contemporaneously outstanding. 
 In case any such mutilated, destroyed, lost or stolen Note has become or is about to become due and payable, the Issuer in its discretion may, instead of issuing a new Note, pay such Note. 

Upon the issuance of any new Note under this Section 2.10, the Issuer may require that such Holder pay a sum sufficient to
cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of counsel and of the Trustee and its counsel) in connection therewith. 

Subject to the proviso in the initial paragraph of this Section 2.10, every new Note issued pursuant to this Section in lieu
of any mutilated, destroyed, lost or stolen Note shall constitute an original additional contractual obligation of the Issuer, any Guarantor (if applicable) and any other obligor upon the Notes, whether or not the mutilated, destroyed, lost or
stolen Note shall be at any time enforceable by anyone, and shall be entitled to all benefits of this Indenture equally and proportionately with any and all other Notes duly issued hereunder. 

The provisions of this Section 2.10 are exclusive and shall preclude (to the extent lawful) all other rights and remedies
with respect to the replacement or payment of mutilated, destroyed, lost or stolen Notes. 
 SECTION 2.11. Outstanding
Notes. 
 Notes outstanding at any time are all Notes authenticated by the Trustee except for those cancelled by it, those
delivered to it for cancellation and those described in this Section as not outstanding. A Note does not cease to be outstanding in the event the Issuer or an Affiliate of the Issuer holds the Note; provided, however, that (i) for
purposes of determining which are outstanding for consent or voting purposes hereunder, the provisions of Section 12.6 shall apply and (ii) in determining whether the Trustee shall be protected in making a determination whether the
Holders of the requisite principal amount of outstanding Notes are present at a meeting of Holders of Notes for quorum purposes or have consented to or voted in favor of any request, demand, authorization, direction, notice, consent, waiver,
amendment or modification hereunder, or relying upon any such quorum, consent or vote, only Notes which a Trust Officer of the Trustee actually knows to be held by the Issuer or an Affiliate of the Issuer shall not be considered outstanding.

  
 59 

 If a Note is replaced pursuant to Section 2.10 (other than a mutilated Note
surrendered for replacement), it ceases to be outstanding unless the Trustee and the Issuer receive proof satisfactory to them that the replaced Note is held by a protected purchaser. A mutilated Note ceases to be outstanding upon surrender of such
Note and replacement pursuant to Section 2.10. 
 If the Paying Agent segregates and holds in trust, in accordance
with this Indenture, on a Redemption Date or maturity date money sufficient to pay all principal, premium, if any, and accrued interest payable on that date with respect to the Notes (or portions thereof) to be redeemed or maturing, as the case may
be, and the Paying Agent is not prohibited from paying such money to the Holders on that date pursuant to the terms of this Indenture, then on and after that date such Notes (or portions thereof) cease to be outstanding and interest on them ceases
to accrue. 
 SECTION 2.12. Temporary Notes. 
 In the event that Definitive Notes are to be issued under the terms of this Indenture, until such Definitive Notes are ready for delivery, the Issuer may prepare and the Trustee shall authenticate
temporary Notes. Temporary Notes shall be substantially in the form, and shall carry all rights, of Definitive Notes but may have variations that the Issuer considers appropriate for temporary Notes. Without unreasonable delay, the Issuer shall
prepare and the Trustee shall authenticate Definitive Notes. After the preparation of Definitive Notes, the temporary Notes shall be exchangeable for Definitive Notes upon surrender of the temporary Notes at any office or agency maintained by the
Issuer for that purpose and such exchange shall be without charge to the Holder. Upon surrender for cancellation of any one or more temporary Notes, the Issuer shall execute, and the Trustee shall authenticate and make available for delivery in
exchange therefor, one or more Definitive Notes representing an equal principal amount of Notes. Until so exchanged, the Holder of temporary Notes shall in all respects be entitled to the same benefits under this Indenture as a Holder of Definitive
Notes. 
 SECTION 2.13. Cancellation. 
 The Issuer at any time may deliver Notes to the Trustee for cancellation. The Registrar and the Paying Agent shall forward to the Trustee any Notes surrendered to them for registration of transfer,
exchange or payment. The Trustee and no one else shall cancel all Notes surrendered for registration of transfer, exchange, payment or cancellation and dispose of such Notes in accordance with its internal policies and customary procedures including
delivery of a certificate describing such Notes disposed (subject to the record retention requirements of the Exchange Act) to the Issuer pursuant to written direction by one Officer. If the Issuer or any Guarantor acquires any of the Notes, such
acquisition shall not operate as a redemption or satisfaction of the Indebtedness represented by such Notes unless and until the same are surrendered to the Trustee for cancellation pursuant to this Section 2.13. The Issuer may not issue
new Notes to replace Notes it has paid or delivered to the Trustee for cancellation for any reason other than in connection with a transfer or exchange. 

  
 60 

 At such time as all beneficial interests in a Global Note have either been exchanged for
Definitive Notes, transferred, redeemed, repurchased or canceled, such Global Note shall be returned by DTC to the Trustee for cancellation or retained and canceled by the Trustee. At any time prior to such cancellation, if any beneficial interest
in a Global Note is exchanged for Definitive Notes, transferred in exchange for an interest in another Global Note, redeemed, repurchased or canceled, the principal amount of Notes represented by such Global Note shall be reduced and an adjustment
shall be made on the Schedule of Increases and Decreases to such Global Note and on the books and records of the Trustee (if it is then the Notes Custodian for such Global Note) with respect to such Global Note, by the Trustee or the Notes
Custodian, to reflect such reduction. 
 SECTION 2.14. Payment of Interest; Defaulted Interest. 

Interest on any Note which is payable, and is punctually paid or duly provided for, on any interest payment date shall be paid to the
Person in whose name such Note (or one or more Predecessor Notes) is registered at the close of business on the regular record date for such payment at the office or agency of the Issuer maintained for such purpose pursuant to
Section 2.3. 
 Any interest on any Note which is payable, but is not paid when the same becomes due and payable and
such nonpayment continues for a period of 30 days shall forthwith cease to be payable to the Holder on the regular record date, and such defaulted interest and (to the extent lawful) interest on such defaulted interest at the rate borne by the Notes
(such defaulted interest and interest thereon herein collectively called “Defaulted Interest”) shall be paid by the Issuer, at its election in each case, as provided in clause (a) or (b) below: 

(a) The Issuer may elect to make payment of any Defaulted Interest to the Persons in whose names the Notes (or their respective
predecessor Notes) are registered at the close of business on a Special Record Date (as defined below) for the payment of such Defaulted Interest, which shall be fixed in the following manner. The Issuer shall notify the Trustee in writing of the
amount of Defaulted Interest proposed to be paid on each Note and the date (not less than 30 days after such notice) of the proposed payment (the “Special Interest Payment Date”), and at the same time the Issuer shall deposit with
the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when
deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Interest as in this Section 2.14(a). Thereupon the Issuer shall fix a record date (the “Special Record Date”) for the payment of
such Defaulted Interest, which date shall be not more than 15 days and not less than 10 days prior to the Special Interest Payment Date and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment. The Issuer
shall promptly notify the Trustee of such Special Record Date, and in the name and at the expense of the Issuer, the Trustee shall cause notice of the proposed payment of such Defaulted Interest and the Special Record Date and Special Interest
Payment Date therefor to be given in the manner provided for in Section 12.2, not less than 10 days prior to such Special Record Date. Notice of the proposed payment of such Defaulted Interest and the Special Record Date and Special
Interest Payment Date therefor having been so given, such Defaulted Interest shall be paid on the Special Interest Payment Date to the Persons in whose names the Notes (or their respective predecessor Notes) are registered at the close of business
on such Special Record Date and shall no longer be payable pursuant to the provisions in Section 2.14(b). 

  
 61 

 (b) The Issuer may make payment of any Defaulted Interest in any other lawful manner not
inconsistent with the requirements of any securities exchange on which the Notes may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Issuer to the Trustee of the proposed payment pursuant to this
Section 2.14(b), such manner of payment shall be deemed practicable by the Trustee. 
 Subject to the foregoing
provisions of this Section 2.14, each Note delivered under this Indenture upon registration of, transfer of or in exchange for or in lieu of any other Note shall carry the rights to interest accrued and unpaid, and to accrue, which were
carried by such other Note. 
 SECTION 2.15. CUSIP, Common Code and ISIN Numbers. 

The Issuer in issuing the Notes may use “CUSIP”, “Common Code” and “ISIN” numbers and, if so, the Trustee
shall use “CUSIP”, “Common Code” and “ISIN” numbers in notices, including notices of redemption or purchase, as a convenience to Holders; provided, however, that any such notice may state that no representation
is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice of a redemption or purchase and that reliance may be placed only on the other identification numbers printed on the Notes, and any such
notice, redemption or purchase shall not be affected by any defect in or omission of such CUSIP, Common Code and ISIN numbers. The Issuer shall promptly notify the Trustee in writing of any change in the CUSIP, Common Code and ISIN numbers.

 ARTICLE III  
 COVENANTS 
 SECTION 3.1. Payment of Notes. 

The Issuer shall pay the principal of, premium, if any, and interest (including Additional Interest) on the Notes on the dates and in the
manner provided in the Notes and in this Indenture. Principal, premium, if any, and interest (including Additional Interest) shall be considered paid on the date due if on such date the Trustee or the Paying Agent holds in accordance with this
Indenture money sufficient to pay all principal, premium, if any, and interest (including Additional Interest) then due. 
 The
Issuer shall pay interest on overdue principal at the rate specified therefor in the Notes, and it shall pay interest on overdue installments of interest (including Additional Interest) at the same rate to the extent lawful. 

Notwithstanding anything to the contrary contained in this Indenture, the Issuer may, to the extent it is required to do so by law,
deduct or withhold income or other similar taxes imposed by the United States of America from principal or interest payments hereunder. 

  
 62 

 SECTION 3.2. Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock. 
 (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or
indirectly, create, incur, issue, assume, guarantee or otherwise become directly or indirectly liable, contingently or otherwise, (collectively, “incur” and collectively, an “incurrence”) with respect to any
Indebtedness (including Acquired Indebtedness) and the Issuer shall not issue any shares of Disqualified Stock and shall not permit any Restricted Subsidiary to issue any shares of Disqualified Stock or Preferred Stock; provided, however,
that the Issuer may incur Indebtedness (including Acquired Indebtedness) or issue shares of Disqualified Stock, and any of its Restricted Subsidiaries may incur Indebtedness (including Acquired Indebtedness), issue shares of Disqualified Stock
and issue shares of Preferred Stock, if the Fixed Charge Coverage Ratio on a consolidated basis for the Issuer and its Restricted Subsidiaries’ most recently ended four fiscal quarters for which internal financial statements are available
immediately preceding the date on which such additional Indebtedness is incurred or such Disqualified Stock or Preferred Stock is issued would have been at least 2.00 to 1.00, determined on a pro forma basis (including a pro forma application of the
net proceeds therefrom), as if the additional Indebtedness had been incurred, or the Disqualified Stock or Preferred Stock had been issued, as the case may be, and the application of proceeds therefrom had occurred at the beginning of such
four-quarter period; provided, further, that Non-Guarantor Subsidiaries may not incur Indebtedness or issue Disqualified Stock or Preferred Stock if, after giving pro forma effect to such incurrence or issuance (including a pro forma
application of the net proceeds therefrom), more than an aggregate of $35.0 million of Indebtedness or Disqualified Stock or Preferred Stock of such Non-Guarantor Subsidiaries would be outstanding pursuant to this Section 3.2(a) at such
time. 
 (b) The limitations of Section 3.2(a) shall not apply to: 

(1) the incurrence of Indebtedness under Debt Facilities by the Issuer or any of the Subsidiary Guarantors and the
issuance and creation of letters of credit and bankers’ acceptances thereunder (with letters of credit and bankers’ acceptances being deemed to have a principal amount equal to the face amount thereof), up to an aggregate principal amount
equal to the greater of (x) $650.0 million and (y) the amount such that at the time of incurrence, and after giving pro forma effect thereto, the Consolidated Secured Debt Ratio would be no greater than 4.0 to 1.0; provided that the
aggregate principal amount of Indebtedness incurred pursuant to this Section 3.2(b)(1) shall not exceed $725.0 million; and provided further that any Indebtedness incurred by the Issuer or any Subsidiary Guarantor pursuant to
clause (y) above shall be deemed to be secured by Liens for the purpose of calculating the Consolidated Secured Debt Ratio; 
 (2) the incurrence by the Issuer and any Subsidiary Guarantor of Indebtedness represented by the Notes (including any Guarantee) (other than any Additional Notes) and Exchange Notes issued in respect of
such Notes and any Guarantee thereof; 
 (3) Indebtedness of the Issuer and its Restricted Subsidiaries in
existence on the Issue Date (other than Indebtedness described in Sections 3.2(b)(1) and 3.2(b)(2)); 

  
 63 

 (4) Indebtedness (including Capitalized Lease Obligations) incurred or,
Disqualified Stock and Preferred Stock issued by the Issuer or any of its Restricted Subsidiaries to finance the purchase, lease or improvement of property (real or personal) or equipment that is used or useful in a Similar Business, whether through
the direct purchase of assets or the Capital Stock of any Person owning such assets; provided that the aggregate amount of Indebtedness, Disqualified Stock and Preferred Stock incurred pursuant to this Section 3.2(b)(4), when
aggregated with the outstanding amount of Indebtedness, Disqualified Stock and Preferred Stock incurred pursuant to Section 3.2(b)(13) to refinance Indebtedness, Disqualified Stock and Preferred Stock initially incurred in reliance on this
Section 3.2(b)(4), does not exceed the greater of (x) $25.0 million and (y) 1.50% of Total Assets at any one time outstanding; 
 (5) Indebtedness incurred by the Issuer or any of its Restricted Subsidiaries constituting reimbursement obligations with respect to letters of credit issued in the ordinary course of business, including,
without limitation, letters of credit in respect of workers’ compensation claims, health, disability or other employee benefits or property, casualty or liability insurance or self insurance, or other Indebtedness with respect to reimbursement
type obligations regarding workers’ compensation claims; provided, however, that upon the drawing of such letters of credit or the incurrence of such Indebtedness, such obligations are reimbursed within 30 days following such drawing or
incurrence; 
 (6) Indebtedness arising from agreements of the Issuer or its Restricted Subsidiaries providing
for indemnification, adjustment of purchase price or similar obligations, in each case, incurred or assumed in connection with the acquisition or disposition of any business, assets or a Subsidiary, other than guarantees of Indebtedness incurred by
any Person acquiring all or any portion of such business, assets or a Subsidiary for the purpose of financing such acquisition; provided, however, that 
  

	 	(A)	such Indebtedness is not reflected on the balance sheet of the Issuer, or any of its Restricted Subsidiaries prepared in accordance with GAAP (contingent obligations
referred to in a footnote to financial statements and not otherwise reflected on the balance sheet shall not be deemed to be reflected on such balance sheet for purposes of this Section 3.2(b)(6)(A)); and 

 

	 	(B)	with respect to a disposition, the maximum assumable liability in respect of all such Indebtedness shall at no time exceed the gross proceeds including non-cash
proceeds (the fair market value of such non-cash proceeds being measured at the time received and without giving effect to any subsequent changes in value) actually received by the Issuer and its Restricted Subsidiaries in connection with such
disposition; 

 (7) Indebtedness of the Issuer to a Restricted Subsidiary; provided that any
such Indebtedness owing to a Non-Guarantor Subsidiary is expressly subordinated in right of payment to the Notes; provided, further, that any subsequent issuance or transfer of 

  
 64 

 
any Capital Stock or any other event which results in any Restricted Subsidiary ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such Indebtedness (except to the
Issuer or another Restricted Subsidiary) shall be deemed, in each case, to be an incurrence of such Indebtedness not permitted by this Section 3.2(b)(7); 

(8) Indebtedness of a Restricted Subsidiary owing to the Issuer or another Restricted Subsidiary; provided that if
a Subsidiary Guarantor incurs such Indebtedness owing to a Restricted Subsidiary that is not a Subsidiary Guarantor, such Indebtedness is expressly subordinated in right of payment to the Guarantee of the Notes of such Subsidiary Guarantor;
provided further that any subsequent issuance or transfer of any Capital Stock or any other event which results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any subsequent transfer of any such Indebtedness
(except to the Issuer or another Restricted Subsidiary) shall be deemed, in each case, to be an incurrence of such Indebtedness not permitted by this Section 3.2(b)(8); 

(9) shares of Preferred Stock of a Restricted Subsidiary issued to the Issuer or another Restricted Subsidiary;
provided that any subsequent issuance or transfer of any Capital Stock or any other event which results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such shares of Preferred
Stock (except to the Issuer or another of its Restricted Subsidiaries) shall be deemed in each case to be an issuance of such shares of Preferred Stock not permitted by this Section 3.2(b)(9); 

(10) Hedging Obligations (excluding Hedging Obligations entered into for speculative purposes) for the purpose of limiting
interest rate risk or exchange rate risk; 
 (11) obligations in respect of performance, bid, appeal and surety
bonds and performance and completion guarantees or obligations in respect of letters of credit related thereto provided by the Issuer or any of its Restricted Subsidiaries in the ordinary course of business; 

(12) (A) Indebtedness or Disqualified Stock of the Issuer and Indebtedness, Disqualified Stock or Preferred Stock of any
Restricted Subsidiary of the Issuer equal to 100.0% of the net cash proceeds received by the Issuer since immediately after the Issue Date from the issue or sale of Equity Interests of the Issuer or cash contributed to the capital of the Issuer (in
each case, other than contributions in connection with the Transactions and Excluded Contributions or proceeds of Disqualified Stock or Designated Preferred Stock or sales of Equity Interests to the Issuer or any of its Subsidiaries or amounts
applied to make a Restricted Payment in accordance with Section 3.3(b)(2)) as determined in accordance with Sections 3.3(a)(C)(ii) and 3.3(a)(C)(iii) to the extent such net cash proceeds or cash have not been applied
pursuant to such clauses to make Restricted Payments or to make other Investments, payments or exchanges pursuant to Section 3.3(b) or to make Permitted Investments (other than Permitted Investments specified in clauses (1) and
(3) of the definition thereof) (together with amounts applied under Section 3.2(b)(13) to refinance Indebtedness or Disqualified Stock initially incurred in reliance on this clause 12(A)) and (B) Indebtedness or Disqualified
Stock of the Issuer and Indebtedness, Disqualified Stock or Preferred Stock of any Restricted Subsidiary not 

  
 65 

 
otherwise permitted hereunder in an aggregate principal amount or liquidation preference, which when aggregated with the principal amount and liquidation preference of all other Indebtedness,
Disqualified Stock and Preferred Stock then outstanding and incurred pursuant to this clause (12)(B), does not at any one time outstanding exceed the greater of (x) $40.0 million and (y) 2.50% of Total Assets; 

(13) the incurrence or issuance by the Issuer of Indebtedness or Disqualified Stock or the incurrence or issuance by a
Restricted Subsidiary of Indebtedness, Disqualified Stock or Preferred Stock which serves to refund or refinance any Indebtedness incurred or Disqualified Stock or Preferred Stock issued as permitted under Section 3.2(a) and Sections
3.2(b)(2), 3.2(b)(3), 3.2(b)(4), 3.2(b)(12)(A) above, this Section 3.2(b)(13) and Section 3.2(b)(14) below or any Indebtedness incurred or Disqualified Stock or Preferred Stock issued to so refund or
refinance such Indebtedness, Disqualified Stock or Preferred Stock including additional Indebtedness incurred or Disqualified Stock or Preferred Stock issued to pay premiums (including tender premiums), defeasance costs and fees in connection
therewith (the “Refinancing Indebtedness”) prior to its respective maturity; provided, however, that such Refinancing Indebtedness: 
  

	 	(A)	has a Weighted Average Life to Maturity at the time such Refinancing Indebtedness is incurred which is not less than the remaining Weighted Average Life to Maturity of
the Indebtedness, Disqualified Stock or Preferred Stock being refunded or refinanced; 

  

	 	(B)	to the extent such Refinancing Indebtedness refinances (i) Indebtedness subordinated or pari passu to the Notes or any Guarantee thereof, such Refinancing
Indebtedness is subordinated or pari passu to the Notes or the Guarantee at least to the same extent as the Indebtedness being refinanced or refunded or (ii) Disqualified Stock or Preferred Stock, such Refinancing Indebtedness must be
Disqualified Stock or Preferred Stock, respectively; 

  

	 	(C)	shall not include: 

 (x)
Indebtedness, Disqualified Stock or Preferred Stock of a Non-Guarantor Subsidiary that refinances Indebtedness, Disqualified Stock or Preferred Stock of the Issuer; 
 (y) Indebtedness, Disqualified Stock or Preferred Stock of a Non-Guarantor Subsidiary that refinances Indebtedness, Disqualified Stock or Preferred Stock of a Subsidiary Guarantor; or 

(z) Indebtedness, Disqualified Stock or Preferred Stock of the Issuer or a Restricted Subsidiary that refinances Indebtedness,
Disqualified Stock or Preferred Stock of an Unrestricted Subsidiary; 

  
 66 

	 	(D)	shall not be in a principal amount in excess of the principal amount of, premium, if any, accrued interest on and related fees and expenses (including tender premiums)
of, the Indebtedness being refunded or refinanced; and 

  

	 	(E)	shall not have a Stated Maturity date prior to the earlier of the Stated Maturity of the Indebtedness being so refunded or refinanced or the Stated Maturity of the
Notes; 

 and provided further that subclauses (A) and (E) of this clause (13) shall not
apply to any refunding or refinancing of any Indebtedness outstanding under the Senior Credit Facility; 
 (14)
Indebtedness, Disqualified Stock or Preferred Stock of (x) the Issuer or a Restricted Subsidiary incurred or issued to finance an acquisition or (y) Persons that are acquired by the Issuer or any Restricted Subsidiary or merged into or
consolidated with the Issuer or a Restricted Subsidiary in accordance with the terms of the Indenture; provided that after giving effect to such acquisition, merger or consolidation, either 

 

	 	(A)	the Issuer would be permitted to incur at least $1.00 of additional Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in
Section 3.2(a), or 

  

	 	(B)	the Fixed Charge Coverage Ratio of the Issuer and the Restricted Subsidiaries is greater than immediately prior to such acquisition, merger or consolidation;

 (15) Indebtedness arising from the honoring by a bank or other financial institution of a check,
draft or similar instrument drawn against insufficient funds in the ordinary course of business; provided that such Indebtedness is extinguished within five Business Days of its incurrence; 

(16) Indebtedness of the Issuer or any of its Restricted Subsidiaries supported by a letter of credit issued pursuant to
the Senior Credit Facility, in a principal amount not in excess of the stated amount of such letter of credit; 

(17) (A) any guarantee by the Issuer or a Subsidiary Guarantor of Indebtedness or other obligations of any Restricted
Subsidiary so long as the incurrence of such Indebtedness is permitted under the terms of the Indenture; provided that if such Indebtedness is by its express terms subordinated in right of payment to the Guarantee of such Restricted
Subsidiary, any such guarantee of the Issuer or such Subsidiary Guarantor with respect to such Indebtedness shall be subordinated in right of payment to the Notes or such Subsidiary Guarantors’ Guarantee with respect to the Notes substantially
to the same extent as such Indebtedness is subordinated to the Guarantee of such Restricted Subsidiary, as applicable; 

  
 67 

	 	(B)	any guarantee by a Subsidiary Guarantor of Indebtedness of the Issuer provided that such guarantee is incurred in accordance with Section 3.7; provided
that if such Indebtedness is by its express terms subordinated in right of payment to the Notes, any such guarantee of such Subsidiary Guarantor with respect to such Indebtedness shall be subordinated in right of payment to such Subsidiary
Guarantors’ Guarantee with respect to the Notes substantially to the same extent as such Indebtedness is subordinated to the Notes, as applicable or 

  

	 	(C)	any guarantee by a Non-Guarantor Subsidiary of Indebtedness of another Non-Guarantor Subsidiary incurred in accordance with the terms of the Indenture;

 (18) Indebtedness of the Issuer or any of its Restricted Subsidiaries consisting of (i) the
financing of insurance premiums or (ii) take-or-pay obligations contained in supply arrangements, in each case incurred in the ordinary course of business; 
 (19) Indebtedness consisting of Indebtedness issued by the Issuer or any of its Restricted Subsidiaries to current or former officers, members of the board of directors and employees and consultants
thereof, their respective estates, spouses or former spouses, in each case to finance, either directly or through promissory notes issued to such persons, the purchase or redemption of Equity Interests of the Issuer or any direct or indirect parent
company of the Issuer to the extent described in Section 3.3(b)(4); 
 (20) to the extent
constituting Indebtedness, customer deposits and advance payments (including progress premiums) received in the ordinary course of business from customers for products, goods and services purchased by customers in the ordinary course of business;
and 
 (21) Indebtedness of Foreign Subsidiaries of the Issuer not to exceed the greater of (x) $15.0
million and (y) 1.00% of Total Assets at any one time outstanding. 
 (c) For purposes of determining compliance with this
covenant: 
 (1) in the event that an item of Indebtedness, Disqualified Stock or Preferred Stock (or any portion
thereof) meets the criteria of more than one of the categories of permitted Indebtedness, Disqualified Stock or Preferred Stock described in Section 3.2(b)(1) through Section 3.2(b)(21) above or is entitled to be incurred
pursuant to Section 3.2(a), the Issuer, in its sole discretion, shall classify or reclassify such item of Indebtedness, Disqualified Stock or Preferred Stock (or any portion thereof) and shall only be required to include the amount and
type of such Indebtedness, Disqualified Stock or Preferred Stock in one of the clauses set forth in Section 3.2(a) or Section 3.2(b). Additionally, all or any portion of any item of Indebtedness may later be classified as
having been incurred pursuant to any category of permitted Indebtedness described in Section 3.2(b)(1) through Section 3.2(b)(21) above or pursuant to Section 3.2(a) so long as such Indebtedness is permitted to be
incurred pursuant to such provision at the time of reclassification. Notwithstanding the foregoing, all Indebtedness outstanding under the Senior Credit Facility on the Issue Date shall be treated as incurred on the Issue Date under
Section 3.2(b)(1) and may not later be reclassified; and 

  
 68 

 (2) at the time of incurrence, the Issuer shall be entitled to divide and
classify an item of Indebtedness in more than one of the types of Indebtedness described in Sections 3.2(a) and 3.2(b). 
 Accrual of interest or dividends, the accretion of accreted value, the accretion or amortization of original issue discount and the payment of interest or dividends in the form of additional Indebtedness,
Disqualified Stock or Preferred Stock shall not be deemed to be an incurrence of Indebtedness, Disqualified Stock or Preferred Stock for purposes of this Section 3.2. 

For purposes of determining compliance with any U.S. dollar-denominated restriction on the incurrence of Indebtedness, the U.S.
dollar-equivalent principal amount of Indebtedness denominated in a foreign currency shall be calculated based on the relevant currency exchange rate in effect on the date such Indebtedness was incurred, in the case of term debt, or first committed,
in the case of revolving credit debt; provided that if such Indebtedness is incurred to refinance other Indebtedness denominated in a foreign currency, and such refinancing would cause the applicable U.S. dollar-denominated restriction to be
exceeded if calculated at the relevant currency exchange rate in effect on the date of such refinancing, such U.S. dollar-denominated restriction shall be deemed not to have been exceeded so long as the principal amount of such refinancing
Indebtedness does not exceed the principal amount of such Indebtedness being refinanced. 
 The principal amount of any
Indebtedness incurred to refinance other Indebtedness, if incurred in a different currency from the Indebtedness being refinanced, shall be calculated based on the currency exchange rate applicable to the currencies in which such respective
Indebtedness is denominated that is in effect on the date of such refinancing. 
 The Issuer shall not, and shall not permit any
Subsidiary Guarantor to, directly or indirectly, incur any Indebtedness (including Acquired Indebtedness) that is subordinated or junior in right of payment to any Indebtedness of the Issuer or such Subsidiary Guarantor, as the case may be, unless
such Indebtedness is expressly subordinated in right of payment to the Notes or such Subsidiary Guarantor’s Guarantee to the extent and in the same manner as such Indebtedness is subordinated to other Indebtedness of the Issuer or such
Subsidiary Guarantor, as the case may be. 
 For purposes of this Indenture, (1) unsecured Indebtedness shall not be
treated as subordinated or junior to Secured Indebtedness merely because it is unsecured or (2) Senior Indebtedness shall not be treated as subordinated or junior to any other Senior Indebtedness merely because it has a junior priority with
respect to the same collateral or is secured by different collateral. 
 SECTION 3.3. Limitation on
Restricted Payments. 
 (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or
indirectly: 
 (i) declare or pay any dividend or make any payment or distribution on account of the
Issuer’s or any of its Restricted Subsidiaries’ Equity Interests, including any dividend or distribution payable in connection with any merger or consolidation other than: 

  
 69 

	 	(A)	dividends or distributions by the Issuer payable solely in Equity Interests (other than Disqualified Stock) of the Issuer; or 

 

	 	(B)	dividends or distributions by a Restricted Subsidiary to the Issuer or any other Restricted Subsidiary (and if such Restricted Subsidiary is not a Wholly-Owned
Subsidiary, to its other holders of Equity Interests on a pro rata basis) so long as, in the case of any dividend or distribution payable on or in respect of any class or series of securities issued by a Restricted Subsidiary other than a
Wholly-Owned Subsidiary, the Issuer or a Restricted Subsidiary receives at least its pro rata share of such dividend or distribution in accordance with its Equity Interests in such class or series of securities; 

(ii) purchase, redeem, defease or otherwise acquire or retire for value any Equity Interests of the Issuer or any direct
or indirect parent of the Issuer, including in connection with any merger or consolidation involving the Issuer; 

(iii) make any principal payment on, or redeem, repurchase, defease or otherwise acquire or retire for value, in each
case, prior to any scheduled repayment, sinking fund payment or maturity, any Subordinated Indebtedness, other than: 
  

	 	(A)	Indebtedness permitted under Sections 3.2(b)(7) and 3.2(b)(8); or 

 

	 	(B)	the purchase, repurchase or other acquisition of Subordinated Indebtedness purchased in anticipation of satisfying a sinking fund obligation, principal installment or
final maturity, in each case due within one year of the date of purchase, repurchase or acquisition; or 

  

	 	(iv)	make any Restricted Investment; 

(all such payments and other actions set forth in clauses (i) through (iv) above being collectively referred to as
“Restricted Payments”), unless, at the time of such Restricted Payment: 
  

	 	(A)	no Default shall have occurred and be continuing or would occur as a consequence thereof; 

 

	 	(B)	immediately after giving effect to such transaction on a pro forma basis, the Issuer could incur $1.00 of additional Indebtedness under Section 3.2(a); and

  

	 	(C)	such Restricted Payment, together with the aggregate amount of all other Restricted Payments made by the Issuer and its Restricted Subsidiaries after the Issue Date
(including Restricted Payments permitted by Sections 3.3(b)(1), (9) and (14), but excluding all other Restricted Payments permitted by Section 3.3(b)), is less than the sum of (without duplication):

  
 70 

 
			
	 i        50% of the Consolidated Net Income of the Issuer for the period
(taken as one accounting period) commencing on the Issue Date, to the end of the Issuer’s most recently ended fiscal quarter for which internal financial statements are available at the time of such Restricted Payment, or, in the case such
Consolidated Net Income for such period is a deficit, minus 100% of such deficit; plus

	
	 ii       100% of the aggregate net cash proceeds and the fair market value, as
determined in Good Faith by the Issuer, of marketable securities or other property received by the Issuer since immediately after the Issue Date (other than net cash proceeds to the extent such net cash proceeds have been used to incur Indebtedness,
Disqualified Stock or Preferred Stock pursuant to Section 3.2(b)(12)(A)) from the issue or sale of:

	
	 a        (x) Equity Interests of the Issuer, including Treasury Capital Stock
(as defined below), but excluding cash proceeds and the fair market value, as determined in Good Faith by the Issuer, of marketable securities or other property received from the sale of:

	
	 1       Equity Interests to members of management, members of the board of
directors or consultants of the Issuer, any direct or indirect parent company of the Issuer and the Issuer’s Subsidiaries after the Issue Date to the extent such amounts have been applied to Restricted Payments made in accordance with
Section 3.3(b)(4); and

	
	 2       Designated Preferred Stock; and

	
	 (y) to the extent such net cash proceeds are actually contributed to the Issuer, Equity Interests of the Issuer’s direct or indirect
parent companies (excluding contributions of the proceeds from the sale of Designated Preferred Stock of such companies or contributions to the extent such amounts have been applied to Restricted Payments made in accordance with Section
3.3(b)(4); or

	
	 b       debt securities of the Issuer that have been converted into or exchanged
for such Equity Interests of the Issuer or any direct or indirect parent of the Issuer;

  
 71 

			
	
	 provided, however, that in addition to clauses a. and b. referred to above, this clause (ii) shall not include the proceeds from
(V) the sale of Equity Interests used to incur Indebtedness or issue shares of Disqualified Stock or Preferred Stock pursuant to Section 3.2(b)(12)(A), (W) Refunding Capital Stock (as defined below), (X) Equity Interests or convertible debt
securities of the Issuer, in either case, sold to a Restricted Subsidiary, (Y) Disqualified Stock or debt securities that have been converted into Disqualified Stock or (Z) Excluded Contributions; plus

	
	 iii      100% of the aggregate amount of cash and the fair market value, as determined
in Good Faith by the Issuer, of marketable securities or other property contributed to the capital of the Issuer following the Issue Date (other than contributions in connection with the Transactions and net cash proceeds to the extent such net cash
proceeds (i) have been used to incur Indebtedness or issue Disqualified Stock or Preferred Stock pursuant to Section 3.2(b)(12)(A), (ii) are contributed by a Restricted Subsidiary or (iii) constitute Excluded Contributions);
plus

	
	 iv      100% of the aggregate amount received in cash or Cash Equivalents and the fair
market value, as determined in Good Faith by the Issuer, of marketable securities or other property received by means of:

	
	 a       the sale or other disposition (other than to the Issuer or a Restricted
Subsidiary) of Restricted Investments made by the Issuer or its Restricted Subsidiaries and repurchases and redemptions of such Restricted Investments from the Issuer or its Restricted Subsidiaries and repayments of loans or advances, and releases
of guarantees, which constitute Restricted Investments by the Issuer or its Restricted Subsidiaries, in each case after the Issue Date; or

	
	 b       the sale (other than to the Issuer or a Restricted Subsidiary) of the
stock of an Unrestricted Subsidiary or a distribution from an Unrestricted Subsidiary (other than in each case to the extent of the amount of the

  
 72 

			
	          Investment in such Unrestricted Subsidiary made by the Issuer
or a Restricted Subsidiary pursuant to Sections 3.3(b)(7) or 3.3(b)(11) hereof or to the extent of the amount of the Investment that constituted a Permitted Investment) or a dividend from an Unrestricted Subsidiary after the Issue
Date; plus

	
	 v       in the case of the redesignation of an Unrestricted Subsidiary as a
Restricted Subsidiary or the merger or consolidation of an Unrestricted Subsidiary into the Issuer or a Restricted Subsidiary or the transfer of all or substantially all of the assets of an Unrestricted Subsidiary to the Issuer or a Restricted
Subsidiary after the Issue Date, the fair market value of the Investment in such Unrestricted Subsidiary (or the assets transferred), as determined in Good Faith by the Issuer or, if such fair market value exceeds $30.0 million, in writing by an
Independent Financial Advisor, at the time of the redesignation of such Unrestricted Subsidiary as a Restricted Subsidiary or at the time of such merger or consolidation or transfer of assets (after taking into consideration any Indebtedness
associated with the Unrestricted Subsidiary so designated or merged or consolidated or Indebtedness associated with the assets so transferred), other than to the extent of the amount of the Investment in such Unrestricted Subsidiary made by the
Issuer or a Restricted Subsidiary pursuant to Sections 3.3(b)(7) or 3.3(b)(11) or to the extent of the amount of the Investment that constituted a Permitted Investment.

 (b) The foregoing provisions of Section 3.3(a) hereof shall not prohibit: 

(1) the payment of any dividend or distribution within 60 days after the date of declaration thereof, if at the date of
declaration such payment would have complied with the provisions of the Indenture or the redemption, repurchase or retirement of Indebtedness if, at the date of any irrevocable redemption notice such payment would have complied with the provisions
of the Indenture; 
 (2) (a) the redemption, repurchase, retirement or other acquisition of any Equity Interests
(“Treasury Capital Stock”) or Subordinated Indebtedness of the Issuer, or any Equity Interests of any direct or indirect parent company of the Issuer, in exchange for, or out of the proceeds of, the substantially concurrent sale or
issuance (other than to a Restricted Subsidiary) of, Equity Interests of the Issuer or any direct or indirect parent company of the Issuer to the extent contributed to the Issuer (in each case, other than any Disqualified Stock) (“Refunding
Capital Stock”), (b) the declaration and payment of dividends on Treasury Capital Stock out of the proceeds of the substantially concurrent 

  
 73 

 
sale or issuance (other than to a Subsidiary of the Issuer or to an employee stock ownership plan or any trust established by the Issuer or any of its Subsidiaries) of Refunding Capital Stock,
and (c) if immediately prior to the retirement of Treasury Capital Stock, the declaration and payment of dividends thereon was permitted under Section 3.3(b)(6), the declaration and payment of dividends on the Refunding Capital
Stock (other than Refunding Capital Stock the proceeds of which were used to redeem, repurchase, retire or otherwise acquire any Equity Interests of any direct or indirect parent company of the Issuer) in an aggregate amount per year no greater than
the aggregate amount of dividends per annum that were declarable and payable on such Treasury Capital Stock immediately prior to such retirement; 
 (3) the redemption, repurchase, defeasance or other acquisition or retirement for value of Subordinated Indebtedness of the Issuer or a Subsidiary Guarantor made by exchange for, or out of the proceeds of
the substantially concurrent sale of, new Indebtedness of the Issuer or such Subsidiary Guarantor, as the case may be, which is incurred in compliance with the provisions of Section 3.2 so long as: 

 

	 	(A)	the principal amount (or accreted value, if applicable) of such new Indebtedness does not exceed the principal amount of (or accreted value, if applicable), plus any
accrued and unpaid interest on, the Subordinated Indebtedness being so redeemed, repurchased, defeased, exchanged, acquired or retired for value, plus the amount of any premium (including any tender premiums), defeasance costs and any fees and
expenses incurred in connection with such redemption, repurchase, defeasance, exchange, acquisition or retirement and the issuance of such new Indebtedness; 

 

	 	(B)	such new Indebtedness is subordinated to the Notes or the applicable Guarantee at least to the same extent as such Subordinated Indebtedness so repurchased, defeased,
exchanged, redeemed, acquired or retired for value; 

  

	 	(C)	such new Indebtedness has a final scheduled maturity date equal to or later than the earlier of the final scheduled maturity date of the Subordinated Indebtedness being
so redeemed, repurchased, defeased, exchanged, acquired or retired, and the maturity date of the Notes; and 

  

	 	(D)	such new Indebtedness has a Weighted Average Life to Maturity equal to or greater than the remaining Weighted Average Life to Maturity of the Subordinated Indebtedness
being so redeemed, repurchased, defeased, exchanged, acquired or retired; 

 (4) a Restricted
Payment to pay for the repurchase, retirement or other acquisition or retirement for value of Equity Interests (other than Disqualified Stock) of the Issuer or any of its direct or indirect parent companies held by any future, present or former
employee, member of the board of directors or consultant of the Issuer, any of its 

  
 74 

 
Subsidiaries or any of its direct or indirect parent companies (permitted transferees, assigns, estates or heirs of such employee, director or consultant), pursuant to any management equity plan
or stock option plan or any other management or employee benefit plan or agreement; provided, however, that the aggregate Restricted Payments made under this clause (4) do not exceed in any calendar year $10.0 million (with unused
amounts in any calendar year being carried over to succeeding calendar years subject to a maximum (without giving effect to the following proviso) of $15.0 million in any calendar year); provided further that such amount in any calendar year
may be increased by an amount not to exceed: 
  

	 	(A)	the cash proceeds from the sale of Equity Interests (other than Disqualified Stock) of the Issuer and, to the extent contributed to the Issuer, Equity Interests of any
of the Issuer’s direct or indirect parent companies, in each case to any employee, member of the board of directors or consultant of the Issuer, any of its Subsidiaries or any of its direct or indirect parent companies that occurs after the
Issue Date, to the extent the cash proceeds from the sale of such Equity Interests have not otherwise been applied to the payment of Restricted Payments by virtue of Section 3.3(a)(C); plus 

 

	 	(B)	the cash proceeds of key man life insurance policies received by the Issuer or its Restricted Subsidiaries after the Issue Date; less 

 

	 	(C)	the amount of any Restricted Payments previously made with the cash proceeds described in clauses (A) and (B) of this clause (4); 

and provided further that cancellation of Indebtedness owing to the Issuer or any Restricted Subsidiary from any employee, member
of the board of directors or consultant of the Issuer, any of the Issuer’s direct or indirect parent companies or any of the Issuer’s Restricted Subsidiaries in connection with a repurchase of Equity Interests of the Issuer or any of its
direct or indirect parent companies shall not be deemed to constitute a Restricted Payment for purposes of this covenant or any other provision of the Indenture; 

(5) the declaration and payment of dividends to holders of any class or series of Disqualified Stock of the Issuer or any
of its Restricted Subsidiaries issued in accordance with the covenant described under Section 3.2 to the extent such dividends are included in the definition of “Fixed Charges”; 

(6) (A) the declaration and payment of dividends and distributions to holders of any class or series of Designated
Preferred Stock (other than Disqualified Stock) issued by the Issuer after the Issue Date; provided that the amount of dividends paid pursuant to this clause (A) shall not exceed the aggregate amount of cash actually received by the
Issuer from the sale of such Designated Preferred Stock; 
  

	 	(B)	 the declaration and payment of dividends and distributions to a direct or indirect parent company of the Issuer, the proceeds of which shall be used to
fund the payment of dividends to holders of 

  
 75 

	 	
any class or series of Designated Preferred Stock (other than Disqualified Stock) of such parent company issued after the Issue Date; provided that the amount of dividends paid pursuant to
this clause (B) shall not exceed the aggregate amount of cash actually contributed to the Issuer from the sale of such Designated Preferred Stock; or 

  

	 	(C)	the declaration and payment of dividends and distributions on Refunding Capital Stock that is Preferred Stock in excess of the dividends declarable and payable thereon
pursuant to clause (2) of this paragraph; 

 provided, however, in the case of each of (a),
(b) and (c) of this clause (6), that for the most recently ended four full fiscal quarters for which internal financial statements are available immediately preceding the date of issuance of such Designated Preferred Stock, after giving
effect to such issuance or declaration on a pro forma basis, the Issuer and its Restricted Subsidiaries on a consolidated basis would have had a Fixed Charge Coverage Ratio of at least 2.00 to 1.00; 

(7) Investments in Unrestricted Subsidiaries taken together with all other Investments made pursuant to this clause
(7) that are at the time outstanding, without giving effect to the sale of an Unrestricted Subsidiary to the extent the proceeds of such sale do not consist of cash or marketable securities, not to exceed the greater of (x) $15.0 million
and (y) 1.00% of Total Assets; 
 (8) repurchases of Equity Interests deemed to occur upon exercise of stock
options or warrants if such Equity Interests represent a portion of the exercise price of such options or warrants; 
 (9) the declaration and payment of dividends and distributions on the Issuer’s common stock (or the payment of dividends to any direct or indirect parent entity of the Issuer to fund a payment of
dividends on such entity’s common stock), following the consummation of the first public offering of the Issuer’s common stock or the common stock of any of its direct or indirect parent companies after the Issue Date, of up to 6% per
annum of the net cash proceeds received by or contributed to the Issuer in or from any such public offering, other than public offerings with respect to the Issuer’s common stock registered on Form S-4 or Form S-8 and other than any public sale
constituting an Excluded Contribution; 
 (10) Restricted Payments that are made with Excluded Contributions,
other than any Excluded Contributions made on or before the Issue Date and Excluded Contributions in connection with the Transactions; 
 (11) other Restricted Payments in an aggregate amount taken together with all other Restricted Payments made pursuant to this clause (11), that are at the time outstanding (without giving effect to the
sale of an Investment to the extent the proceeds of such sale do not consist of, or have not been subsequently sold or transferred for, cash or marketable securities) not to exceed $35.0 million at the time made; 

  
 76 

 (12) distributions or payments of Securitization Fees, sales contributions
and other transfers of Securitization Assets and purchases of Securitization Assets pursuant to a Securitization Repurchase Obligation, in each case in connection with a Qualified Securitization Financing; 

(13) any Restricted Payment used to fund the Transactions and the fees and expenses related thereto or used to fund
amounts owed to Affiliates (including as a result of the cancellation or vesting of outstanding options and other equity-based awards, in connection therewith), in each case as described in the Offering Memorandum and to the extent permitted under
Section 3.8; provided that payments to Affiliates due to the termination of agreements with the Sponsor as described in the Offering Memorandum shall be permitted by this clause (13) only to the extent such termination is
attributable to an underwritten registered public offering of common stock of the Issuer or any direct or indirect parent of the Issuer or to a Change of Control; 

(14) the repurchase, redemption or other acquisition or retirement for value of any Preferred Stock or Subordinated
Indebtedness pursuant to Section 3.5 and Section 3.10; provided that all Notes tendered by Holders in connection with a Change of Control Offer or Asset Sale Offer, as applicable, have been repurchased, redeemed or
acquired for value; 
 (15) the declaration and payment of dividends by the Issuer to, or the making of loans to,
any direct or indirect parent company in amounts required for any direct or indirect parent companies to pay, in each case without duplication, 
  

	 	(A)	franchise taxes and other fees, taxes and expenses required to maintain their corporate existence in an aggregate amount not to exceed $500,000 in any fiscal year;

  

	 	(B)	 for any taxable period in which the Issuer or any of its Subsidiaries is a member of a consolidated, combined, or similar income tax group of which
Parent is the common parent (the “Tax Group”), to pay federal, state and local income taxes of the Tax Group that are directly attributable to the income of the Issuer or any of its Subsidiaries; provided that, for each
taxable period, the amount of such payments made in respect of such taxable period in the aggregate shall not exceed the amount that the Issuer and its Subsidiaries would have been required to pay had the Issuer been the common parent of a separate
standalone tax group that included the Issuer and its Subsidiaries, reduced by any portion of such income taxes directly paid by the Issuer or any of its Subsidiaries; provided further that the amount of any such dividends under this
paragraph (B) attributable to any income of an Unrestricted Subsidiary shall be limited to the cash distributions made by such 

  
 77 

	 	
Unrestricted Subsidiary to the Issuer or its Restricted Subsidiaries for such purpose, and in determining the standalone income tax liability of the Issuer and its Subsidiaries for purposes of
this clause (B) any interest expense of Parent shall be treated as an interest expense of the Issuer; 

  

	 	(C)	customary salary, bonus and other benefits payable to officers and employees of any direct or indirect parent company of the Issuer to the extent such salaries, bonuses
and other benefits are attributable to the ownership or operation of the Issuer and its Restricted Subsidiaries; 

  

	 	(D)	general corporate operating and overhead costs and expenses of any direct or indirect parent company of the Issuer to the extent such costs and expenses are
attributable to the ownership or operation of the Issuer and its Restricted Subsidiaries; and 

  

	 	(E)	amounts required for any direct or indirect parent company of the Issuer to pay fees and expenses incurred by any direct or indirect parent company of the Issuer
related to (i) the maintenance by such parent entity of its corporate or other entity existence and (ii) any unsuccessful equity or debt offering of such parent company. 

(16) the distribution, by dividend or otherwise, of shares of Capital Stock of, or Indebtedness owed to the Issuer or a
Restricted Subsidiary by, Unrestricted Subsidiaries (other than Unrestricted Subsidiaries, the primary assets of which are cash and/or Cash Equivalents); and 
 (17) cash payments in lieu of the issuance of fractional shares or interests in connection with the exercise of warrants, options or other rights or securities convertible into or exchangeable for Capital
Stock of the Issuer or any direct or indirect parent company of the Issuer; provided that any such cash payment shall not be for the purpose of evading the limitation of this covenant; 
 provided, however, that at the time of, and after giving effect to, any Restricted Payment permitted under Sections 3.3(b)(7), 3.3(b)(9), 3.3(b)(11) and 3.3(b)(16)
hereof, no Default shall have occurred and be continuing or would occur as a consequence thereof. 
 The amount of all
Restricted Payments (other than cash) shall be the fair market value (as determined in Good Faith by the Issuer) on the date of such Restricted Payment of the assets or securities proposed to be paid, transferred or issued by the Issuer or such
Restricted Subsidiary, as the case may be, pursuant to such Restricted Payment. 
 As of the Issue Date, all of the
Issuer’s Subsidiaries shall be Restricted Subsidiaries. The Issuer shall not permit any Unrestricted Subsidiary to become a Restricted Subsidiary except pursuant to the last sentence of the definition of “Unrestricted Subsidiary.” For
purposes of designating any Restricted Subsidiary as an Unrestricted Subsidiary, all outstanding Investments by the Issuer and its Restricted Subsidiaries (except to the extent repaid) in the 

  
 78 

 
Subsidiary so designated shall be deemed to be Investments in an amount determined as set forth in the last sentence of the definition of “Investments.” Such designation shall be
permitted only if a Restricted Payment in such amount would be permitted at such time, whether pursuant to this Section 3.3 or pursuant to the definition of “Permitted Investments,” and if such Subsidiary otherwise meets the
definition of an Unrestricted Subsidiary. Unrestricted Subsidiaries shall not be subject to any of the restrictive covenants set forth in the Indenture. 
 SECTION 3.4. Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries. 
 (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, create or otherwise cause or suffer to exist or become effective any consensual encumbrance or
consensual restriction on the ability of any Restricted Subsidiary to: 
 (1) (i) pay dividends or make any other
distributions to the Issuer or any of its Restricted Subsidiaries on its Capital Stock or with respect to any other interest or participation in, or measured by, its profits, or (ii) pay any Indebtedness owed to the Issuer or any of its
Restricted Subsidiaries; 
 (2) make loans or advances to the Issuer or any of its Restricted Subsidiaries; or

 (3) sell, lease or transfer any of its properties or assets to the Issuer or any of its Restricted
Subsidiaries. 
 (b) The restrictions in Section 3.4(a) shall not apply (in each case) to encumbrances or
restrictions existing under or by reason of: 
  

	 	(i)	contractual encumbrances or restrictions in effect on the Issue Date, including pursuant to the Senior Credit Facility and the related documentation and related Hedging
Obligations and Cash Management Obligations; 

  

	 	(ii)	the Indenture, the Notes and the Guarantees (including any exchange notes and related guarantees); 

 

	 	(iii)	purchase money obligations for property acquired in the ordinary course of business that impose restrictions of the nature described in Section 3.4(a)(3) on
the property so acquired; 

  

	 	(iv)	applicable law or any applicable rule, regulation or order; 

  

	 	(v)	any agreement or other instrument of a Person acquired by the Issuer or any Restricted Subsidiary in existence at the time of such acquisition (or at the time it merges
with or into the Issuer or any Restricted Subsidiary or assumed in connection with the acquisition of assets from such Person), but, in each case, not created in contemplation thereof, which encumbrance or restriction is not applicable to any
Person, or the properties or assets of any Person, other than the Person and its Subsidiaries, or the property or assets of the Person and its Subsidiaries, so acquired; 

  
 79 

	 	(vi)	contracts for the sale of assets, including customary restrictions with respect to a Subsidiary of the Issuer pursuant to an agreement that has been entered into for
the sale or disposition of all or substantially all of the Capital Stock or assets of such Subsidiary; 

  

	 	(vii)	Secured Indebtedness otherwise permitted to be incurred pursuant to the covenants described in Sections 3.2 and 3.6 that limit the right of the debtor to
dispose of the assets securing such Indebtedness; 

  

	 	(viii)	restrictions on cash or other deposits or net worth imposed by customers under contracts entered into in the ordinary course of business; 

 

	 	(ix)	other Indebtedness, Disqualified Stock or Preferred Stock of Foreign Subsidiaries permitted to be incurred or issued subsequent to the Issue Date pursuant to the
provisions of the covenant described in Section 3.2 that impose restrictions solely on the Foreign Subsidiaries party thereto or their Subsidiaries; 

 

	 	(x)	customary provisions in joint venture agreements or arrangements and other similar agreements relating solely to such joint venture provided that with respect to
any joint venture agreement relating to a Restricted Subsidiary, such provisions shall not materially affect the Issuer’s ability to make anticipated principal or interest payments on the Notes (as determined in Good Faith by the Issuer);

  

	 	(xi)	customary provisions contained in leases, subleases, licenses, sublicenses or other agreements, in each case, entered into in the ordinary course of business;

  

	 	(xii)	any agreement or instrument (A) relating to any Indebtedness or preferred stock of a Restricted Subsidiary permitted to be incurred subsequent to the Issue Date
pursuant to Section 3.2 if the encumbrances and restrictions are not materially more disadvantageous to the Holders than is customary in comparable financings (as determined in good faith by the Issuer) and (B) either (x) the
Issuer determines that such encumbrance or restriction shall not adversely affect the Issuer’s ability to make principal and interest payments on the Notes as and when they come due or (y) such encumbrances and restrictions apply only
during the continuance of a default in respect of a payment or financial maintenance covenant relating to such Indebtedness; 

  

	 	(xiii)	any encumbrances or restrictions of the type referred to in clauses (1), (2) and (3) of Section 3.4(a) above imposed by any amendments,
modifications, restatements, renewals, increases, supplements, refundings, replacements or refinancings of the contracts, instruments or obligations 

  
 80 

	 	
referred to in clauses (i) through (xii) above; provided that such amendments, modifications, restatements, renewals, increases, supplements, refundings, replacements or
refinancings are, in the good faith judgment of the Issuer, no more restrictive in any material respect with respect to such encumbrance and other restrictions taken as a whole than those prior to such amendment, modification, restatement, renewal,
increase, supplement, refunding, replacement or refinancing; and 

  

	 	(xiv)	restrictions created in connection with any Qualified Securitization Financing that, in the good faith determination of the Issuer, are necessary or advisable to effect
such Securitization Facility. 

 SECTION 3.5. Limitation on Asset Sales. (a) The Issuer shall not, and
shall not permit any of its Restricted Subsidiaries to, consummate any Asset Sale, unless: 
 (1) the
Issuer or such Restricted Subsidiary, as the case may be, receives consideration at the time of such Asset Sale at least equal to the fair market value (as determined in Good Faith by the Issuer) of the assets sold or otherwise disposed of; and

 (2) except in the case of a Permitted Asset Swap, at least 75% of the consideration therefor received by the
Issuer or such Restricted Subsidiary, as the case may be, is in the form of cash or Cash Equivalents; provided that the amount of: 
  

	 	(A)	any liabilities (as shown on the Issuer’s or such Restricted Subsidiary’s most recent balance sheet or in the footnotes thereto, or if incurred or accrued
subsequent to the date of such balance sheet, such liabilities that would have been shown on the Issuer’s or such Restricted Subsidiary’s balance sheet or in the footnotes thereto if such incurrence or accrual had taken place on or prior
to the date of such balance sheet, as determined in Good Faith by the Issuer) of the Issuer or such Restricted Subsidiary, other than liabilities that are by their terms subordinated to the Notes or the Guarantees, that are assumed by the transferee
of any such assets and for which the Issuer and all of its Restricted Subsidiaries have been validly released by all creditors in writing; 

  

	 	(B)	any securities or other obligations received by the Issuer or such Restricted Subsidiary from such transferee that are converted by the Issuer or such Restricted
Subsidiary into cash or Cash Equivalents (to the extent of the cash or Cash Equivalents received) within 180 days following the closing of such Asset Sale; and 

 

	 	(C)	any Designated Non-cash Consideration received by the Issuer or such Restricted Subsidiary in such Asset Sale having an aggregate fair market value, taken together with
all other Designated Non-cash Consideration received pursuant to this clause (c) that is at that time outstanding, not to exceed 2.00% of Total Assets at the time of the 

  
 81 

	 	    	receipt of such Designated Non-cash Consideration, with the fair market value of each item of Designated Non-cash Consideration being measured at the time received and
without giving effect to subsequent changes in value, shall in each case be deemed to be Cash Equivalents for purposes of this provision and for no other purpose. 

(b) Within 365 days after the receipt of any Net Proceeds of any Asset Sale (the “Application Period”), the Issuer or
such Restricted Subsidiary, at its option, may apply the Net Proceeds from such Asset Sale: 
 (1) to reduce or
repay: 
  

	 	a.	Obligations under the Senior Credit Facility and to correspondingly reduce commitments with respect thereto; 

 

	 	b.	Obligations under Indebtedness (other than Subordinated Indebtedness) that is secured by a Lien, which Lien is permitted by the Indenture, and to correspondingly reduce
commitments with respect thereto; 

  

	 	c.	Obligations under other Indebtedness (other than Subordinated Indebtedness) (and to correspondingly reduce commitments with respect thereto); provided that, to
the extent the Issuer elects to reduce Obligations under such Indebtedness, the Issuer shall reduce Obligations under the Notes (x) as provided under Section 5.7, (y) through open-market purchases (to the extent such purchases
are at or above 100% of the principal amount thereof) or (z) by making an offer (in accordance with the procedures set forth below for an Asset Sale Offer) to all Holders to purchase their Notes at 100% of the principal amount thereof, plus the
amount of accrued but unpaid interest, if any, and Additional Interest, if any, in each case on a pro rata basis and, in the aggregate, not to exceed the amount that would equally and ratably reduce the Obligations under the Notes; or

  

	 	d.	Indebtedness of a Non-Guarantor Subsidiary, other than Indebtedness owed to the Issuer or another Restricted Subsidiary (and correspondingly reduce commitments with
respect thereto); 

 (2) to make (a) an Investment in any one or more businesses; provided
that such Investment in any business is in the form of the acquisition of Capital Stock and results in the Issuer or another of its Restricted Subsidiaries, as the case may be, owning an amount of the Capital Stock of such business such that it
constitutes a Restricted Subsidiary, (b) capital expenditures or (c) acquisitions of other properties or assets (other than working capital assets), in the case of each of (a), (b) and (c), used or useful in a Similar Business; or

  
 82 

 (3) to make an Investment in (a) any one or more businesses;
provided that such Investment in any business is in the form of the acquisition of Capital Stock and results in the Issuer or another of its Restricted Subsidiaries, as the case may be, owning an amount of the Capital Stock of such business
such that it constitutes a Restricted Subsidiary, (b) capital expenditures or properties (other than working capital assets) or (c) acquisitions of other assets (other than working capital assets) that, in the case of each of (a),
(b) and (c), replace the businesses, properties and/or assets that are the subject of such Asset Sale; 
 provided
that, in the case of clauses (2) and (3) above, a binding commitment shall be treated as a permitted application of the Net Proceeds from the date of such commitment so long as the Issuer or such other Restricted Subsidiary enters into
such commitment with the good faith expectation that such Net Proceeds shall be applied to satisfy such commitment within the later of (x) 180 days after the date such commitment is entered into and (y) the expiration of the Application
Period (an “Acceptable Commitment”) and, in the event any Acceptable Commitment is later cancelled or terminated for any reason before the Net Proceeds are applied in connection therewith, the Issuer or such Restricted Subsidiary
enters into another Acceptable Commitment (a “Second Commitment”) within 180 days of such cancellation or termination; provided further that if any Second Commitment is later cancelled or terminated for any reason before such
Net Proceeds are applied, then such Net Proceeds shall constitute “Excess Proceeds”. 
 Any Net Proceeds from
the Asset Sale that are not invested or applied as provided and within the time period set forth in the first sentence of the preceding paragraph shall be deemed to constitute “Excess Proceeds.” When the aggregate amount of Excess
Proceeds exceeds $20.0 million, the Issuer shall make an offer to all Holders and, if required by the terms of any Indebtedness that is pari passu with the Notes (“Pari Passu Indebtedness”), to the holders of such Pari Passu
Indebtedness (an “Asset Sale Offer”), to purchase the maximum aggregate principal amount of the Notes and such Pari Passu Indebtedness that is equal to $2,000 or an integral multiple of $1,000 in excess thereof that may be purchased
out of the Excess Proceeds at an offer price in cash in an amount equal to 100% of the principal amount thereof, plus accrued and unpaid interest and Additional Interest, if any, to the date fixed for the closing of such offer, in accordance with
the procedures set forth in the Indenture. The Issuer shall commence an Asset Sale Offer with respect to Excess Proceeds within ten Business Days after the date that Excess Proceeds exceed $20.0 million by mailing the notice required pursuant to the
terms of the Indenture, with a copy to the Trustee or otherwise in accordance with the procedures of DTC. The Issuer may satisfy the foregoing obligations with respect to such Net Proceeds from an Asset Sale by making an Asset Sale Offer with
respect to such Net Proceeds prior to the expiration of the Application Period. 
 To the extent that the aggregate amount of
Notes and such Pari Passu Indebtedness tendered pursuant to an Asset Sale Offer is less than the Excess Proceeds, the Issuer may use any remaining Excess Proceeds for general corporate purposes, subject to compliance with other covenants contained
in the Indenture. If the aggregate principal amount of Notes or the Pari Passu Indebtedness surrendered by such holders thereof exceeds the amount of Excess Proceeds, the Trustee shall select the Notes and the Issuer or the agent for such Pari Passu
Indebtedness shall 

  
 83 

 
select such Pari Passu Indebtedness to be purchased on a pro rata basis based on the accreted value or principal amount of the Notes or such Pari Passu Indebtedness tendered. Upon completion of
any such Asset Sale Offer, the amount of Excess Proceeds shall be reset at zero. Pending the final application of any Net Proceeds pursuant to this Section 3.5, the holder of such Net Proceeds may apply such Net Proceeds temporarily to
reduce Indebtedness outstanding under a revolving credit facility or otherwise use such Net Proceeds in any manner not prohibited by the Indenture. 
 The Issuer shall comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent such laws or regulations are applicable in
connection with the repurchase of the Notes pursuant to an Asset Sale Offer. To the extent that the provisions of any securities laws or regulations conflict with the provisions of the Indenture, the Issuer shall comply with the applicable
securities laws and regulations and shall not be deemed to have breached its obligations described in the Indenture by virtue thereof. 
 SECTION 3.6. Liens. The Issuer shall not, and shall not permit any Subsidiary Guarantor to, directly or indirectly, create, incur, assume or suffer to exist any Lien (except Permitted Liens) (each,
an “Initial Lien”) that secures obligations under any Indebtedness or any related guarantee, on any asset or property of the Issuer or any Subsidiary Guarantor, or any income or profits therefrom, unless: 

(a) in the case of Liens securing Subordinated Indebtedness, the Notes and related Guarantees are secured by a Lien on such property,
assets or proceeds that is senior in priority to such Liens; or 
 (b) in all other cases, the Notes or the Subsidiary
Guarantees are equally and ratably secured. 
 Any Lien created for the benefit of the Holders of the Notes pursuant to this
Section 3.6 shall provide by its terms that such Lien shall be automatically and unconditionally released and discharged upon the release and discharge of the Initial Lien that gave rise to the obligation to so secure the Notes and the
Guarantees. 
 SECTION 3.7. Limitation on Guarantees of Indebtedness by Restricted Subsidiaries. 

(a) The Issuer shall not permit any of its Wholly-Owned Subsidiaries that are Restricted Subsidiaries (and non-Wholly-Owned Subsidiaries
if such non-Wholly-Owned Subsidiaries guarantee other capital markets debt securities of the Issuer or any Restricted Subsidiary or guarantee all or a portion of the Senior Credit Facility), other than a Subsidiary Guarantor, to guarantee the
payment of any Indebtedness of the Issuer or any other Subsidiary Guarantor unless: 
 (A) such Restricted
Subsidiary within 30 days executes and delivers a supplemental indenture to this Indenture and joinder or supplement to the Registration Rights Agreement providing for a senior Guarantee by such Restricted Subsidiary, except that (a) with
respect to a guarantee of Indebtedness of the Issuer or any Subsidiary Guarantor, if such Indebtedness is by its express terms subordinated in right of payment to the Notes or such Subsidiary Guarantor’s Guarantee, any such guarantee by such

  
 84 

 
Restricted Subsidiary with respect to such Indebtedness shall be subordinated in right of payment to such Guarantee substantially to the same extent as such Indebtedness is subordinated to the
Notes or such Subsidiary Guarantor’s Guarantee; and (b) if the Notes or such Subsidiary Guarantor’s Guarantee are subordinated in right of payment to such Indebtedness, the Guarantee under the supplemental indenture shall be
subordinated to such Restricted Subsidiary’s guarantee with respect to such Indebtedness substantially to the same extent as the Notes or the Subsidiary Guarantor’s Guarantee are subordinated to such Indebtedness; and 

(B) such Restricted Subsidiary waives and shall not in any manner whatsoever claim or take the benefit or advantage of,
any rights of reimbursement, indemnity or subrogation or any other rights against the Issuer or any other Restricted Subsidiary as a result of any payment by such Restricted Subsidiary under its Guarantee until payment in full of Obligations under
this Indenture; and 
 (C) such Restricted Subsidiary shall deliver to the Trustee an Opinion of Counsel to the
effect that: 
  

	 	(1)	such Guarantee has been duly executed and authorized; and 

  

	 	(2)	such Guarantee constitutes a valid, binding and enforceable obligation of such Restricted Subsidiary, except insofar as enforcement thereof may be limited by
bankruptcy, insolvency or similar laws (including, without limitation, all laws relating to fraudulent transfers) and except insofar as enforcement thereof is subject to general principles of equity; 

provided that this Section 3.7 shall not be applicable to any guarantee of any Restricted Subsidiary that existed at the time such
Person became a Restricted Subsidiary and was not incurred in connection with, or in contemplation of, such Person becoming a Restricted Subsidiary. 
 The Issuer may elect, in its sole discretion, to cause any Subsidiary that is not otherwise required to be a Guarantor to become a Guarantor, in which case, such Subsidiary shall only be required to
comply with the 30-day period described above. 
 SECTION 3.8. Transactions with Affiliates. (a) The Issuer shall
not, and shall not permit any of its Restricted Subsidiaries to, make any payment to, or sell, lease, transfer or otherwise dispose of any of its properties or assets to, or purchase any property or assets from, or enter into or make or amend any
transaction, contract, agreement, understanding, loan, advance or guarantee with, or for the benefit of, any Affiliate of the Issuer (each of the foregoing, an “Affiliate Transaction”) involving aggregate payments or consideration
in excess of $5.0 million, unless: 
 (1) such Affiliate Transaction is on terms that are not materially less
favorable to the Issuer or its relevant Restricted Subsidiary than those that would have been obtained in a comparable transaction by the Issuer or such Restricted Subsidiary with an unrelated Person on an arm’s-length basis; and 

  
 85 

 (2) with respect to any Affiliate Transaction or series of related Affiliate
Transactions involving aggregate payments or consideration in excess of $15.0 million, a majority of the board of directors of the Issuer adopts a Board Resolution approving such Affiliate Transaction and concluding that such Affiliate Transaction
complies with clause (1) above. 
 (b) The foregoing provisions shall not apply to the following: 

(1) transactions between or among the Issuer or any of its Restricted Subsidiaries; 

(2) Restricted Payments permitted by the provisions of this Indenture described above under Section 3.3 (other
than clause (b)(7)) and the definition of “Permitted Investments” (other than pursuant to clauses (3) and (12) thereof); 
 (3) the payment of management, consulting, monitoring, transaction and advisory fees and related expenses to the Sponsor pursuant to the Sponsor Management Agreement and the termination fees pursuant to
the Sponsor Management Agreement, in each case as in effect on the Issue Date or any amendment thereto (so long as any such amendment is not materially disadvantageous, in the good faith judgment of the board of directors of the Issuer, to the
Holders when taken as a whole as compared to the Sponsor Management Agreement in effect on the Issue Date); 

(4) the payment of reasonable and customary fees and compensation paid to, and indemnities and reimbursements provided for
the benefit of, former, current or future officers, directors, employees or consultants of the Issuer, any of its direct or indirect parent companies or any of its Restricted Subsidiaries, as determined in Good Faith by the Issuer; 

(5) transactions in which the Issuer or any of its Restricted Subsidiaries, as the case may be, delivers to the Trustee a
letter from an Independent Financial Advisor stating that such transaction is fair to the Issuer or such Restricted Subsidiary from a financial point of view or stating that the terms are not materially less favorable to the Issuer or its relevant
Restricted Subsidiary than those that would have been obtained in a comparable transaction by the Issuer or such Restricted Subsidiary with an unrelated Person on an arm’s-length basis; 

(6) any agreement or arrangement as in effect as of the Issue Date (other than the Sponsor Management Agreement, but
including, without limitation, each of the other agreements entered into in connection with the Transactions), or any amendment thereto (so long as any such amendment is not materially disadvantageous to the Holders when taken as a whole as compared
to the applicable agreement as in effect on the Issue Date); 
 (7) the existence of, or the performance by the
Issuer or any of its Restricted Subsidiaries of its obligations under the terms of, any stockholders’ agreement (including any registration rights agreement or purchase agreement related thereto) to which it is a party as of the Issue Date and
any similar agreements which it may enter into thereafter; provided, however, that the existence of, or the performance by the Issuer or any of its Restricted Subsidiaries of obligations under any future amendment to any such

  
 86 

 
existing agreement or under any similar agreement entered into after the Issue Date shall only be permitted by this clause (7) to the extent that the terms of any such existing agreement,
together with all amendments thereto, taken as a whole, or any such similar agreement are not otherwise materially disadvantageous to the Holders when taken as a whole as compared to the applicable agreement in effect on the Issue Date; 

(8) the Transactions and the payment of all fees and expenses related to the Transactions, in each case as contemplated in
the Offering Memorandum; 
 (9) transactions with customers, clients, suppliers, or purchasers or sellers of
goods or services, in each case in the ordinary course of business and otherwise in compliance with the terms of the Indenture which are fair to the Issuer and its Restricted Subsidiaries, in the reasonable determination of the board of directors of
the Issuer or the senior management thereof, or are on terms at least as favorable as might reasonably have been obtained at such time from an unaffiliated party; 

(10) if otherwise permitted under this Indenture, the issuance or transfer of Equity Interests of the Issuer (other than
Disqualified Stock) to Affiliates of the Issuer and the granting of registration and other customary rights in connection therewith or any contribution to the capital of direct or indirect parent companies, the Issuer or any Restricted Subsidiary;

 (11) any customary transaction with a Securitization Subsidiary effected as part of a Qualified Securitization
Financing; 
 (12) payments by the Issuer or any of its Restricted Subsidiaries to the Sponsor made for any
financial advisory, financing, underwriting or placement services or in respect of other investment banking activities, including, without limitation, in connection with acquisitions or divestitures which payments are approved by a majority of the
disinterested members of the board of directors of the Issuer in good faith; 
 (13) payments or loans (or
cancellation of loans) to employees or consultants of the Issuer, any of its direct or indirect parent companies or any of its Restricted Subsidiaries and employment agreements, stock option plans, restricted stock plans, bonus programs and other
similar arrangements with such employees or consultants which, in each case, are approved in Good Faith by the Issuer and in accordance with applicable law; 
 (14) investments in securities of the Issuer or any of its Restricted Subsidiaries so long as (i) the investment is being offered generally to other investors on the same or more favorable terms and
(ii) the investment constitutes less than 5.0% of the proposed or outstanding issue amount of such class of securities; and 
 (15) transactions with a Person (other than an Unrestricted Subsidiary of the Issuer) that is an Affiliate of the Issuer solely because the Issuer or a Restricted Subsidiary of the Issuer owns an equity
interest in or otherwise controls such Person; 

  
 87 

 SECTION 3.9. Limitation on Activities of Parent. Parent shall not conduct, transact
or otherwise engage, or commit to conduct, transact or otherwise engage, in any business or operations other than: 
 (a) its
direct ownership of all of the Equity Interests in, and its management of, the Issuer; 
 (b) the Transactions and the other
transactions contemplated by the Purchase Agreement and the other agreements contemplated thereby; 
 (c) performance of its
obligations under the Senior Credit Facility, this Indenture, the Registration Rights Agreement and the other agreements contemplated thereby (collectively, the “Transaction Documents”) and other activities to the extent permitted
by and in compliance with the Transaction Documents; 
 (d) the provision of administrative, legal, accounting, tax and
management services to, or on behalf of, any of its Subsidiaries; 
 (e) the entry into, and exercise of rights and performance
of obligations in respect of: (1) any other agreement to which it is a party on the Issue Date and described in the Offering Memorandum; in each case, as amended, supplemented, waived or otherwise modified from time to time, and any
refinancings, refundings, renewals or extension thereof in accordance with such Transaction Documents, (2) contracts and agreements with officers, directors and employees of Parent or any of its Subsidiaries relating to their employment or
directorships, (3) insurance policies and related contracts and agreements and (4) equity subscription agreements, registration rights agreements, voting and other stockholder agreements, engagement letters, underwriting agreements and
other agreements in respect of its equity securities or the equity securities of any Subsidiaries or any offering, issuance or sale thereof; 
 (f) the offering, issuance, sale and repurchase or redemption of, and dividends or distributions on its equity securities; 
 (g) the filing of registration statements, and compliance with applicable reporting and other obligations under federal, state or other securities laws; 

(h) the listing of its equity securities and compliance with applicable reporting and other obligations in connection therewith;

 (i) the retention of (and entry into, and exercise of rights and performance of obligations in respect of, contracts and
agreements with) transfer agents, private placement agents and underwriters with respect to equity securities and, counsel, accountants and other advisors and consultants; 
 (j) the performance of obligations under and compliance with its certificate of incorporation and by-laws, or any applicable law, ordinance, regulation, rule, order, judgment, decree or permit, including,
without limitation, as a result of or in connection with the activities of its Subsidiaries; 

  
 88 

 (k) the incurrence and payment of its operating and business expenses and any taxes for
which it may be liable; 
 (l) the incurrence, repayment and redemption of Indebtedness; and 

(m) other activities incidental or related to the foregoing. 
 SECTION 3.10. Change of Control. 
 (a) If a Change of Control occurs,
unless the Issuer has previously or concurrently mailed (or otherwise transmitted in accordance with DTC procedures) a redemption notice with respect to all the outstanding Notes as described in Section 5.7, the Issuer shall make an offer to
purchase all of the Notes pursuant to the offer described below (the “Change of Control Offer”) at a price in cash (the “Change of Control Payment”) equal to 101% of the aggregate principal amount thereof plus
accrued and unpaid interest and Additional Interest, if any, to but excluding the date of purchase, subject to the right of Holders of record of the Notes on the relevant record date to receive interest due on the relevant interest payment date;
provided that to the extent any transmitted redemption notice includes a condition that is not satisfied or waived and the redemption referenced therein does not occur, the obligation to make a Change of Control Offer shall be reinstated. If
the Issuer is obligated to make a Change of Control Offer, then within 30 days following any Change of Control, the Issuer shall send notice of such Change of Control Offer by first-class mail, with a copy to the Trustee, to each Holder of Notes to
the address of such Holder appearing in the security register or otherwise in accordance with the procedures of DTC, with the following information: 
 (1) that a Change of Control Offer is being made pursuant to this Section 3.10, and that all Notes properly tendered pursuant to such Change of Control Offer shall be accepted for payment by
the Issuer; 
 (2) the purchase price and the purchase date, which shall be no earlier than 30 days nor later
than 60 days from the date such notice is mailed (the “Change of Control Payment Date”); 
 (3)
that any Note not properly tendered shall remain outstanding and continue to accrue interest; 
 (4) that unless
the Issuer defaults in the payment of the Change of Control Payment, all Notes accepted for payment pursuant to the Change of Control Offer shall cease to accrue interest on the Change of Control Payment Date; 

(5) that Holders electing to have any Notes purchased pursuant to a Change of Control Offer shall be required to surrender
such Notes, with the form titled “Option of Holder to Elect Purchase” on the reverse of such Notes completed, to the paying agent specified in the notice at the address specified in the notice prior to the close of business on the third
Business Day preceding the Change of Control Payment Date; 

  
 89 

 (6) that Holders shall be entitled to withdraw their tendered Notes and
their election to require the Issuer to purchase such Notes; provided that the paying agent receives, not later than the expiration time of the Change of Control Offer, a facsimile transmission or letter setting forth the name of the Holder
of the Notes, the principal amount of Notes tendered for purchase, and a statement that such Holder is withdrawing its tendered Notes and its election to have such Notes purchased; 

(7) that if the Issuer is redeeming less than all of the Notes, the Holders of the remaining Notes shall be issued new
Notes and such new Notes shall be equal in principal amount to the unpurchased portion of the Notes surrendered. The unpurchased portion of the Notes must be equal to $2,000 or an integral multiple of $1,000 in excess thereof. 

(8) if such notice is delivered prior to the occurrence of a Change of Control, stating that the Change of Control Offer
is conditional on the occurrence of such Change of Control; and 
 (9) any other instructions, as determined by
us, consistent with the covenant described hereunder, that a Holder must follow. 
 (b) On the Change of Control Payment Date,
the Issuer shall, to the extent permitted by law, 
 (1) accept for payment all Notes or portions thereof
properly tendered pursuant to the Change of Control Offer; 
 (2) deposit with the paying agent an amount equal
to the aggregate Change of Control Payment in respect of all Notes or portions thereof so tendered; and 
 (3)
deliver, or cause to be delivered, to the Trustee for cancellation the Notes so accepted together with an Officer’s Certificate to the Trustee stating that such Notes or portions thereof have been tendered to and purchased by the Issuer.

 (c) The Issuer shall not be required to make a Change of Control Offer following a Change of Control if a third party makes
the Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Section 3.10 applicable to a Change of Control Offer. Notwithstanding anything to the contrary in this
Section 3.10, a Change of Control Offer may be made in advance of a Change of Control, conditional upon such Change of Control, if a definitive agreement is in place for the Change of Control at the time of making of the Change of
Control Offer. 
 (d) The provisions of this Section 3.10 relating to the Issuer’s obligation to make an offer
to repurchase the Notes as a result of a Change of Control may be waived or modified with the written consent of the Holders of a majority in principal amount of the Notes. 
 (e) While the Notes are in global form and the Issuer makes an offer to purchase all of the Notes pursuant to the Change of Control Offer, a Holder may exercise its option to elect for the purchase of the
Notes through the facilities of DTC, subject to its rules and regulations. 

  
 90 

 (f) The Issuer shall comply with the requirements of Rule 14e-1 under the Exchange Act and
any other securities laws and regulations thereunder to the extent such laws or regulations are applicable in connection with the repurchase by the Issuer of Notes pursuant to a Change of Control Offer. To the extent that the provisions of any
securities laws or regulations conflict with provisions of this Indenture, the Issuer shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations described in this Indenture by virtue
thereof. 
 SECTION 3.11. Reports and Other Information. 

(a) Notwithstanding that the Issuer may not be subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act or
otherwise report on an annual and quarterly basis on forms provided for such annual and quarterly reporting pursuant to rules and regulations promulgated by the SEC, the Issuer shall file with the SEC and furnish or make available to the Trustee
within 15 days after the dates set forth below: 
 (1) within 90 days after the end of each fiscal year, all
financial information that would be required to be contained in an annual report on Form 10-K, or any successor or comparable form, filed with the SEC, including a “Management’s discussion and analysis of financial condition and results of
operations” and a report on the annual financial statements by the Issuer’s independent registered public accounting firm; 
 (2) within 45 days after the end of each of the first three fiscal quarters of each fiscal year (60 days for the fiscal quarter ended June 30, 2012), all financial information that would be required
to be contained in a quarterly report on Form 10-Q, or any successor or comparable form, filed with the SEC; 

(3) all current reports that would be required to be filed with the SEC on Form 8-K if the Issuer were required to file
such reports; and 
 (4) any other information, documents and other reports which the Issuer would be required to
file with the SEC if it were subject to Section 13 or 15(d) of the Exchange Act; 
 in each case, in a manner that complies in all material
respects with the requirements specified in such form. Notwithstanding the foregoing, the Issuer shall not be so obligated to file such reports with the SEC (i) if the SEC does not permit such filing or (ii) prior to the consummation of an
exchange offer or the effectiveness of a shelf registration statement as required by the Registration Rights Agreement, so long as if clause (i) or (ii) is applicable, the Issuer makes available such information to prospective purchasers
of the Notes, in addition to providing such information to the Trustee and the Holders, in each case, at the Issuer’s expense and by the applicable date the Issuer would be required to file such information pursuant to the immediately preceding
sentence. To the extent any such information is not so filed or furnished, as applicable, within the time periods specified above and such information is subsequently filed or furnished, as applicable, the Issuer shall be deemed to have satisfied
its obligations with respect thereto at such time and any Default with respect thereto shall be deemed to have been cured; provided that such cure shall not otherwise affect the rights of the Holders under Article VI if Holders of at
least 25% in principal 

  
 91 

 
amount of the then total outstanding Notes have declared the principal, premium, if any, interest and any other monetary obligations on all the then outstanding Notes to be due and payable
immediately and such declaration shall not have been rescinded or cancelled prior to such cure. In addition, to the extent not satisfied by the foregoing, the Issuer shall, for so long as any Notes are outstanding, furnish to Holders and to
securities analysts and prospective investors, upon their request, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act. The Issuer shall deliver the financial statements and information of the type required
to be delivered pursuant to Section 3.11(a)(2) with respect to the fiscal quarter ended June 30, 2012, which, notwithstanding the foregoing, shall not be required to contain financial statement footnote disclosure and shall not be
required to contain consolidating financial data with respect to the Guarantor and Non-Guarantor Subsidiaries of the type contemplated by Rule 3-10 of Regulation S-X promulgated under the Securities Act or otherwise; provided that the Issuer
shall only be required to present a reasonably detailed “Management’s discussion and analysis of financial condition and results of operations” to the extent of the information provided by Thomson Reuters Corporation. 

(b) Substantially concurrently with the furnishing or making such information available to the Trustee pursuant to the immediately
preceding paragraph, the Issuer shall also post copies of such information required by the immediately preceding paragraph on a website (which may be nonpublic and may be maintained by the Issuer or a third party) to which access shall be given to
Holders, prospective investors in the Notes (which prospective investors shall be limited to “qualified institutional buyers” within the meaning of Rule 144A of the Securities Act or non-U.S. persons (as defined in Regulation S under the
Securities Act) that certify their status as such to the reasonable satisfaction of the Issuer), and securities analysts and market making financial institutions that are reasonably satisfactory to the Issuer. The Issuer shall hold quarterly
conference calls that are publicly accessible after the Issuer’s financial statements for the prior fiscal period have been made available, provided that such conference calls shall be held no later than five Business Days after the date that
such financial statements are required to be made available. No fewer than three Business Days prior to the date of the conference call required to be held in accordance with the preceding sentence the Issuer shall issue a press release to the
appropriate U.S. wire services announcing the time and the date of such conference call and directing the beneficial owners of, and prospective investors in, the Notes and securities analysts to contact an individual at the Issuer (for whom contact
information shall be provided in such press release) to obtain information on how to access such conference call. 
 (c) The
Issuer may satisfy its obligations in this Section 3.11 with respect to financial information relating to the Issuer by furnishing financial information relating to Parent or any other direct or indirect parent company of the Issuer that
becomes a guarantor of the Notes; provided that the same is accompanied by consolidating information that explains in reasonable detail the differences between the information relating to such parent, on the one hand, and the information
relating to the Issuer and its Restricted Subsidiaries on a standalone basis, on the other hand, in the form prescribed in clause (a) above. 
 (d) Notwithstanding the foregoing, such requirements shall be deemed satisfied prior to the commencement of the offering of the Exchange Securities or the effectiveness of the Shelf Registration Statement
by the filing with the SEC of any registration statement or other filing, and any amendments thereto, with such financial information that satisfies Regulation S-X of the Securities Act. 

  
 92 

 Delivery of such reports, information and documents to the Trustee hereunder is for
informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Issuer’s compliance with any of
its covenants hereunder (as to which the Trustee is entitled to rely exclusively on Officer’s Certificates or certificates delivered pursuant to Section 3.16). 

SECTION 3.12. Maintenance of Office or Agency. 
 The Issuer shall maintain an office or agency where the Notes may be presented or surrendered for payment, where, if applicable, the Notes may be surrendered for registration of transfer or exchange and
where notices and demands to or upon the Issuer in respect of the Notes and this Indenture may be served. The corporate trust office of the Trustee, which initially shall be located at 2 N. LaSalle Street, Suite 1020, Chicago, IL 60602, Attn:
Corporate Trust Administration shall be such office or agency of the Issuer, unless the Issuer shall designate and maintain some other office or agency for one or more of such purposes. The Issuer shall give prompt written notice to the Trustee of
any change in the location of any such office or agency. If at any time the Issuer shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and
demands may be made or served at the corporate trust office of the Trustee, and the Issuer hereby appoints the Trustee as its agent to receive all such presentations, surrenders, notices and demands. 

The Issuer may also from time to time designate one or more other offices or agencies where the Notes may be presented or surrendered for
any or all such purposes and may from time to time rescind any such designation. The Issuer shall give prompt written notice to the Trustee of any such designation or rescission and any change in the location of any such other office or agency.

 SECTION 3.13. Corporate Existence. Except as otherwise provided in this Article III, Article IV and
Section 10.2(b), the Issuer shall do or cause to be done all things necessary to preserve and keep in full force and effect its respective corporate existence and the corporate, partnership, limited liability company or other existence
of each Restricted Subsidiary and the rights (charter and statutory), licenses and franchises of the Issuer and each Restricted Subsidiary; provided, however, that the Issuer shall not be required to preserve any such right, license or
franchise or the corporate, partnership, limited liability company or other existence of any Restricted Subsidiary if the respective board of directors or, with respect to a Restricted Subsidiary that is not a Significant Subsidiary (or group of
Restricted Subsidiaries that taken together would not be a Significant Subsidiary), senior management of the Issuer determines that the preservation thereof is no longer desirable in the conduct of the business of the Issuer and each of its
Restricted Subsidiaries, taken as a whole. 
 SECTION 3.14. Payment of Taxes. The Issuer shall pay or discharge or cause
to be paid or discharged, before the same shall become delinquent, all material taxes, assessments and governmental charges levied or imposed upon the Issuer or any Subsidiary; provided,

  
 93 

 
however, that the Issuer shall not be required to pay or discharge or cause to be paid or discharged any such tax, assessment, charge or claim the amount, applicability or validity of
which is being contested in good faith by appropriate proceedings and for which appropriate reserves, if necessary (in the good faith judgment of management of the Issuer), are being maintained in accordance with GAAP or where the failure to effect
such payment shall not be disadvantageous to the Holders. 
 SECTION 3.15. Payments for Consent. Neither the Issuer nor
any of its Restricted Subsidiaries shall, directly or indirectly, pay or cause to be paid any consideration to or for the benefit of any Holder for or as an inducement to any consent, waiver or amendment of any of the terms or provisions of the
Indenture or the Notes unless such consideration is offered to be paid and is paid to all Holders that are “qualified institutional buyers” within the meaning of Rule 144A of the Securities Act, who, upon request, confirm that they are
“qualified institutional buyers,” consent, waive or agree to amend in the time frame set forth in the solicitation documents relating to such consent, waiver or amendment. 

SECTION 3.16. Compliance Certificate. The Issuer shall deliver to the Trustee within 120 days after the end of each Fiscal Year of
the Issuer beginning with the Fiscal Year ending December 31, 2012 an Officer’s Certificate stating that in the course of the performance by the signer of his or her duties as an Officer of the Issuer he or she would normally have
knowledge of any Default or Event of Default and whether or not the signer knows of any Default or Event of Default that occurred during the previous Fiscal Year; provided that no such Officer’s Certificate shall be required for any
Fiscal Year ended prior to the Issue Date. Within ten Business Days after becoming aware of any Default or Event of Default, the Issuer shall deliver to the Trustee a certificate describing the Default or Event of Default, its status and the action
the Issuer is taking or proposes to take with respect thereto. The Issuer also shall comply with TIA § 314(a)(4). 

SECTION 3.17. Further Instruments and Acts. Upon request of the Trustee, the Issuer shall execute and deliver such further
instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purpose of this Indenture. 
 SECTION 3.18. [RESERVED]. 
 SECTION 3.19. Statement by Officer as to
Default. The Issuer shall deliver to the Trustee, as soon as possible and in any event within 10 Business Days after the Issuer becomes aware of the occurrence of any Event of Default or an event which, with notice or the lapse of time or both,
would constitute an Event of Default, an Officer’s Certificate setting forth the details of such Event of Default or Default, its status and the actions which the Issuer is taking or proposes to take with respect thereto. 

SECTION 3.20. Suspension of Certain Covenants. Following the first day (a) the Notes have an Investment Grade Rating from
both of the Ratings Agencies and (b) no Default has occurred and is continuing under this Indenture, the Issuer and its Restricted Subsidiaries shall not be subject to Sections 3.2, 3.3, 3.4, 3.5, 3.7 (but
only with respect to any Person that is required to become a Guarantor after the date of the commencement of the applicable Suspension Period (as defined below) and prior to the related Reinstatement Date (as defined below)), 3.8 and
4.1(a)(4) (collectively, the “Suspended Covenants”). 

  
 94 

 If at any time the Notes’ credit rating is downgraded from an Investment Grade Rating
by any Rating Agency or if a Default or Event of Default occurs and is continuing, then the Suspended Covenants shall thereafter be reinstated as if such covenants had never been suspended (the “Reinstatement Date”) and be
applicable pursuant to the terms of the Indenture (including in connection with performing any calculation or assessment to determine compliance with the terms of the Indenture), unless and until the Notes subsequently attain an Investment Grade
Rating and no Default or Event of Default is in existence (in which event the Suspended Covenants shall no longer be in effect for such time that the Notes maintain an Investment Grade Rating and no Default or Event of Default is in existence);
provided, however, that no Default, Event of Default or breach of any kind shall be deemed to exist under this Indenture, the Registration Rights Agreement, the Notes or the Guarantees with respect to the Suspended Covenants based on, and
none of Parent, the Issuer or any of its Subsidiaries shall bear any liability for, any actions taken or events occurring during the Suspension Period, or any actions taken at any time pursuant to any contractual obligation arising prior to the
Reinstatement Date, regardless of whether such actions or events would have been permitted if the applicable Suspended Covenants remained in effect during such period. The period of time between the date of suspension of the covenants and the
Reinstatement Date is referred to as the “Suspension Period.” The Issuer shall notify the Trustee of the commencement or termination of any Suspension Period. 
 On the Reinstatement Date, all Indebtedness incurred during the Suspension Period shall be classified to have been incurred pursuant to Section 3.2(a) or one of the clauses of
Section 3.2(b) (to the extent such Indebtedness would be permitted to be incurred thereunder as of the Reinstatement Date and after giving effect to Indebtedness incurred prior to the Suspension Period and outstanding on the
Reinstatement Date). To the extent such Indebtedness would not be so permitted to be incurred pursuant to Sections 3.2(a) or (b), such Indebtedness shall be deemed to have been outstanding on the Issue Date, so that it is classified as
permitted under Section 3.2(b)(3). Calculations made after the Reinstatement Date of the amount available to be made as Restricted Payments under Section 3.3 shall be made as though the covenant described under
Section 3.3 had been in effect since the Issue Date and throughout the Suspension Period. Accordingly, Restricted Payments made during the Suspension Period shall reduce the amount available to be made as Restricted Payments under
Section 3.3(a). 
 During any period when the Suspended Covenants are suspended, the board of directors of the
Issuer may not designate any of the Issuer’s Subsidiaries as Unrestricted Subsidiaries pursuant to this Indenture. 
 The
Issuer shall provide an Officer’s Certificate to the Trustee indicating the occurrence of any Suspended Covenants or Reinstatement Date. The Trustee shall have no obligation to (i) independently determine or verify if such events have
occurred, (ii) make any determination regarding the impact of any actions taken during the Suspension Period on the Issuer and its Restricted Subsidiaries’ future compliance with their covenants or (iii) notify the Holders of any
Suspended Covenants or Reinstatement Date. 

  
 95 

 ARTICLE IV  
 SUCCESSOR COMPANY 
 SECTION 4.1. Merger, Consolidation or Sale of All or
Substantially All Assets. 
 (a) The Issuer shall not consolidate or merge with or into or wind up into (whether or not the
Issuer is the surviving corporation), or sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of its properties or assets, in one or more related transactions, to any Person unless: 

(1) the Issuer is the surviving Person or the Person formed by or surviving any such consolidation or merger (if other
than the Issuer) or to which such sale, assignment, transfer, lease, conveyance or other disposition shall have been made is a Person organized or existing under the laws of the jurisdiction of organization of the Issuer or the laws of the United
States, any state thereof, the District of Columbia or any territory thereof (such Person, as the case may be, being herein called the “Successor Company”); provided that in the case where the surviving Person is not a
corporation, a co-obligor of the Notes is a corporation; 
 (2) the Successor Company, if other than the Issuer,
expressly assumes all the obligations of the Issuer under this Indenture and the Notes pursuant to supplemental indentures or other documents or instruments in form reasonably satisfactory to the Trustee; 

(3) immediately after such transaction, no Default exists; 

(4) immediately after giving pro forma effect to such transaction and any related financing transactions, as if such
transactions had occurred at the beginning of the applicable four-quarter period, 
  

	 	(A)	the Successor Company or the Issuer would be permitted to incur at least $1.00 of additional Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in
Section 3.2(a) or 

  

	 	(B)	the Fixed Charge Coverage Ratio for the Successor Company and its Restricted Subsidiaries would be greater than the Fixed Charge Coverage Ratio for the Issuer and its
Restricted Subsidiaries immediately prior to such transaction; 

 (5) each Guarantor, unless it is
the other party to the transactions described above, in which case clause (ii) of Section 10.2(b) shall apply, shall have by supplemental indenture confirmed that its Guarantee shall apply to such Person’s obligations under
this Indenture, the Notes and the Registration Rights Agreement; and 

  
 96 

 (6) the Issuer shall have delivered to the Trustee an Officer’s
Certificate and an Opinion of Counsel, each stating that such consolidation, merger or transfer and such supplemental indentures, if any, comply with this Indenture; 
 (b) The Successor Company shall succeed to, and be substituted for the Issuer, as the case may be, under the Indenture, the Registration Rights Agreement, the Guarantees and the Notes, as applicable.
Sections 4.1(a)(3) through (a)(6) shall not apply to the transaction contemplated by the Purchase Agreement and the merger of the Issuer with and into Thomson Reuters (Healthcare) Inc., with Thomson Reuters (Healthcare) Inc. as the
surviving entity. 
 (c) Notwithstanding Sections 4.1(a)(3) and (a)(4), 

 

	 	(a)	any Non-Guarantor Subsidiary may consolidate with or merge into or transfer all or part of its properties and assets to the Issuer or another Restricted Subsidiary;

  

	 	(b)	the Issuer may consolidate with, merge into or transfer all or part of its properties and assets to the Issuer or a Subsidiary Guarantor, as applicable; and

  

	 	(c)	the Issuer may consolidate or merge with an Affiliate of the Issuer, as the case may be, solely for the purpose of reincorporating the Issuer in any state of the United
States, the District of Columbia or any territory thereof. 

 (d) For purposes of this Section 4.1, the
sale, lease, conveyance, assignment, transfer or other disposition of all or substantially all of the properties and assets of one or more Subsidiaries of the Issuer or a Guarantor, which properties and assets, if held by the Issuer or such
Guarantor, as the case may be, instead of such Subsidiaries, would constitute all or substantially all of the properties and assets of the Issuer or such Guarantor on a consolidated basis, shall be deemed to be the transfer of all or substantially
all of the properties and assets of such Guarantor, as the case may be. The predecessor company shall be released from its obligations under the Indenture and the Successor Company shall succeed to, and be substituted for, and may exercise every
right and power of, the Issuer under this Indenture, but, in the case of a lease of all or substantially all its assets, the predecessor shall not be released from the obligation to pay the principal of and interest on the Notes. 

  
 97 

 ARTICLE V  
 REDEMPTION OF SECURITIES 
 SECTION 5.1. Notices to Trustee.

 If the Issuer elects to redeem Notes pursuant to the optional redemption provisions of Section 5.7 hereof, it
must furnish to the Trustee, at least 30 days but not more than 60 days before a redemption date, an Officer’s Certificate setting forth: 
  

	 	(1)	the clause of this Indenture pursuant to which the redemption shall occur; 

 

	 	(2)	the redemption date; 

  

	 	(3)	the principal amount of Notes to be redeemed; and 

  

	 	(4)	the redemption price. 

 Any
redemption referenced in such Officer’s Certificate may be cancelled by the Issuer at any time prior to notice of redemption being mailed to any Holder and thereafter shall be null and void. 

If the redemption price is not known at the time such notice is to be given, the actual redemption price, calculated as described in the
terms of the Notes, will be set forth in an Officer’s Certificate of the Issuer delivered to the Trustee no later than two Business Days prior to the redemption date. 
 SECTION 5.2. Selection of Notes to Be Redeemed or Purchased. 
 If the
Issuer is redeeming less than all of the Notes issued by it at any time pursuant to Section 5.7 or purchasing Notes in an Asset Sale Offer or a Change of Control Offer pursuant to Section 3.5 or Section 3.10, the
Trustee or the applicable Registrar shall select the Notes to be redeemed (a) if the Notes are listed on any national securities exchange, in compliance with the requirements of the principal national securities exchange on which the Notes are
listed or (b) by lot or such other similar method in accordance with the procedures of DTC. 
 No Notes of $2,000 or less
can be redeemed in part. In the event of partial redemption, the particular Notes to be redeemed or purchased shall be selected, unless otherwise provided herein, not less than 30 nor more than 60 days prior to the redemption or purchase date from
the outstanding Notes not previously called for redemption or purchase. 
 The Trustee shall promptly notify the Issuer in
writing of the Notes selected for redemption or purchase and, in the case of any Note selected for partial redemption or purchase, the principal amount thereof to be redeemed or purchased. Notes and portions of Notes selected shall be in amounts of
$2,000 or an integral multiple of $1,000 in excess thereof; except that if all of the Notes of a Holder are to be redeemed or purchased, the entire outstanding amount of Notes held by such Holder, even if not a multiple of $1,000, shall be redeemed
or purchased. Except as provided in the preceding sentence, provisions of this Indenture that apply to Notes called for redemption or purchase also apply to portions of Notes called for redemption or purchase. 

SECTION 5.3. Notice of Redemption. Notices of purchase or redemption shall be mailed, by first class mail, postage prepaid, at
least 30 but not more than 60 days before the purchase or redemption date to each Holder of record of Notes at such Holder’s registered address or otherwise delivered in accordance with the procedures of DTC, except that redemption notices may
be mailed more than 60 days prior to a redemption date if the notice is issued in connection with a defeasance of the Notes or a satisfaction and discharge of this Indenture pursuant to Articles VIII or XI hereof. For Notes that are
represented by global certificates on behalf of DTC, the Issuer may deliver the relevant notices to DTC for communication to entitled account holders in substitution of the aforementioned mailing. 

  
 98 

 The notice shall identify the Notes (including the CUSIP number) to be redeemed and shall
state: 
 (1) the redemption date; 

(2) the redemption price (or manner of calculation if not then known); 

(3) if any Note is being redeemed in part, the portion of the principal amount of such Note to be redeemed and that, after
the redemption date upon surrender of such Note, a new Note or Notes in principal amount equal to the unredeemed portion shall be issued upon cancellation of the original Note; 

(4) the name and address of the Paying Agent; 

(5) that Notes called for redemption must be surrendered to the Paying Agent to collect the redemption price; 

(6) that, unless the Issuer defaults in making such redemption payment, interest on Notes called for redemption ceases to
accrue on and after the redemption date; 
 (7) the paragraph of the Notes and/or Section of this Indenture
pursuant to which the Notes called for redemption are being redeemed; and 
 (8) that no representation is made
as to the correctness or accuracy of the CUSIP number, if any, listed in such notice or printed on the Notes. 
 At the
Issuer’s request, the Trustee shall give the notice of redemption in the Issuer’s name and at its expense; provided, however, that the Issuer has delivered to the Trustee, at least 45 days prior to the redemption date (or such
shorter period as the Trustee shall agree), an Officer’s Certificate requesting that the Trustee give such notice and setting forth the information to be stated in such notice as provided in the preceding paragraph. 

SECTION 5.4. Effect of Notice of Redemption. Once notice of redemption is mailed in accordance with Section 5.3
hereof, Notes called for redemption, unless such redemption is conditioned on the happening of a future event, become irrevocably due and payable on the redemption date at the redemption price. Any redemption or notice of redemption may, at the
Issuer’s discretion, be subject to one or more conditions precedent, including, but not limited to, completion of an Equity Offering, other offering or other corporate transaction or event. Notice of any redemption in respect of an Equity
Offering may be given prior to the completion thereof. 
 SECTION 5.5. Deposit of Redemption or Purchase Price. Prior to
11:00 a.m. (New York City time) on the redemption or purchase date, the Issuer shall deposit with the Trustee or with the Paying Agent money sufficient to pay the redemption or purchase price of and accrued interest and Additional Interest, if any,
on, all Notes to be redeemed or purchased on that date. The Trustee or the Paying Agent shall promptly return to the Issuer any money deposited with the Trustee or the Paying Agent by the Issuer in excess of the amounts necessary to pay the
redemption or purchase price of, and accrued interest and Additional Interest, if any, on, all Notes to be redeemed or purchased. 

  
 99 

 If the Issuer complies with the provisions of the preceding paragraph, on and after the
redemption or purchase date, interest shall cease to accrue on the Notes or the portions of Notes called for redemption or purchase. If a Note is redeemed or purchased on or after an interest record date but on or prior to the related interest
payment date, then any accrued and unpaid interest shall be paid to the Person in whose name such Note was registered at the close of business on such record date. If any Note called for redemption or purchase is not so paid upon surrender for
redemption or purchase because of the failure of the Issuer to comply with the preceding paragraph, interest shall be paid on the unpaid principal, from the redemption or purchase date until such principal is paid, and to the extent lawful on any
interest not paid on such unpaid principal, in each case at the rate provided in the Notes and in Section 3.1 hereof. 
 SECTION 5.6. Notes Redeemed or Purchased in Part. Upon surrender of a Note that is redeemed or purchased in part, the Issuer shall issue and, upon receipt of an Issuer Order, the Trustee shall
adjust the Schedule of Increases or Decreases of any Global Note and authenticate for the Holder at the expense of the Issuer a new Note equal in principal amount to the unredeemed or unpurchased portion of the Note surrendered; provided,
that each such new Note shall be in a principal amount of $2,000 or integral multiple of $1,000 in excess thereof. 

SECTION 5.7. Optional Redemption. 
 (a) At any time prior to June 1, 2016, the Issuer may redeem all or a part of the Notes, on a pro rata basis, upon notice as provided in Section 5.3, at a redemption price equal to 100%
of the principal amount of the Notes redeemed plus the Applicable Premium as of, and accrued and unpaid interest and Additional Interest, if any, to but excluding the date of redemption (the “Redemption Date”), subject to the rights
of Holders of record on the relevant record date to receive interest due on the relevant interest payment date. 
 (b) Prior to
June 1, 2015, the Issuer may, at its option, upon notice as provided in Section 5.3, on one or more occasions redeem up to 35% of the aggregate principal amount of the Notes issued under this Indenture, at a redemption price equal
to 110.625% of the aggregate principal amount of the Notes, plus accrued and unpaid interest thereon and Additional Interest, if any, to, but excluding the applicable Redemption Date, subject to the right of Holders of record on the relevant record
date to receive interest due on the relevant interest payment date, with the net cash proceeds of one or more Equity Offerings; provided that (a) at least 50% of the sum of the aggregate principal amount of Notes originally issued under
this Indenture on the Issue Date and any Additional Notes of the relevant series that are issued under the Indenture after the Issue Date remains outstanding immediately after the occurrence of each such redemption and (b) each such redemption
occurs within 90 days of the date of closing of each such Equity Offering. The Notes to be redeemed shall be selected in the manner described under Sections 5.1 through 5.6. 

(c) Except pursuant to clause (a) or (b) of this Section 5.7, the Notes shall not be redeemable at the
Company’s option prior to June 1, 2016. 

  
 100

 (d) On and after June 1, 2016, the Issuer may redeem the Notes, in whole or in part,
upon notice as provided in Section 5.3, at the redemption prices (expressed as percentages of principal amount of the Notes to be redeemed) set forth in the table below, plus accrued and unpaid interest thereon and Additional Interest,
if any, to but excluding the applicable Redemption Date, subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date, if redeemed during the twelve-month period beginning on
June 1, of each of the years indicated in the table below: 
  

					
	 Period
	  	Percentage	 
	 2016
	  	 	105.313	% 
	 2017
	  	 	102.656	% 
	 2018 and thereafter
	  	 	100.000	% 

 (e) Unless the Issuer defaults in the payment of the redemption price, interest shall cease to accrue on
the Notes or portions thereof called for redemption on the applicable Redemption Date. 
 (f) Any redemption pursuant to this
Section 5.7 shall be made pursuant to the provisions of Sections 5.1 through 5.6. 
 SECTION 5.8.
Mandatory Redemption. The Issuer is not required to make any mandatory redemption or sinking fund payments with respect to the Notes. 
 ARTICLE VI  
 DEFAULTS AND REMEDIES 

SECTION 6.1. Events of Default. Each of the following is an “Event of Default”: 

(1) default in payment when due and payable, upon redemption, acceleration or otherwise, of principal of, or premium, if
any, on the Notes; 
 (2) default for 30 days or more in the payment when due of interest or Additional Interest
on or with respect to the Notes; 
 (3) failure by the Issuer or any Guarantor for 60 days after receipt of
written notice given by the Trustee or the Holders of not less than 25% in principal amount of the outstanding Notes to comply with any of its obligations, covenants or agreements (other than a default referred to in clauses (1) and
(2) above) contained in this Indenture or the Notes; 
 (4) default under any mortgage, indenture or
instrument under which there is issued or by which there is secured or evidenced any Indebtedness for money borrowed by the Issuer or any of its Restricted Subsidiaries or the payment of which is guaranteed by the Issuer or any of its Restricted
Subsidiaries, other than Indebtedness 

  
 101

 
owed to the Issuer or a Restricted Subsidiary, whether such Indebtedness or guarantee now exists or is created after the issuance of the Notes, if both: 

 

	 	(A)	such default either results from the failure to pay any principal of such Indebtedness at its stated final maturity (after giving effect to any applicable grace
periods) or relates to an obligation other than the obligation to pay principal of any such Indebtedness at its stated final maturity and results in the holder or holders of such Indebtedness causing such Indebtedness to become due prior to its
stated maturity; and 

  

	 	(B)	the principal amount of such Indebtedness, together with the principal amount of any other such Indebtedness in default for failure to pay principal at stated final
maturity (after giving effect to any applicable grace periods), or the maturity of which has been so accelerated, aggregate $30.0 million or more at any one time outstanding; 

(5) failure by the Issuer or any Significant Subsidiary (or group of Restricted Subsidiaries that together (determined as
of the most recent consolidated financial statements of the Issuer for a fiscal period end provided as required under Section 3.11) would constitute a Significant Subsidiary) to pay final judgments aggregating in excess of $30.0 million
other than any judgments covered by indemnities provided by, or insurance policies issued by, reputable and creditworthy companies, which final judgments remain unpaid, undischarged and unstayed for a period of more than 60 days after such judgment
becomes final, and in the event such judgment is covered by insurance, an enforcement proceeding has been commenced by any creditor upon such judgment or decree which is not promptly stayed; 

(6) the Issuer or any Significant Subsidiary (or group of Restricted Subsidiaries that together (determined as of the
most recent consolidated financial statements of the Issuer for a fiscal period end provided as required under Section 3.11), would constitute a Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law: 

(i)   commences a voluntary case or proceeding; 

(ii)  consents to the entry of an order for relief against it in an involuntary case or proceeding; 

(iii) consents to the appointment of a Custodian of it or for substantially all of its property; or 

(iv) makes a general assignment for the benefit of its creditors; or 

(v)  consents to or acquiesces in the institution of a bankruptcy or an insolvency proceeding against it; or

  
 102

 (vi) takes any comparable action under any foreign laws relating to
insolvency; 
 (7) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that:

 (i) is for relief against the Issuer or any Significant Subsidiary (or any group of Restricted Subsidiaries
that together (determined as of the most recent consolidated financial statements of the Issuer for a fiscal period end provided as required under Section 3.11), would constitute a Significant Subsidiary, in an involuntary case;

 (ii) appoints a Custodian of the Issuer or any Significant Subsidiary (or any group of Restricted Subsidiaries
that together (determined as of the most recent consolidated financial statements of the Issuer for a fiscal period end provided as required under Section 3.11), would constitute a Significant Subsidiary, for substantially all of its
property; or 
 (iii) orders the winding up or liquidation of the Issuer or any Significant Subsidiary (or any
group of Restricted Subsidiaries that together (determined as of the most recent consolidated financial statements of the Issuer for a fiscal period end provided as required under Section 3.11), would constitute a Significant Subsidiary;
or 
 (iv) or any similar relief is granted under any foreign laws and the order, decree or relief remains
unstayed and in effect for 60 consecutive days; and 
 (8) the Guarantee of Parent or any Significant Subsidiary
(or group of Subsidiaries that together (determined as of the most recent consolidated financial statements of the Issuer for a fiscal period end provided as required under Section 3.11) would constitute a Significant Subsidiary) shall
for any reason cease to be in full force and effect or be declared null and void or any responsible officer of Parent or any Subsidiary Guarantor that is a Significant Subsidiary (or the responsible officers of any group of Restricted Subsidiaries
that, taken together (determined as of the most recent consolidated financial statements of the Issuer for a fiscal period end provided as required under Section 3.11) would constitute a Significant Subsidiary), as the case may be,
denies that it has any further liability under its or their Guarantee(s) or gives notice to such effect, other than by reason of the termination of this Indenture or the release of any such Guarantee in accordance with this Indenture. 

SECTION 6.2. Acceleration. If any Event of Default (other than an Event of Default described in clause (6) or (7) of
Section 6.1) occurs and is continuing, the Trustee by notice to the Issuer, or the Holders of at least 25% in principal amount of the then total outstanding Notes by notice to the Issuer and the Trustee, may, declare the principal of,
premium, if any, and accrued and unpaid interest (including Additional Interest), if any, and any other monetary obligations on all the then outstanding Notes to be due and payable immediately. Upon the effectiveness of such a declaration, such
principal, premium and accrued and unpaid interest (including Additional Interest) and any other monetary obligations shall be due and payable immediately. 

  
 103

 In the event of any Event of Default specified in clause (4) of
Section 6.1, such Event of Default and all consequences thereof (excluding any resulting payment default, other than as a result of acceleration of the Notes) shall be annulled, waived and rescinded, automatically and without any action
by the Trustee or the Holders, if within 30 days after such Event of Default arose: 
 (x) the Indebtedness or
guarantee that is the basis for such Event of Default has been discharged; or 
 (y) the holders thereof have
rescinded or waived the acceleration, notice or action (as the case may be) giving rise to such Event of Default; or 
 (z) if the default that is the basis for such Event of Default has been cured. 

If an Event of Default described in clause (6) or (7) of Section 6.1 occurs and is continuing, the principal of,
premium, if any, and accrued and unpaid interest (including Additional Interest) and any other monetary obligations on all the Notes shall become and be immediately due and payable without any declaration or other act on the part of the Trustee or
any Holders. 
 SECTION 6.3. Other Remedies. If an Event of Default occurs and is continuing, the Trustee may pursue any
available remedy by proceeding at law or in equity to collect the payment of principal of (or premium, if any) or interest (including Additional Interest) on the Notes or to enforce the performance of any provision of the Notes, this Indenture or
the Guarantees. 
 The Trustee may maintain a proceeding even if it does not possess any of the Notes or does not produce any of
them in the proceeding. A delay or omission by the Trustee or any Holder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. No
remedy is exclusive of any other remedy. All available remedies are cumulative. 
 SECTION 6.4. Waiver of Past Defaults.
The Holders of a majority in principal amount of the then outstanding Notes by notice to the Trustee (with a copy to the Issuer, but the applicable waiver or rescission shall be effective when the notice is given to the Trustee) may, on behalf of
the Holders of all the Notes, (a) waive, by their consent (including, without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, Notes), an existing Default and its consequences under this
Indenture except (i) a continuing Default in the payment of the principal of, or premium, if any, or interest (including Additional Interest) on a Note held by a non-consenting Holder or (ii) a Default in respect of a provision that under
Section 9.2 cannot be amended without the consent of each Holder affected and (b) rescind any acceleration and its consequences with respect to the Notes provided such rescission would not conflict with any judgment of a court of
competent jurisdiction. When a Default or Event of Default is waived, it is deemed cured, but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any consequent right. 

  
 104

 SECTION 6.5. Control by Majority. The Holders of a majority in principal amount of
the outstanding Notes may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or of exercising any trust or power conferred on the Trustee. However, the Trustee may refuse to follow any direction
that conflicts with law or this Indenture, the Notes or the Guarantees or, subject to Sections 7.1 and 7.2, that the Trustee determines is unduly prejudicial to the rights of other Holders (it being understood that the Trustee does not
have an affirmative duty to ascertain whether or not any such directions are unduly prejudicial to such Holders) or would involve the Trustee in personal liability; provided, however, that the Trustee may take any other action deemed proper
by the Trustee that is not inconsistent with such direction. Prior to taking any such action hereunder, the Trustee shall be entitled to indemnification satisfactory to it in its sole discretion against all losses and expenses caused by taking or
not taking such action. 
 SECTION 6.6. Limitation on Suits. Subject to Section 6.7, a Holder may not pursue
any remedy with respect to this Indenture or the Notes unless: 
 (1) such Holder has previously given to the
Trustee written notice stating that an Event of Default is continuing; 
 (2) Holders of at least 25% in
principal amount of the total outstanding Notes have requested that the Trustee pursue the remedy; 
 (3) Holders
of the Notes have offered and, if requested, provide to the Trustee indemnity or security reasonably satisfactory to the Trustee against any loss, liability or expense; 

(4) the Trustee has not complied with such request within 60 days after the receipt thereof and the offer of security or
indemnity; and 
 (5) Holders of a majority in principal amount of the total outstanding Notes have not given the
Trustee a direction inconsistent with such request within such 60-day period. 
 A Holder may not use this Indenture to prejudice
the rights of another Holder or to obtain a preference or priority over another Holder. 
 SECTION 6.7. Rights of Holders to
Receive Payment. Notwithstanding any other provision of this Indenture (including, without limitation, Section 6.6), the right of any Holder to receive payment of principal of, premium (if any), or interest (including Additional
Interest) on the Notes held by such Holder, on or after the respective due dates expressed or provided for in the Notes, or to bring suit for the enforcement of any such payment on or after such respective dates, shall not be impaired or affected
without the consent of such Holder. 
 SECTION 6.8. Collection Suit by Trustee. If an Event of Default specified in
clauses (1) or (2) of Section 6.1 occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Issuer for the whole amount then due and owing (together with interest
on any unpaid interest to the extent lawful) and the amounts provided for in Section 7.7. 

  
 105

 SECTION 6.9. Trustee May File Proofs of Claim. The Trustee may file such proofs of
claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and
the Holders allowed in any judicial proceedings relative to the Issuer, its Subsidiaries or its or their respective creditors or properties and, unless prohibited by law or applicable regulations, may be entitled and empowered to participate as a
member of any official committee of creditors appointed in such matter and may vote on behalf of the Holders in any election of a trustee in bankruptcy or other Person performing similar functions, and any Custodian in any such judicial proceeding
is hereby authorized by each Holder to make payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due it for the reasonable compensation,
expenses, disbursements and advances of the Trustee, its agents and its counsel, and any other amounts due the Trustee under Section 7.7. 
 No provision of this Indenture shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or
composition affecting the Notes or the rights of any Holder thereof or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding. 
 SECTION 6.10. Priorities. (a) If the Trustee collects any money or property pursuant to this Article VI, it shall pay out the money or property in the following order: 

FIRST: to the Trustee for amounts due to it under Section 7.7; 

SECOND: to Holders for amounts due and unpaid on the Notes for principal, premium, if any, and interest, ratably, without
preference or priority of any kind, according to the amounts due and payable on the Notes for principal, premium, if any, and interest (including Additional Interest), respectively; and 

THIRD: to the Issuer, or to the extent the Trustee collects any amount for any Guarantor, to such Guarantor. 

(b) The Trustee may fix a record date and payment date for any payment to Holders pursuant to this Section 6.10. At least 15
days before such record date, the Issuer shall mail to each Holder and the Trustee a notice that states the record date, the payment date and amount to be paid. 
 SECTION 6.11. Undertaking for Costs. In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or omitted by it as Trustee,
a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’ fees and expenses,
against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.11 does not apply to a suit by the Trustee, a suit by the Issuer, a suit by a
Holder pursuant to Section 6.7 or a suit by Holders of more than 10% in outstanding principal amount of the Notes. 

  
 106

 ARTICLE VII  
 TRUSTEE 
 SECTION 7.1. Duties of Trustee. If an Event of Default has
occurred and is continuing, the Trustee shall exercise the rights and powers vested in it by this Indenture and use the same degree of care and skill in their exercise as a prudent Person would exercise or use under the circumstances in the conduct
of such person’s own affairs; provided that the Trustee shall be under no obligation to exercise any of the rights or powers under this Indenture, the Notes or the Guarantees at the request or direction of any of the Holders unless the
Holders have offered the Trustee indemnity or security satisfactory to the Trustee against any loss, liability or expense. 
 (a)
Except during the continuance of an Event of Default: 
 (1) the Trustee undertakes to perform such duties and
only such duties as are specifically set forth in this Indenture and no implied covenants or obligations shall be read into this Indenture against the Trustee; and 

(2) in the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the
correctness of the opinions expressed therein, upon certificates, opinions or orders furnished to the Trustee and conforming to the requirements of this Indenture, the Notes or the Guarantees, as applicable. However, in the case of any such
certificates or opinions which by any provisions hereof are specifically required to be furnished to the Trustee, the Trustee shall examine such certificates and opinions to determine whether or not they conform to the requirements of this
Indenture, the Notes or the Guarantees, as the case may be (but need not confirm or investigate the accuracy of mathematical calculations or other facts stated therein). 
 (b) The Trustee may not be relieved from liability for its own negligent action, its own negligent failure to act or its own willful misconduct, except that: 

(1) this paragraph does not limit the effect of paragraph (a) of this Section 7.1; 

(2) the Trustee shall not be liable for any error of judgment made in good faith by a Trust Officer unless it is proved
that the Trustee was negligent in ascertaining the pertinent facts; 
 (3) the Trustee shall not be liable with
respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.5; and 
 (4) No provision of this Indenture, the Notes or the Guarantees shall require the Trustee to expend or risk its own funds or otherwise incur financial liability in the performance of any of its duties
hereunder or thereunder or in the exercise of any of its rights or powers, if it shall have reasonable grounds to believe that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured to it. 

  
 107

 (c) Every provision of this Indenture that in any way relates to the Trustee is subject to
paragraphs (a), (b) and (c) of this Section 7.1. 
 (d) The Trustee shall not be liable for interest on any
money received by it except as the Trustee may agree in writing with the Issuer. 
 (e) Money held in trust by the Trustee need
not be segregated from other funds except to the extent required by law. 
 (f) Every provision of this Indenture relating to the
conduct or affecting the liability of or affording protection to the Trustee shall be subject to the provisions of this Section 7.1 and to the provisions of the TIA. 

(g) Unless otherwise specifically provided in this Indenture, any demand, request, direction or notice from the Issuer shall be sufficient
if signed by one Officer of the Issuer. 
 SECTION 7.2. Rights of Trustee. Subject to
Section 7.1: 
 (a) The Trustee may conclusively rely on and shall be fully protected in acting or refraining from
acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document (whether in its original or facsimile form) reasonably believed by it to be genuine and to have
been signed or presented by the proper person. The Trustee need not investigate any fact or matter stated in the document. The Trustee shall receive and retain financial reports and statements of the Issuer as provided herein, but shall have no duty
to review or analyze such reports or statements to determine compliance with covenants or other obligations of the Issuer. 
 (b)
Before the Trustee acts or refrains from acting, it may require an Officer’s Certificate and/or an Opinion of Counsel. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on an Officer’s
Certificate or Opinion of Counsel. 
 (c) The Trustee may execute any of the trusts and powers hereunder or perform any duties
hereunder either directly by or through its attorneys and agents and shall not be responsible for the misconduct or negligence of any agent or attorney appointed with due care by it hereunder. 

(d) In the absence of willful misconduct or negligence, the Trustee shall not be liable for any action it takes or omits to take in good
faith which it believes to be authorized or within its rights or powers, conferred upon it by this Indenture. 
 (e) The Trustee
may consult with counsel of its selection, and the advice or opinion of counsel with respect to legal matters relating to this Indenture, the Notes or the Guarantees shall be full and complete authorization and protection from liability in respect
of any action taken, omitted or suffered by it hereunder or under the Notes or the Guarantees in good faith and in accordance with the advice or opinion of such counsel. 

  
 108

 (f) The Trustee shall not be deemed to have notice of any Default or Event of Default or
whether any entity or group of entities constitutes a Significant Subsidiary unless a Trust Officer of the Trustee has actual knowledge thereof or unless written notice of any event which is in fact such a Default or of any such Significant
Subsidiary is received by the Trustee at the corporate trust office of the Trustee specified in Section 12.2, and such notice references the Notes and this Indenture. 

(g) The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be
indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and to each agent, custodian and other Person employed to act hereunder. 

(h) The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture, the Notes or the
Guarantees at the request, order or direction of any of the Holders pursuant to the provisions of this Indenture, unless the Holders shall have offered to the Trustee security or indemnity satisfactory to it against the costs, expenses and
liabilities which may be incurred therein or thereby. 
 (i) The Trustee shall not be deemed to have knowledge of any fact or
matter unless such fact or matter is known to a Trust Officer of the Trustee. 
 (j) Whenever in the administration of this
Indenture, the Notes or the Guarantees the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder or thereunder, the Trustee (unless other evidence be herein specifically
prescribed) may, in the absence of bad faith or willful misconduct on its part, rely upon an Officer’s Certificate. 
 (k)
In no event shall the Trustee be responsible or liable for any special, indirect, punitive or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit), irrespective of whether the Trustee has been advised
of the likelihood of such loss or damage and regardless of the form of action. 
 (l) The Trustee shall not be bound to make any
investigation into the facts or matters stated in any resolution, certificate, statement, instrument, report, notice, request, direction, consent, order, bond, debenture, coupon or other paper or document, but the Trustee, in its discretion, may
make such further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine, during business hours and upon reasonable
notice, the books, records and premises of the Issuer and the Restricted Subsidiaries, personally or by agent or attorney at the sole cost of the Issuer and shall incur no liability or additional liability of any kind by reason of such inquiry or
investigation. 
 (m) The Trustee shall not be required to give any bond or surety in respect of the performance of its powers
and duties hereunder. 
 (n) The Trustee may request that the Issuer deliver a certificate setting forth the names of individuals
and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture or the Notes. 

  
 109

 SECTION 7.3. Individual Rights of Trustee. The Trustee in its individual or any other
capacity may become the owner or pledgee of Notes and may otherwise deal with the Issuer, Guarantors or their Affiliates with the same rights it would have if it were not Trustee. Any Paying Agent, Registrar, co-registrar or co-paying agent may do
the same with like rights. However, the Trustee must comply with Sections 7.10 and 7.11. In addition, the Trustee shall be permitted to engage in transactions with the Issuer; provided, however, that if the Trustee acquires any
conflicting interest under the TIA, the Trustee must (i) eliminate such conflict within 90 days of acquiring such conflicting interest, (ii) apply to the SEC for permission to continue acting as Trustee or (iii) resign. 

SECTION 7.4. Trustee’s Disclaimer. The Trustee shall not be responsible for and makes no representation as to the validity or
adequacy of this Indenture, the Offering Memorandum, the Purchase Agreement, the Guarantees or the Notes, shall not be accountable for the Issuer’s use of the proceeds from the sale of the Notes, shall not be responsible for the use or
application of any money received by any Paying Agent other than the Trustee or any money paid to the Issuer pursuant to the terms of this Indenture and shall not be responsible for any statement of the Issuer in this Indenture or in any document
issued in connection with the sale of the Notes or in the Notes other than the Trustee’s certificate of authentication. 

SECTION 7.5. Notice of Defaults. If a Default or Event of Default occurs and is continuing and if a Trust Officer has actual
knowledge thereof, the Trustee shall mail by first class mail to each Holder at the address set forth in the Notes Register notice of the Default or Event of Default within 90 days after it is actually known to a Trust Officer. Except in the case of
a Default relating to the payment of principal of, premium (if any), or interest on any Note (including payments pursuant to the optional redemption or required repurchase provisions of such Note), the Trustee may withhold the notice if and so long
as a committee of its Trust Officers in good faith determines that withholding the notice is in the interests of Holders. 

SECTION 7.6. Reports by Trustee to Holders. Within 60 days after each April 15 beginning April 15, 2013, the Trustee
shall mail to each Holder a brief report dated as of such April 15 that complies with TIA § 313(a) if and to the extent required thereby. The Trustee also shall comply with TIA § 313(b) and TIA § 313(c). 

A copy of each report at the time of its mailing to Holders shall be filed with the SEC and each stock exchange (if any) on which the
Notes are listed. The Issuer agrees to notify promptly the Trustee in writing whenever the Notes become listed on any stock exchange and of any delisting thereof and the Trustee shall comply with TIA § 313(d). 

SECTION 7.7. Compensation and Indemnity. The Issuer shall pay to the Trustee from time to time reasonable compensation for its
services hereunder and under the Notes and the Guarantees as the Issuer and the Trustee or the Issuer shall from time to time agree in writing. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an
express trust. The Issuer and Guarantors jointly and severally shall reimburse the Trustee upon request for all out-of-pocket expenses incurred or made by it, including, but not limited to, costs of collection, costs of preparing reports,
certificates and other documents, costs of preparation and mailing of notices to Holders. Such expenses shall include the reasonable compensation and expenses, disbursements and advances of the respective agents, counsel, accountants and experts of
the 

  
 110

 
Trustee. The Issuer and Guarantors jointly and severally shall indemnify each of the Trustee and its officers, directors, shareholders, employees and agents against any and all loss, liability,
damages, claims or expense (including reasonable attorneys’ fees and expenses) incurred by it without willful misconduct, negligence or bad faith on its part in connection with the acceptance or administration of this trust, the exercise of its
rights and powers, and the performance of its duties hereunder and under the Notes and the Guarantees, including the costs and expenses of enforcing this Indenture (including this Section 7.7), the Notes and the Guarantees and of
defending itself against any claims (whether asserted by any Holder, the Issuer or otherwise). Each of the Trustee shall notify the Issuer promptly of any claim for which it may seek indemnity of which it has received written notice. Failure by the
Trustee to so notify the Issuer shall not relieve the Issuer of its obligations hereunder. The Issuer shall defend the claim and each of the Trustee shall provide reasonable cooperation at the Issuer’s expense in the defense. The Trustee may
each have separate counsel and the Issuer shall pay the fees and expenses of such counsel. 
 To secure the Issuer’s
payment obligations in this Section 7.7, the Trustee shall have a lien prior to the Notes on all money or property held or collected by the Trustee other than money or property held in trust to pay principal of and interest on particular
Notes. Such lien shall survive the satisfaction and discharge of this Indenture. The Trustee’s right to receive payment of any amounts due under this Section 7.7 shall not be subordinate to any other liability or Indebtedness of the
Issuer. 
 The Issuer’s payment obligations pursuant to this Section 7.7 shall survive the discharge of this
Indenture and the resignation or removal of the Trustee. “Trustee” for the purposes of this Section 7.7 shall include any predecessor Trustee and the Trustee in each of its capacities hereunder and each agent, custodian and other
person employed to act hereunder; provided, however, that the negligence, willful misconduct or bad faith of any Trustee hereunder shall not affect the rights of any other Trustee hereunder. Without prejudice to any other rights available to
the Trustee under applicable law, when the Trustee incurs expenses or renders services after the occurrence of a Default specified in clause (6) or clause (7) of Section 6.1, the expenses (including the reasonable fees and
expenses of its counsel) are intended to constitute expenses of administration under any Bankruptcy Law. 
 SECTION 7.8.
Replacement of Trustee. The Trustee may resign at any time by so notifying the Issuer in writing not less than 30 days prior to the effective date of such resignation. The Holders of a majority in principal amount of the Notes may remove the
Trustee by so notifying the removed Trustee in writing not less than 30 days prior to the effective date of such removal and may appoint a successor Trustee with the Issuer’s written consent, which consent shall not be unreasonably withheld.
The Issuer shall remove the Trustee if: 
 (1) the Trustee fails to comply with Section 7.10 hereof;

 (2) the Trustee is adjudged bankrupt or insolvent; 

(3) a receiver or other public officer takes charge of the Trustee or its property; or 

(4) the Trustee otherwise becomes incapable of acting. 

  
 111

 If the Trustee resigns or is removed by the Issuer or by the Holders of a majority in
principal amount of the Notes and such Holders do not reasonably promptly appoint a successor Trustee as described in the preceding paragraph, or if a vacancy exists in the office of the Trustee for any reason (the Trustee in such event being
referred to herein as the retiring Trustee), the Issuer shall promptly appoint a successor Trustee. 
 A successor Trustee shall
deliver a written acceptance of its appointment to the retiring Trustee and to the Issuer. Thereupon the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of
the Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to Holders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee, subject to the lien provided for in
Section 7.7. 
 If a successor Trustee does not take office within 60 days after the retiring Trustee resigns or is
removed, the retiring Trustee or the Holders of at least 10% in principal amount of the Notes may petition, at the Issuer’s expense, any court of competent jurisdiction for the appointment of a successor Trustee. 

If the Trustee fails to comply with Section 7.10, unless the Trustee’s duty to resign is stayed as provided in TIA
§ 310(b), any Holder, who has been a bona fide holder of a Note for at least six months, may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 

Notwithstanding the replacement of the Trustee pursuant to this Section 7.8, the Issuer’s obligations under
Section 7.7 shall continue for the benefit of the retiring Trustee. 
 SECTION 7.9. Successor Trustee by
Merger. If the Trustee consolidates with, merges or converts into, or transfers all or substantially all its corporate trust business or assets to, another corporation or banking association, the resulting, surviving or transferee corporation
without any further act shall be the successor Trustee. 
 In case at the time such successor or successors by merger,
conversion or consolidation to the Trustee shall succeed to the trusts created by this Indenture, any of the Notes shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any
predecessor trustee, and deliver such Notes so authenticated; and in case at that time any of the Notes shall not have been authenticated, any successor to the Trustee may authenticate such Notes either in the name of any predecessor hereunder or in
the name of the successor to the Trustee; provided that the right to adopt the certificate of authentication of any predecessor Trustee or authenticate Notes in the name of any predecessor Trustee shall only apply to its successor or
successors by merger, consolidation or conversion. 
 SECTION 7.10. Eligibility; Disqualification. This Indenture shall
always have a Trustee that satisfies the requirements of TIA § 310(a)(1), (2) and (5) in every respect. The Trustee shall have a combined capital and surplus of at least $100 million as set forth in its most recent published annual
report of condition. The Trustee shall comply with TIA § 310(b); provided, however, that there shall be excluded from the operation of TIA § 310(b)(1) any indenture or indentures under which other securities or certificates of
interest or participation in other securities of the Issuer are outstanding if the requirements for such exclusion set forth in TIA § 310(b)(1) are met. 

  
 112

 SECTION 7.11. Preferential Collection of Claims Against the Issuer. The Trustee shall
comply with TIA § 311(a), excluding any creditor relationship listed in TIA § 311(b). A Trustee who has resigned or been removed shall be subject to TIA § 311(a) to the extent indicated. 

SECTION 7.12. Trustee’s Application for Instruction from the Issuer. Any application by the Trustee for written instructions
from the Issuer may, at the option of the Trustee, set forth in writing any action proposed to be taken or omitted by the Trustee under this Indenture and the date on and/or after which such action shall be taken or such omission shall be effective.
The Trustee shall not be liable for any action taken by, or omission of, the Trustee in accordance with a proposal included in such application on or after the date specified in such application (which date shall not be less than three Business Days
after the date any Officer of the Issuer actually receives such application, unless any such Officer shall have consented in writing to any earlier date) unless prior to taking any such action (or the effective date in the case of an omission), the
Trustee shall have received written instructions in response to such application specifying the action to be taken or omitted. 

ARTICLE VIII  
 LEGAL DEFEASANCE AND COVENANT DEFEASANCE 
 SECTION 8.1. Option to Effect
Legal Defeasance or Covenant Defeasance; Defeasance. The Issuer may, at its option and at any time, elect to have either Section 8.2 or 8.3 hereof be applied to all outstanding Notes upon compliance with the conditions set
forth below in this Article VIII. 
 SECTION 8.2. Legal Defeasance and Discharge. Upon the Issuer’s exercise
under Section 8.1 hereof of the option applicable to this Section 8.2, the Issuer and each of the Guarantors shall, subject to the satisfaction of the conditions set forth in Section 8.4 hereof, be deemed to have
been discharged from their obligation with respect to all outstanding Notes (including the Guarantees) on the date the conditions set forth below are satisfied (hereinafter, “Legal Defeasance”). For this purpose, Legal Defeasance
means that the Issuer and the Guarantors shall be deemed to have paid and discharged the entire Indebtedness represented by the outstanding Notes (including the Guarantees), which shall thereafter be deemed to be “outstanding” only for the
purposes of Section 8.5 hereof and the other Sections of this Indenture referred to in clauses (1) through (3) below, and to have satisfied all of their other obligations under such Notes, the Guarantees and this Indenture (and
the Trustee, on demand of and at the expense of the Issuer, shall execute proper instruments acknowledging the same) and to have cured all then existing Events of Default, except for the following provisions which shall survive until otherwise
terminated or discharged hereunder: 

  
 113

 (1) the rights of Holders of Notes to receive payments in respect of the
principal of, premium, if any, and interest on the Notes when such payments are due solely out of the trust referred to in Section 8.4 hereof; 
 (2) the Issuer’s obligations with respect to Notes under Article II concerning issuing temporary Notes, registration of such Notes, mutilated, destroyed, lost or stolen Notes and
Section 3.12 hereof concerning the maintenance of an office or agency for payment and money for security payments held in trust; 
 (3) the rights, powers, trusts, duties and immunities of the Trustee and the Issuer’s obligations in connection therewith; and 

(4) this Article VIII with respect to provisions relating to Legal Defeasance. 

SECTION 8.3. Covenant Defeasance. Upon the Issuer’s exercise under Section 8.1 hereof of the option applicable to
this Section 8.3, the Issuer and each of the Guarantors shall, subject to the satisfaction of the conditions set forth in Section 8.4 hereof, be released from each of their obligations under the covenants contained in
Sections 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9, 3.10, 3.11, 3.12, 3.15 and Section 4.1(a)(4) hereof with respect to the outstanding Notes on and after
the date the conditions set forth in Section 8.4 hereof are satisfied (hereinafter, “Covenant Defeasance”), and the Notes shall thereafter be deemed not “outstanding” for the purposes of any direction, waiver,
consent or declaration or act of Holders (and the consequences of any thereof) in connection with such covenants, but shall continue to be deemed “outstanding” for all other purposes hereunder. For this purpose, Covenant Defeasance means
that, with respect to the outstanding Notes and Guarantees, the Issuer and the Guarantors may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such covenant, whether directly or
indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such omission to comply shall not constitute a Default or an
Event of Default under Section 6.1 hereof, but, except as specified above, the remainder of this Indenture and such Notes and Guarantees shall be unaffected thereby. In addition, upon the Issuer’s exercise under
Section 8.1 hereof of the option applicable to this Section 8.3, subject to the satisfaction of the conditions set forth in Section 8.4 hereof, Sections 6.1(3), 6.1(4), 6.1(5), 6.1(6)
(with respect only to a Restricted Subsidiary that is a Significant Subsidiary or any group of Restricted Subsidiaries that taken together would constitute a Significant Subsidiary), 6.1(7) (with respect only to a Restricted Subsidiary that
is a Significant Subsidiaries or any group of Restricted Subsidiaries that taken together would constitute a Significant Subsidiary), and 6.1(8) hereof shall not constitute Events of Default. 

SECTION 8.4. Conditions to Legal or Covenant Defeasance. In order to exercise either Legal Defeasance or Covenant Defeasance under
either Section 8.2 or 8.3 hereof: 
 (1) the Issuer must irrevocably deposit with the Trustee,
in trust, for the benefit of the Holders of the Notes, cash in U.S. dollars, Government Securities, or a combination thereof, in such amounts as shall be sufficient, in the opinion of a nationally recognized firm of independent public accountants,
to pay the principal of, premium, if 

  
 114

 
any, and interest due on the Notes on the Stated Maturity date or on the redemption date, as the case may be, of such principal, premium, if any, or interest on such Notes, and the Issuer must
specify whether such Notes are being defeased to maturity or to a particular redemption date; 
 (2) in the case
of Legal Defeasance, the Issuer shall have delivered to the Trustee an Opinion of Counsel reasonably acceptable to the Trustee confirming that, subject to customary assumptions and exclusions; 

(A) the Issuer has received from, or there has been published by, the U.S. Internal Revenue Service a ruling, or

 (B) since the issuance of the Notes, there has been a change in the applicable U.S. federal income tax law,

 in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, subject to customary
assumptions and exclusions, the Holders of the Notes shall not recognize income, gain or loss for U.S. federal income tax purposes, as applicable, as a result of such Legal Defeasance and shall be subject to such U.S. federal income tax on the same
amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred; 
 (3) in the case of Covenant Defeasance, the Issuer shall have delivered to the Trustee an Opinion of Counsel reasonably acceptable to the Trustee confirming that, subject to customary assumptions and
exclusions, the Holders of the Notes shall not recognize income, gain or loss for U.S. federal income tax purposes as a result of such Covenant Defeasance and shall be subject to U.S. federal income tax on the same amounts, in the same manner and at
the same times as would have been the case if such Covenant Defeasance had not occurred; 
 (4) no Default
(other than that resulting from borrowing funds to be applied to make such deposit and any similar and simultaneous deposit relating to other Indebtedness, and, in each case the granting of Liens in connection therewith) shall have occurred and be
continuing on the date of such deposit; 
 (5) such Legal Defeasance or Covenant Defeasance shall not result in
a breach or violation of, or constitute a default under the Senior Credit Facility or any other material agreement or instrument (other than this Indenture) to which the Issuer or any Guarantor is a party or by which the Issuer or any Guarantor is
bound (other than that resulting from borrowing funds to be applied to make such deposit and any similar and simultaneous deposit relating to other Indebtedness and, in each case, the granting of Liens in connection therewith); 

(6) the Issuer shall have delivered to the Trustee an Opinion of Counsel to the effect that, as of the date of such
opinion and subject to customary assumptions and exclusions following the deposit, the trust funds shall not be subject to the effect of Section 547 of Title 11 of the United States Code; 

  
 115

 (7) the Issuer shall have delivered to the Trustee an Officer’s
Certificate stating that the deposit was not made by the Issuer with the intent of defeating, hindering, delaying or defrauding any creditors of the Issuer or any Guarantor or others; and 

(8) the Issuer shall have delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel (which Opinion
of Counsel may be subject to customary assumptions and exclusions) each stating that all conditions precedent provided for or relating to the Legal Defeasance or the Covenant Defeasance, as the case may be, have been complied with. 

SECTION 8.5. Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions. Subject to
Section 8.6 hereof, all money and non-callable Government Securities (including the proceeds thereof) deposited with the Trustee (or other qualifying trustee, collectively for purposes of this Section 8.5, the
“Trustee”) pursuant to Section 8.4 hereof in respect of the outstanding Notes shall be held in trust and applied by the Trustee, in accordance with the provisions of such Notes and this Indenture, to the payment, either
directly or through any Paying Agent (including the Issuer acting as Paying Agent) as the Trustee may determine, to the Holders of such Notes of all sums due and to become due thereon in respect of principal, premium and Additional Interest, if any,
and interest, but such money need not be segregated from other funds except to the extent required by law. 
 The Issuer shall
pay and indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the cash or non-callable Government Securities deposited pursuant to Section 8.4 hereof or the principal and interest received in respect
thereof other than any such tax, fee or other charge which by law is for the account of the Holders of the outstanding Notes. 

Notwithstanding anything in this Article VIII to the contrary, the Trustee shall deliver or pay to the Issuer from time to time
upon the request of the Issuer any money or non-callable Government Securities held by it as provided in Section 8.4 hereof which, in the opinion of a nationally recognized firm of independent public accountants expressed in a written
certification thereof delivered to the Trustee (which may be the opinion delivered under Section 8.4(1) hereof), are in excess of the amount thereof that would then be required to be deposited to effect an equivalent Legal Defeasance or
Covenant Defeasance. 
 SECTION 8.6. Repayment to the Issuer. Any money deposited with the Trustee or any Paying Agent,
or then held by the Issuer, in trust for the payment of the principal of, premium or Additional Interest, if any, or interest on, any Note and remaining unclaimed for two years after such principal, premium or Additional Interest, if any, or
interest has become due and payable shall be paid to the Issuer on its request unless an abandoned property law designates another Person or (if then held by the Issuer) shall be discharged from such trust; and the Holder of such Note shall
thereafter be permitted to look only to the Issuer for payment thereof unless an abandoned property law designates another Person, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the
Issuer as trustee thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, may at the expense of the Issuer cause to be published once, in the New York Times
and The Wall Street Journal (national edition), notice that such money remains unclaimed and that, after a date specified therein, which shall not be less than 30 days from the date of such notification or publication, any unclaimed balance of such
money then remaining shall be repaid to the Issuer. 

  
 116

 SECTION 8.7. Reinstatement. If the Trustee or Paying Agent is unable to apply any
money or U.S. dollars or non-callable Government Securities in accordance with Section 8.2 or 8.3 hereof, as the case may be, by reason of any order or judgment of any court or governmental authority enjoining, restraining or
otherwise prohibiting such application, then the Issuer’s and the Guarantors’ obligations under this Indenture and the Notes and the Guarantees shall be revived and reinstated as though no deposit had occurred pursuant to
Section 8.2 or 8.3 hereof until such time as the Trustee or Paying Agent is permitted to apply all such money in accordance with Section 8.2 or 8.3 hereof, as the case may be; provided, however, that, if
the Issuer makes any payment of principal of, premium or Additional Interest, if any, or interest on, any Note following the reinstatement of its obligations, the Issuer shall be subrogated to the rights of the Holders of such Notes to receive such
payment from the money or non-callable Government Securities held by the Trustee or Paying Agent. 
 ARTICLE IX 

 AMENDMENTS 
 SECTION 9.1. Without Consent of Holders. Notwithstanding Section 9.2 of this Indenture, the Issuer, any Guarantor (with respect to a Guarantee or this Indenture to which it is a party)
and the Trustee may amend or supplement this Indenture and any Guarantee and the Notes without the consent of any Holder: 
 (1) to cure any ambiguity, omission, mistake, defect or inconsistency; 
 (2) to provide for uncertificated Notes of such series in addition to or in place of certificated Notes; 
 (3) to comply with Article IV or Section 10.2(b); 
 (4) to provide for the assumption of the Issuer’s or any Guarantor’s obligations to the Holders in a transaction that complies with this Indenture; 

(5) to make any change that would provide any additional rights or benefits to the Holders or that does not adversely
affect the legal rights under this Indenture, the Notes or the Guarantees of any such Holder; 
 (6) to add
covenants for the benefit of the Holders or to surrender any right or power conferred upon the Issuer or any Guarantor; 
 (7) to comply with requirements of the SEC in order to effect or maintain the qualification of the Indenture under the Trust Indenture Act; 

(8) to evidence and provide for the acceptance and appointment under this Indenture of a successor Trustee hereunder
pursuant to the requirements hereof; 

  
 117

 (9) to provide for the issuance of exchange notes or private exchange notes,
which are identical to exchange notes except that they are not freely transferable; 
 (10) to add a Guarantor
under this Indenture; 
 (11) to conform the text of this Indenture, Guarantee or Notes to any provision under
the heading “Description of notes” in the Offering Memorandum to the extent that an Officer’s Certificate is provided to the Trustee stating that such provision in the Offering Memorandum was intended to be a verbatim recitation of a
provision of this Indenture, Guarantee or Notes; or 
 (12) to make any amendment to the provisions of this
Indenture relating to the transfer and legending of Notes as permitted by this Indenture, including, without limitation to facilitate the issuance and administration of the Notes; provided, however, that (i) compliance with this
Indenture as so amended would not result in Notes being transferred in violation of the Securities Act or any applicable securities law and (ii) such amendment does not materially and adversely affect the rights of Holders to transfer Notes,
each as evidenced by an Opinion of Counsel. 
 Subject to Section 9.2, upon the request of the Issuer, and upon
receipt by the Trustee of the documents described in Section 12.4 hereof, the Trustee shall join with the Issuer and the Guarantors in the execution of such amended or supplemental indenture unless such amended or supplemental indenture
directly affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such amended or supplemental indenture; it being
understood and agreed that Parent shall not be a party to the supplemental indenture that joins Thomson Reuters (Healthcare) Inc. and it being further agreed that, by executing and delivering this Indenture, Parent consents to said supplemental
indenture, the form of which is attached hereto as Exhibit C. 
 After an amendment or supplement under this
Section 9.1 becomes effective, the Issuer shall mail to Holders a notice briefly describing such amendment or supplement. The failure to give such notice to all Holders, or any defect therein, shall not impair or affect the validity of
an amendment or supplement under this Section 9.1. 
 SECTION 9.2. With Consent of Holders. 

Except as provided below in this Section 9.2, the Issuer, the Guarantors and the Trustee may amend or supplement this
Indenture, any related Guarantee and the Notes issued hereunder with the consent of the Holders of at least a majority in aggregate principal amount of the Notes then outstanding, including consents obtained in connection with a purchase of, or
tender offer or exchange offer for, Notes, and, subject to Sections 6.4 and 6.7 hereof, any existing Default or Event of Default (other than a Default or Event of Default in the payment of the principal of, premium, if any, and
Additional Interest, if any, or interest on the Notes, except a payment default resulting from an acceleration that has been rescinded) or compliance with any provision of this Indenture, the Notes and the Guarantees may be waived with the consent
of the Holders of a majority in principal amount of the then outstanding Notes, other than Notes beneficially owned by the Issuer or its Affiliates (including consents obtained in connection with a purchase of, or tender offer or exchange offer for
the Notes). Section 2.11 hereof and Section 12.6 hereof shall determine which Notes are considered to be “outstanding” for the purposes of this Section 9.2. 

  
 118

 Upon the request of the Issuer, and upon the filing with the Trustee of evidence
satisfactory to the Trustee of the consent of the Holders of Notes as aforesaid, and upon receipt by the Trustee of the documents described in Section 12.4 hereof, the Trustee shall join with the Issuer and the Guarantors in the
execution of such amended or supplemental indenture unless such amended or supplemental indenture directly affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its
discretion, but shall not be obligated to, enter into such amended or supplemental Indenture. 
 Without the consent of each
affected Holder of Notes, an amendment or waiver may not, with respect to any Notes held by a non-consenting Holder: 
 (1) reduce the principal amount of such Notes whose Holders must consent to an amendment, supplement or waiver; 
 (2) reduce the principal of or change the fixed final maturity of any such Note or alter or waive the provisions with respect to the redemption of such Notes (other than provisions relating to Sections
3.5 and 3.10); 
 (3) reduce the rate of or change the time for payment of interest on any Note;

 (4) waive a Default or Event of Default in the payment of principal of or premium, if any, or interest on the
Notes, except a rescission of acceleration of the Notes by the Holders of at least a majority in aggregate principal amount of the Notes and a waiver of the payment default that resulted from such acceleration, or in respect of a covenant or
provision contained in the Indenture or any Guarantee which cannot be amended or modified without the consent of all Holders; 
 (5) make any Note payable in money other than that stated therein; 

(6) make any change in the provisions of this Indenture relating to waivers of past Defaults or the rights of Holders to
receive payments of principal of or premium, if any, or interest on the Notes; 
 (7) make any change in to the
amendment and waiver provisions in this Section 9.2; 
 (8) impair the right of any Holder to receive
payment of principal of, or interest on such Holder’s Notes on or after the due dates therefor or to institute suit for the enforcement of any payment on or with respect to such Holder’s Notes; 

(9) make any change to or modify the ranking of the Notes that would adversely affect the Holders; or 

  
 119

 (10) except as expressly permitted by this Indenture, modify the Guarantees
of any Significant Subsidiary (or group of Restricted Subsidiaries that together (determined as of the most recent consolidated financial statements of the Issuer for a fiscal period end provided as required under Section 3.11) would
constitute a Significant Subsidiary), in any manner adverse to the Holders of the Notes. 
 It shall not be necessary for the
consent of the Holders under this Indenture to approve the particular form of any proposed amendment, supplement or waiver, but it shall be sufficient if such consent approves the substance thereof. A consent to any amendment, supplement or waiver
under this Indenture by any Holder of the Notes given in connection with a tender or exchange of such Holder’s Notes shall not be rendered invalid by such tender or exchange. 

After an amendment or supplement under this Section 9.2 becomes effective, the Issuer shall mail to Holders a notice briefly
describing such amendment or supplement. The failure to give such notice to all Holders, or any defect therein, shall not impair or affect the validity of an amendment or supplement. 

SECTION 9.3. Compliance with Trust Indenture Act. 
 Every amendment or supplement to this Indenture, any Guarantee and the Notes shall be set forth in an amended or supplemental indenture that complies with the TIA as then in effect. 

SECTION 9.4. Revocation and Effect of Consents and Waivers. 

Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder of a Note is a continuing consent by the Holder
of a Note and every subsequent Holder of a Note or portion of a Note that evidences the same debt as the consenting Holder’s Note, even if notation of the consent or waiver is not made on any Note. However, any such Holder of a Note or
subsequent Holder of a Note may revoke the consent or waiver as to such Holder’s Note or portion of its Note if the Trustee receives written notice of revocation before the date the amendment, supplement or waiver becomes effective. An
amendment, supplement or waiver becomes effective in accordance with its terms and thereafter binds every Holder. 
 The Issuer
may, but shall not be obligated to, fix a record date for the purpose of determining the Holders entitled to give their consent or take any other action described above or required or permitted to be taken pursuant to this Indenture. If a record
date is fixed, then notwithstanding the immediately preceding paragraph, those Persons who were Holders at such record date (or their duly designated proxies), and only those Persons, shall be entitled to give such consent or to revoke any consent
previously given or to take any such action, whether or not such Persons continue to be Holders after such record date. No such consent shall be valid or effective for more than 120 days after such record date. 

SECTION 9.5. Notation on or Exchange of Notes. 
 The Trustee may place an appropriate notation about an amendment, supplement or waiver on any Note thereafter authenticated. The Issuer in exchange for all Notes may issue and the Trustee shall, upon
receipt of an Issuer Order, authenticate new Notes that reflect the amendment, supplement or waiver. 

  
 120

 Failure to make the appropriate notation or issue a new Note shall not affect the validity
and effect of such amendment, supplement or waiver. 
 SECTION 9.6. Trustee to Sign Amendments. 

The Trustee shall sign any amended or supplemental indenture authorized pursuant to this Article IX if the amendment or supplement
does not adversely affect the rights, duties, liabilities or immunities of the Trustee. In executing any amended or supplemental indenture, the Trustee shall receive and (subject to Sections 7.1 and 7.2 hereof) shall be fully protected
in relying upon, in addition to the documents required by Section 12.4 hereof, an Officer’s Certificate and an Opinion of Counsel stating that the execution of such amended or supplemental indenture is authorized or permitted by
this Indenture. 
 ARTICLE X  
 GUARANTEE 
 SECTION 10.1. Guarantee. Subject to the provisions of
this Article X, each Guarantor hereby fully, unconditionally and irrevocably guarantees, as primary obligor and not merely as surety, jointly and severally with each other Guarantor, to each Holder of the Notes, and the Trustee the full and
punctual payment when due, whether at maturity, by acceleration, by redemption or otherwise, of the principal of, premium, if any, and interest (including Additional Interest) (including interest accruing after the filing of any petition in
bankruptcy, or the commencement of any insolvency, reorganization or like proceeding, relating to the Issuer or any Guarantor whether or not a claim for post-filing or post-petition interest is allowed in such proceeding and the obligations under
Section 7.7) on the Notes and all other obligations and liabilities of the Issuer under this Indenture (including without limitation interest (including Additional Interest)) and the Registration Rights Agreement (all the foregoing being
hereinafter collectively called the “Guaranteed Obligations”). Each Guarantee shall be on an unsecured senior basis. Each Guarantor agrees that the Guaranteed Obligations shall (i) rank equally in right of payment with other
existing and future Senior Indebtedness of each such Guarantor, (ii) be effectively subordinated to all Secured Indebtedness of each such Guarantor to the extent of the value of the assets securing such Indebtedness and (iii) shall be
senior in right of payment to all existing and future Subordinated Indebtedness of each such Guarantor. 
 To evidence its
Guarantee set forth in this Section 10.1, each Guarantor hereby agrees that this Indenture (or a supplemental indenture to the Indenture) shall be executed on behalf of such Guarantor by an Officer of such Guarantor. 

Each Guarantor hereby agrees that its Guarantee set forth in Section 10.1 hereof shall remain in full force and effect
notwithstanding the absence of the endorsement of any notation of such Guarantee on the Notes. 

  
 121

 If an Officer whose signature is on this Indenture no longer holds that office at the time
the Trustee authenticates the Note, the Guarantee shall be valid nevertheless. 
 Upon execution of a supplemental indenture to
this Indenture by the Guarantors, the Guarantees set forth in this Indenture shall be deemed duly delivered, without any further action by any Person, on behalf of the Guarantors. Following the Issue Date, the delivery of any Note by the Trustee,
after the authentication thereof hereunder, shall constitute due delivery of the Guarantee set forth in this Indenture on behalf of the Guarantors. 
 Each Guarantor further agrees (to the extent permitted by law) that the Guaranteed Obligations may be extended or renewed, in whole or in part, without notice or further assent from it, and that it shall
remain bound under this Article X notwithstanding any extension or renewal of any Guaranteed Obligation. 
 Each
Guarantor waives presentation to, demand of payment from and protest to the Issuer of any of the Guaranteed Obligations and also waives notice of protest for nonpayment. Each Guarantor waives notice of any default under the Notes or the Guaranteed
Obligations. 
 Each Guarantor further agrees that its Guarantee herein constitutes a Guarantee of payment when due (and not a
Guarantee of collection) and waives any right to require that any resort be had by any Holder to any security held for payment of the Guaranteed Obligations. 
 Except as set forth in Section 10.2, the obligations of each Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason (other than payment
of the Guaranteed Obligations in full), including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to any defense of setoff, counterclaim, recoupment or termination whatsoever or by reason of the
invalidity, illegality or unenforceability of the Guaranteed Obligations or otherwise. Without limiting the generality of the foregoing, the Guaranteed Obligations of each Guarantor herein shall not be discharged or impaired or otherwise affected by
(a) the failure of any Holder to assert any claim or demand or to enforce any right or remedy against the Issuer or any other person under this Indenture, the Notes or any other agreement or otherwise; (b) any extension or renewal of any
thereof; (c) any rescission, waiver, amendment or modification of any of the terms or provisions of this Indenture, the Notes or any other agreement; (d) the failure of any Holder to exercise any right or remedy against any other
Guarantor; (e) any change in the ownership of the Issuer; (f) any default, failure or delay, willful or otherwise, in the performance of the Guaranteed Obligations, or (g) any other act or thing or omission or delay to do any other
act or thing which may or might in any manner or to any extent vary the risk of any Guarantor or would otherwise operate as a discharge of such Guarantor as a matter of law or equity. 

Each Guarantor agrees that its Guarantee herein shall remain in full force and effect until payment in full of all the Guaranteed
Obligations or such Guarantor is released from its Guarantee in compliance with Section 10.2, Article VIII or Article XI. Each Guarantor further agrees that its Guarantee herein shall continue to be effective or be
reinstated, as the case may be, if at any time payment, or any part thereof, of principal of, premium, if any, or interest on any of the Guaranteed Obligations is rescinded or must otherwise be restored by any Holder upon the bankruptcy or
reorganization of the Issuer or otherwise. 

  
 122

 In furtherance of the foregoing and not in limitation of any other right which any Holder
has at law or in equity against any Guarantor by virtue hereof, upon the failure of the Issuer to pay any of the Guaranteed Obligations when and as the same shall become due, whether at maturity, by acceleration, by redemption or otherwise, each
Guarantor hereby promises to and shall, upon receipt of written demand by the Trustee, forthwith pay, or cause to be paid, in cash, to the Holders or the Trustee on behalf of the Holders an amount equal to the sum of (i) the unpaid amount of
such Guaranteed Obligations then due and owing and (ii) accrued and unpaid interest (including Additional Interest) on such Guaranteed Obligations then due and owing (but only to the extent not prohibited by law) (including interest accruing
after the filing of any petition in bankruptcy or the commencement of any insolvency, reorganization or like proceeding relating to the Issuer or any Guarantor whether or not a claim for post-filing or post-petition interest is allowed in such
proceeding). 
 Each Guarantor further agrees that, as between such Guarantor, on the one hand, and the Holders, on the other
hand, (x) the maturity of the Guaranteed Obligations guaranteed hereby may be accelerated as provided in this Indenture for the purposes of its Guarantee herein, notwithstanding any stay, injunction or other prohibition preventing such
acceleration in respect of the Guaranteed Obligations guaranteed hereby and (y) in the event of any such declaration of acceleration of such Guaranteed Obligations, such Guaranteed Obligations (whether or not due and payable) shall forthwith
become due and payable by the Guarantor for the purposes of this Guarantee. 
 Each Guarantor also agrees to pay any and all
costs and expenses (including reasonable attorneys’ fees and expenses) incurred by the Trustee or the Holders in enforcing any rights under this Section. 
 SECTION 10.2. Limitation on Liability; Termination, Release and Discharge. 

(a) Any term or provision of this Indenture to the contrary notwithstanding, the obligations of each Guarantor hereunder shall be limited
to the maximum amount as shall, after giving effect to all other contingent and fixed liabilities of such Guarantor (including, without limitation, any guarantees under the Senior Credit Facility) and after giving effect to any collections from or
payments made by or on behalf of any other Guarantor in respect of the obligations of such other Guarantor under its Guarantee or pursuant to its contribution obligations under this Indenture, result in the obligations of such Guarantor under its
Guarantee not constituting a fraudulent conveyance or fraudulent transfer under federal or state law and not otherwise being void or voidable under any similar laws affecting the rights of creditors generally. 

(b) Subject to Section 10.2(c), each Guarantor shall not, and the Issuer shall not permit any Guarantor to, consolidate or
merge with or into or wind up into (whether or not the Issuer or such Guarantor is the surviving corporation), or sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of its properties or assets, in one or more
related transactions, to, any Person unless: 
 (i) such Guarantor is the surviving corporation or the Person
formed by or surviving any such consolidation or merger (if other than such Guarantor) or to which such sale, assignment, transfer, lease, conveyance or other disposition shall have been 

  
 123

 
made is a Person organized or existing under the laws of the jurisdiction of organization of such Guarantor, or the laws of the United States, any state thereof, the District of Columbia, or any
territory thereof (such Guarantor or such Person, as the case may be, being herein called the “Successor Person”); 
 (ii) the Successor Person, if other than such Guarantor, expressly assumes all the obligations of such Guarantor under this Indenture and such Guarantor’s related Guarantee pursuant to supplemental
indentures or other documents or instruments in form reasonably satisfactory to the Trustee; 
 (iii) immediately
after such transaction, no Default exists; 
 (iv) the Issuer shall have delivered to the Trustee an
Officer’s Certificate and an Opinion of Counsel, each stating that such consolidation, merger or transfer and such supplemental indentures, if any, comply with this Indenture, provided that clauses (i) through (iv) of this
paragraph (b) shall be inapplicable to a Restricted Subsidiary that previously was a Subsidiary Guarantor if such Restricted Subsidiary is no longer a Restricted Subsidiary of the Company after giving effect to such transaction; and 

(v) the transaction is made in compliance with Section 3.5. 

(c) Subject to the limitations described in this Indenture, the Successor Person shall succeed to, and be substituted for, such Guarantor
under this Indenture, such Guarantor’s Guarantee and the Registration Rights Agreement. Notwithstanding the foregoing, any Guarantor may (i) merge into or with or wind up into or transfer all or part of its properties and assets to a
Guarantor or the Issuer or (ii) merge with an Affiliate of the Issuer solely for the purpose of reincorporating or reorganizing the Guarantor in the United States, any state thereof, the District of Columbia or any territory thereof.
Notwithstanding the foregoing, any Restricted Subsidiary may liquidate or dissolve if the Issuer determines in good faith that such liquidation or dissolution is in the best interests of the Issuer and is not materially disadvantageous to the
Holders. 
 (d) Any Guarantee by a Guarantor of the Notes shall be automatically and unconditionally released and discharged
upon: 
 (1) (A) in the case of a Subsidiary Guarantor, any sale, exchange, disposition or transfer (by
merger or otherwise) of (x) the Capital Stock of such Subsidiary Guarantor, after which the applicable Subsidiary Guarantor is no longer a Restricted Subsidiary, or (y) all or substantially all the assets of such Subsidiary Guarantor,
which sale, exchange, disposition or transfer in each case is made in compliance with the applicable provisions of this Indenture; 
 (B) the release or discharge of the guarantee by such Guarantor of the Senior Credit Facility or the guarantee which resulted in the creation of such Guarantee, except a discharge or release by or as a
result of payment under such guarantee; 

  
 124

 (C) the proper designation of any Restricted Subsidiary that is a Guarantor
as an Unrestricted Subsidiary in compliance with the applicable provisions of this Indenture; or 
 (D) the
Issuer exercising its legal defeasance option or covenant defeasance option as described in Article VIII or if its obligations under this Indenture are discharged in accordance with Article XI. 

(2) such Guarantor delivering to the Trustee an Officer’s Certificate and an Opinion of Counsel, each stating that
all conditions precedent provided for in the Indenture relating to such transaction have been complied with. Upon request, the Trustee shall execute an instrument evidencing the release of such Guarantor. 

SECTION 10.3. Right of Contribution. Each Guarantor hereby agrees that any Guarantor that makes a payment on the obligations under
the Guarantees shall be entitled, upon payment in full of all obligations under the Guarantees, to a contribution from each other Guarantor in an amount equal to such other Guarantor’s pro rata portion of such payment based on the respective
net assets of all the Guarantors at the time of such payment determined in accordance with GAAP. The provisions of this Section 10.3 shall in no respect limit the obligations and liabilities of each Guarantor to the Trustee and the
Holders and each Guarantor shall remain liable to the Trustee and the Holders for the full amount guaranteed by such Guarantor hereunder. 
 SECTION 10.4. No Subrogation. Notwithstanding any payment or payments made by each Guarantor hereunder, no Guarantor shall be entitled to be subrogated to any of the rights of the Trustee or any
Holder against the Issuer or any other Guarantor or any guarantee or right of offset held by the Trustee or any Holder for the payment of the Guaranteed Obligations, nor shall any Guarantor seek or be entitled to seek any contribution or
reimbursement from the Issuer or any other Guarantor in respect of payments made by such Guarantor hereunder, until all amounts owing to the Trustee and the Holders by the Issuer on account of the Guaranteed Obligations are paid in full. If any
amount shall be paid to any Guarantor on account of such subrogation rights at any time when all of the Guaranteed Obligations shall not have been paid in full, such amount shall be held by such Guarantor in trust for the Trustee and the Holders,
segregated from other funds of such Guarantor, and shall, forthwith upon receipt by such Guarantor, be turned over to the Trustee in the exact form received by such Guarantor (duly indorsed by such Guarantor to the Trustee, if required), to be
applied against the Guaranteed Obligations. 

  
 125

 ARTICLE XI 
 SATISFACTION AND DISCHARGE 
 SECTION 11.1. Satisfaction and
Discharge. 
 This Indenture shall be discharged and shall cease to be of further effect as to all Notes, when: 

(a) either: 
 (i) all Notes theretofore authenticated and delivered, except lost, stolen or destroyed Notes that have been replaced or paid and Notes for whose payment money has theretofore been deposited in trust,
have been delivered to the Trustee for cancellation; or 
 (ii) all Notes not theretofore delivered to the
Trustee for cancellation have become due and payable by reason of the making of a notice of redemption or otherwise, shall become due and payable within one year or are to be called for redemption within one year under arrangements satisfactory to
the Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Issuer, and the Issuer or any Guarantor has irrevocably deposited or caused to be deposited with the Trustee as trust funds in trust solely for
the benefit of the Holders of the Notes, cash in U.S. dollars, Government Securities, or a combination thereof, in such amounts as shall be sufficient without consideration of any reinvestment of interest to pay and discharge the entire Indebtedness
on the Notes not theretofore delivered to the Trustee for cancellation for principal, premium, if any, and accrued interest to the date of maturity or redemption; 
 (b) no Default (other than that resulting from borrowing funds to be applied to make such deposit and any similar and simultaneous deposit relating to other Indebtedness and, in each case, the granting of
Liens in connection therewith) with respect to the Indenture or the Notes shall have occurred and be continuing on the date of such deposit or shall occur as a result of such deposit and such deposit shall not result in a breach or violation of, or
constitute a default under, the Senior Credit Facility or any other material agreement or instrument (other than the Indenture) to which the Issuer or any Guarantor is a party or by which the Issuer or any Guarantor is bound (other than that
resulting from borrowing funds to be applied to make such deposit and any similar and simultaneous deposit relating to other Indebtedness and, in each case, the granting of Liens in connection therewith); 

(c) the Issuer has paid or caused to be paid all sums payable by it under the Indenture; and 

(d) the Issuer has delivered irrevocable instructions to the Trustee to apply the deposited money toward the payment of the Notes at
maturity or the redemption date, as the case may be. 
 (e) In addition, the Issuer shall deliver an Officer’s Certificate
and an Opinion of Counsel to the Trustee stating that all conditions precedent to satisfaction and discharge have been satisfied. 
 Notwithstanding the satisfaction and discharge of this Indenture, if money has been deposited with the Trustee pursuant to clause (a)(ii) of this Section 11.1, the provisions of Sections
12.2 and 8.6 hereof shall survive. 

  
 126

 SECTION 11.2. Application of Trust Money. 

Subject to the provisions of Section 8.6 hereof, all money deposited with the Trustee pursuant to Section 11.1
hereof shall be held in trust and applied by it, in accordance with the provisions of the Notes and this Indenture, to the payment, either directly or through any Paying Agent (including the Issuer acting as its own Paying Agent) as the Trustee may
determine, to the Persons entitled thereto, of the principal (and premium and Additional Interest, if any) and interest for whose payment such money has been deposited with the Trustee; but such money need not be segregated from other funds except
to the extent required by law. 
 If the Trustee or Paying Agent is unable to apply any money or Government Securities in
accordance with Section 11.1 hereof by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Issuer’s and
any Guarantor’s obligations under this Indenture and the Notes shall be revived and reinstated as though no deposit had occurred pursuant to Section 11.1 hereof; provided that if the Issuer has made any payment of principal
of, premium or Additional Interest, if any, or interest on, any Notes because of the reinstatement of its obligations, the Issuer shall be subrogated to the rights of the Holders of such Notes to receive such payment from the money or Government
Securities held by the Trustee or Paying Agent. 
 ARTICLE XII 

MISCELLANEOUS 
 SECTION 12.1. Trust Indenture Act Controls. If and to the extent that any provision of this Indenture limits, qualifies or conflicts with another provision which is required to be included in this
Indenture by the TIA, the provision required by the TIA shall control. Each Guarantor in addition to performing its obligations under its Guarantee shall perform such other obligations as may be imposed upon it with respect to this Indenture under
the TIA. 
 SECTION 12.2. Notices. Any notice or communication shall be in writing and delivered in person, sent by
facsimile, sent by electronic mail, delivered by commercial courier service or mailed by first-class mail, postage prepaid, addressed as follows: 
 if to the Issuer or the Guarantors: 
 Wolverine Healthcare
Analytics, Inc. 
 c/o The Veritas Capital Fund IV, L.P. 

590 Madison Avenue, 41st Floor 
 New York, New York 10022 
 Attention: Robert B. McKeon 

Telecopy: (212) 688-9411 
 E-mail: rmckeon@veritascapital.com 

  
 127

 with a copy to: 

Sullivan & Cromwell LLP 

125 Broad Street 
 New York, New York 10004 
 Attention: John E. Estes 

Telecopy: (212) 558-4349 
 E-email: estesj@sullcrom.com 
 if to the Trustee, at its
corporate trust office, which 
 corporate trust office for purposes of this Indenture is at 

the date hereof located at: 
 The Bank of New York Mellon Trust Company, N.A. 
 2 N. LaSalle
Street, Suite 1020 
 Chicago, IL 60602 

Attention: Corporate Trust Administration 
 The Issuer or the Trustee by written notice to the other may designate additional or different addresses for subsequent notices or communications. 

Any notice or communication to the Issuer or the Guarantors shall be deemed to have been given or made as of the date so delivered if
personally delivered; when answered back, if telexed; when receipt is acknowledged, if telecopied; on the first date on which publication is made, when given by publication; and five calendar days after mailing if sent by registered or certified
mail, postage prepaid (except that a notice of change of address shall not be deemed to have been given until actually received by the addressee). Any notice or communication to the Trustee shall be deemed delivered upon receipt. 

The Trustee agrees to accept and act upon instructions or directions pursuant to this Indenture sent by unsecured e-mail, pdf, facsimile
transmission or other similar unsecured electronic methods, provided, however, that the Trustee shall have received an incumbency certificate listing persons designated to give such instructions or directions and containing specimen signatures of
such designated persons, which such incumbency certificate shall be amended and replaced whenever a person is to be added or deleted from the listing. If the Issuer elects to give the Trustee e-mail or facsimile instructions (or instructions by a
similar electronic method) and the Trustee in its discretion elects to act upon such instructions, the Trustee’s understanding of such instructions shall be deemed controlling. The Trustee shall not be liable for any losses, costs or expenses
arising directly or indirectly from the Trustee’s reliance upon and compliance with such instructions notwithstanding such instructions conflict or are inconsistent with a subsequent written instruction. The Issuer agrees to assume all risks
arising out of the use of such electronic methods to submit instructions and directions to the Trustee, including without limitation the risk of the Trustee acting on unauthorized instructions, and the risk or interception and misuse by third
parties. 

  
 128

 Any notice or communication mailed to a Holder shall be mailed to the Holder at the
Holder’s address as it appears in the Notes Register and shall be sufficiently given if so mailed within the time prescribed. 
 Failure to mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders. If a notice or communication is mailed in the manner provided
above, it is duly given, whether or not the addressee receives it, except that notices to the Trustee shall be effective only upon receipt. 
 In case by reason of the suspension of regular mail service or by reason of any other cause it shall be impracticable to give such notice by mail, then such notification as shall be made with the approval
of the Trustee shall constitute a sufficient notification for every purpose hereunder. 
 SECTION 12.3. Communication by
Holders with other Holders. Holders may communicate pursuant to TIA § 312(b) with other Holders with respect to their rights under this Indenture or the Notes. The Issuer, the Trustee, the Registrar and anyone else shall have the protection
of TIA § 312(c). 
 Notwithstanding any other provision of this Indenture or any Note, where this Indenture or any Note
provides for notice of any event (including any notice of redemption) to a Holder of a Global Note (whether by mail or otherwise), such notice shall be sufficiently given if given to DTC for such Note (or its designee), pursuant to the customary
procedures of DTC. 
 SECTION 12.4. Certificate and Opinion as to Conditions Precedent. Upon any request or application
by the Issuer to the Trustee to take or refrain from taking any action under this Indenture, the Issuer shall furnish to the Trustee: 
 (1) an Officer’s Certificate in form reasonably satisfactory to the Trustee stating that, in the opinion of the signer, all conditions precedent, if any, provided for in this Indenture relating to
the proposed action have been complied with; and 
 (2) an Opinion of Counsel in form reasonably satisfactory to
the Trustee stating that, in the opinion of such counsel, all such conditions precedent have been complied with. 
 SECTION
12.5. Statements Required in Certificate or Opinion. Each certificate or opinion with respect to compliance with a covenant or condition provided for in this Indenture shall include: 

(1) a statement that the individual making such certificate or opinion has read such covenant or condition; 

(2) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions
contained in such certificate or opinion are based; 

  
 129

 (3) a statement that, in the opinion of such individual, he has made such
examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and 

(4) a statement as to whether or not, in the opinion of such individual, such covenant or condition has been complied
with. 
 In giving such Opinion of Counsel, counsel may rely as to factual matters on an Officer’s Certificate or on
certificates of public officials. 
 SECTION 12.6. When Notes Disregarded. In determining whether the Holders of the
required aggregate principal amount of Notes have concurred in any direction, waiver or consent, Notes owned by the Issuer, any Guarantor or any Affiliate of them shall be disregarded and deemed not to be outstanding, except that, for the purpose of
determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Notes which the Trustee actually knows are so owned shall be so disregarded. Also, subject to the foregoing, only Notes outstanding at the
time shall be considered in any such determination. 
 SECTION 12.7. Rules by Trustee, Paying Agent and Registrar. The
Trustee may make reasonable rules for action by, or at meetings of, Holders. The Registrar and the Paying Agent may make reasonable rules for their functions. 
 SECTION 12.8. Legal Holidays. If a payment date is a Legal Holiday, payment shall be made on the next succeeding day that is not a Legal Holiday, and no interest shall accrue for the intervening
period. If a regular record date is a Legal Holiday, the record date shall not be affected. 
 SECTION 12.9. GOVERNING
LAW. THIS INDENTURE, THE NOTES AND THE GUARANTEES SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE OR INSTRUMENTS ENTERED INTO AND, IN EACH CASE, PERFORMED IN SAID STATE.
EACH OF THE PARTIES HERETO AGREES TO SUBMIT TO THE JURISDICTION OF THE STATE COURTS OF, AND THE FEDERAL COURTS LOCATED IN, THE STATE OF NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE (INCLUDING THE GUARANTEES SET
FORTH HEREIN) OR THE NOTES. 
 SECTION 12.10. USA Patriot Act. The parties hereto acknowledge that in accordance with
Section 326 of the USA Patriot Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each person or
legal entity that establishes a relationship or opens an account. The parties to this Indenture agree that they shall provide the Trustee with such information as they may request in order to satisfy the requirements of the USA Patriot Act.

 SECTION 12.11. No Recourse Against Others. An incorporator, director, officer, employee or stockholder of the Issuer
or any Guarantor or any of their parent companies, solely by reason of this status, shall not have any liability for any obligations of the Issuer or any 

  
 130

 
Guarantor under the Notes or this Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Note, each Holder waives and releases all
such liability. The waiver and release are a part of the consideration for the issuance of the Notes. 
 SECTION 12.12.
Successors. All agreements of the Issuer and each Guarantor in this Indenture and the Notes shall bind their respective successors. All agreements of the Trustee in this Indenture shall bind its successors. 

SECTION 12.13. Multiple Originals. The parties may sign any number of copies of this Indenture. Each signed copy shall be an
original, but all of them together represent the same agreement. One signed copy is enough to prove this Indenture. 
 SECTION
12.14. Qualification of Indenture. The Issuer has agreed to qualify this Indenture under the TIA in accordance with the terms and conditions of the Registration Rights Agreement and to pay all reasonable costs and expenses (including
attorneys’ fees and expenses for the Issuer, the Trustee and the Holders) incurred in connection therewith, including, but not limited to, costs and expenses of qualification of this Indenture and the Notes and printing this Indenture and the
Notes. The Trustee shall be entitled to receive from the Issuer any such Officer’s Certificates, Opinions of Counsel or other documentation as it may reasonably request in connection with any such qualification of this Indenture under the TIA.

 SECTION 12.15. Table of Contents; Headings. The table of contents, cross-reference sheet and headings of the Articles
and Sections of this Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions hereof. 

SECTION 12.16. WAIVERS OF JURY TRIAL. THE ISSUER, THE GUARANTORS AND THE TRUSTEE HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVE
TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS INDENTURE, THE NOTES OR THE GUARANTEES AND FOR ANY COUNTERCLAIM THEREIN. 
 SECTION 12.17. Force Majeure. In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly
or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or
malfunctions of utilities, communications or computer (software and hardware) services, it being understood that the Trustee shall use reasonable best efforts which are consistent with accepted practices in the banking industry to resume performance
as soon as practicable under the circumstances. 

  
 131

 IN WITNESS WHEREOF, the parties have caused this Indenture to be duly executed all as of the
date and year first written above. 
  

			
	WOLVERINE HEALTHCARE ANALYTICS, INC.
		
	By:	 	 /s/ Ramzi Musallam

		 	Name: Ramzi Musallam
		 	Title: Secretary

 [Signature Page to the Indenture] 

 
			
	VCPH HOLDING CORP.
		
	By:	 	 /s/ Ramzi Musallam

		 	Name: Ramzi Musallam
		 	Title: Secretary

 [Signature Page to the Indenture] 

 
			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	 /s/ Lawrence M. Kusch

		 	Name: Lawrence M. Kusch
		 	Title: Vice President

 [Signature Page to the Indenture] 

 EXHIBIT A: Form of Series A Note 

[FORM OF FACE OF SERIES A NOTE] 
 [Applicable Restricted Notes Legend] 
 [Depository Legend, if applicable]

 [OID Legend, if applicable] 
 [Temporary Regulation S Legend, if applicable] 
  

			
	No. [        ]	  	Principal Amount $[            ] [as
		  	revised by the Schedule of Increases and
		  	Decreases in Global Note attached
hereto]1
		  	CUSIP
NO.                                        
             2

 WOLVERINE HEALTHCARE ANALYTICS, INC. 

10.625% Senior Notes due 2020 
 Wolverine Healthcare Analytics, Inc., a Delaware corporation (the “Issuer”), promises to pay to [Cede & Co.]1, or its registered assigns, the principal sum
of                     Dollars, [as revised by the Schedule of Increases and Decreases in Global Note attached hereto]1, on June 1, 2020. 

Interest Payment Dates: June 1 and December 1, commencing on December 1, 2012 

Record Dates: May 15 and November 15 
 Additional provisions of this Note are set forth on the other side of this Note. 

 
 1 Insert in Global Notes only 

2
 144A – 88514TAA8 
   Reg S – U88408AA4 

  
 A-1

 IN WITNESS WHEREOF, the Issuer has caused this instrument to be duly executed. 

 

			
	WOLVERINE HEALTHCARE ANALYTICS, INC.
		
	By:	 	 
		 	Name:
		 	Title:

  
 A-2

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 
 THE BANK OF NEW YORK MELLON 
 TRUST COMPANY, N.A., as Trustee, 

certifies that this is one of the 
 Notes
referred to in the Indenture. 
  

			
	
By:                       
                                         

	  	Date:                            
    
	       Authorized Officer
	  	

  
 A-3

 [FORM OF REVERSE SIDE OF NOTE] 

WOLVERINE HEALTHCARE ANALYTICS, INC. 
 10.625% Senior Notes due 2020 
 Capitalized terms used herein and not defined
herein have the meanings ascribed thereto in the Indenture. 
 1. Interest 

Wolverine Healthcare Analytics, Inc., a Delaware corporation (such corporation, and its successors and assigns under the Indenture
hereinafter referred to, being herein called the “Issuer”), promises to pay interest on the principal amount of this Note at the rate of 10.625% per annum, which shall accrue from the most recent date to which interest has been paid
or, if no interest has been paid, from June 6, 2012. The Issuer shall pay interest on overdue principal at the rate specified herein, and it shall pay interest on overdue installments of interest (including Additional Interest) at the same rate
to the extent lawful. Interest on the Notes shall be computed on the basis of a 360-day year comprised of twelve 30-day months. 

The Issuer shall make each interest payment in cash semi-annually in arrears on June 1 and December 1 of each year, commencing
on December 1, 2012, or if any such day is not a Business Day, on the next succeeding Business Day (each, an “Interest Payment Date”) to Holders of record of Notes on the immediately preceding May 15 and November 15.

 In addition to the rights provided to Holders under the Indenture, Holders of Registrable Securities shall have all rights
set forth in the Registration Rights Agreement, dated as of June 6, 2012, among Wolverine Healthcare Analytics, Inc., VCPH Holding Corp., as guarantor, and the other parties named on the signature pages thereto (the “Registration Rights
Agreement”), including the right to receive Additional Interest in certain circumstances. If applicable, Additional Interest shall be paid to the same Persons, in the same manner and at the same times as regular interest. 

2. Method of Payment 

By no later than 11:00 a.m. (New York City time) on the date on which any principal of, premium, if any, or interest on any Note is due
and payable, the Issuer shall deposit with the Paying Agent a sum sufficient in immediately available funds to pay such principal, premium or interest when due. Interest on any Note which is payable, and is timely paid or duly provided for, on any
interest payment date shall be paid to the Person in whose name such Note (or one or more Predecessor Notes) is registered at the close of business on the preceding May 15 and November 15 at the office or agency of the Issuer maintained
for such purpose pursuant to Section 2.3 of the Indenture. The principal of (and premium, if any) and interest on the Notes shall be payable at the office or agency of Paying Agent or Registrar designated by the Issuer maintained for
such purpose in the United States or at such other office or agency of the Issuer as may be maintained for such purpose pursuant to Section 2.3 of the Indenture; provided, however, that, at the option of the Issuer, the principal
of (and premium, if any) and interest may be paid by (i) check mailed to addresses of the Persons entitled thereto as such addresses shall appear on the 

  
 A-4

 
Note Register or (ii) wire transfer to an account located in the United States maintained by the payee, subject to the last sentence of this paragraph. Payments in respect of Notes represented by
a Global Note (including principal, premium, if any, and interest) shall be made by wire transfer of immediately available funds to the accounts specified by The Depository Trust Company or any successor depository. 

3. Paying Agent and Registrar 
 The Issuer initially appoints The Bank of New York Mellon Trust Company, N.A. (the “Trustee”) as Registrar and Paying Agent for the Notes. The Issuer may change any Registrar or Paying
Agent without prior notice to the Holders. The Issuer or any Guarantor may act as Paying Agent, Registrar or transfer agent. 
 4.
Indenture 
 The Issuer issued the Notes under an Indenture dated as of June 6, 2012 (as it may be amended or
supplemented from time to time in accordance with the terms thereof, the “Indenture”), among Wolverine Healthcare Analytics, Inc., VCPH Holding Corp, as guarantor, and the Trustee. The terms of the Notes include those stated in the
Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) as in effect on the date of the Indenture (the “Act”). The Notes are subject to all terms
and provisions of the Indenture, and Holders are referred to the Indenture and the Act for a statement of those terms. To the extent any provision of this Note conflicts with the express provisions of the Indenture, the provisions of the Indenture
shall govern and be controlling. 
 The Notes are senior unsecured obligations of the Issuer. The aggregate principal amount of
Notes that may be authenticated and delivered under the Indenture is unlimited. This Note is one of the 10.625% Senior Notes, Series A, due 2020 referred to in the Indenture. The Notes include (i) $327,150,000 principal amount of the
Issuer’s 10.625% Senior Notes, Series A, due 2020 issued under the Indenture on June 6, 2012 (the “Initial Notes”), (ii) if and when issued, additional 10.625% Senior Notes, Series A, due 2020 or 10.625% Senior Notes,
Series B, due 2020 of the Issuer that may be issued from time to time in accordance with the Indenture subsequent to June 6, 2012 (the “Additional Notes”) as provided in Section 2.1(a) of the Indenture and
(iii) if and when issued, the Issuer’s 10.625% Senior Notes, Series B, due 2020 that may be issued from time to time under the Indenture in exchange for Initial Notes or Additional Notes in an offer registered under the Securities Act as
provided in the Registration Rights Agreement (herein called “Exchange Notes”). The Initial Notes, the Additional Notes and the Exchange Notes shall be considered collectively as a single class for all purposes of the Indenture and
any security documents. The Indenture imposes certain limitations on the incurrence of indebtedness and issuance of disqualified stock and preferred stock, the making of restricted payments, the sale of assets and subsidiary stock, the incurrence of
certain liens, the making of payments for consents, the entering into of agreements that restrict distribution from restricted subsidiaries and the consummation of mergers and consolidations. The Indenture also imposes requirements with respect to
the provision of financial information and the provision of guarantees of the Notes by certain subsidiaries. 

  
 A-5

 5. Guarantees 
 To guarantee the due and punctual payment of the principal, premium, if any, and interest (including post-filing or post-petition interest) on the Notes and all other amounts payable by the Issuer under
the Indenture and the Notes when and as the same shall be due and payable, whether at maturity, by acceleration or otherwise, according to the terms of the Notes and the Indenture, the Guarantors shall unconditionally guarantee (and future
guarantors, together with the Guarantors, shall unconditionally Guarantee), jointly and severally, such obligations on a senior unsecured basis pursuant to the terms of the Indenture. 
 6. Redemption 
 At any time prior to June 1, 2016, the Issuer may
redeem all or a part of the Notes upon notice as described in Section 5.3 of the Indenture, at a redemption price equal to 100% of the principal amount of Notes redeemed, plus the Applicable Premium (as defined below) as of, and accrued and
unpaid interest and Additional Interest, if any, to but excluding the date of redemption (the “Redemption Date”), subject to the rights of Holders of record on the relevant record date to receive interest due on the relevant
interest payment date. 
 Until June 1, 2015, the Issuer may, at its option, upon notice as described under
Section 5.3 of the Indenture, on one or more occasions redeem up to 35% of the aggregate principal amount of the Notes issued under the Indenture at a redemption price equal to 110.625% of the aggregate principal amount of the Notes, plus
accrued and unpaid interest and Additional Interest, thereon, if any, to but excluding the applicable Redemption Date, subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment
date, with the net cash proceeds of one or more Equity Offerings; provided that (a) at least 50% of the sum of the aggregate principal amount of Notes originally issued under the Indenture on the Issue Date and any Additional Notes that
are issued under the Indenture after the Issue Date remains outstanding immediately after the occurrence of each such redemption and (b) each such redemption occurs within 90 days of the date of closing of each such Equity Offering. The Trustee
shall select the Notes to be purchased in the manner described under Sections 5.1 through 5.6 of the Indenture. 

Except as set forth above, the Notes shall not be redeemable at the Issuer’s option prior to June 1, 2016. 

On and after June 1, 2016, the Issuer may redeem the Notes in whole or in part, upon notice as described under Section 5.3 of
the Indenture, at the redemption prices (expressed as percentages of principal amount of the Notes to be redeemed) set forth in the table below, plus accrued and unpaid interest thereon and Additional Interest, if any, to but excluding the
applicable Redemption Date, subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date, if redeemed during the twelve-month period beginning on June 1, of each of the
years indicated in the table below: 
  

					
	 Period
	  	Percentage	 
	 2016
	  	 	105.313	% 
	 2017
	  	 	102.656	% 
	 2018 and thereafter
	  	 	100.000	% 

  
 A-6

 Any redemption pursuant to this paragraph 6 shall be made pursuant to the provisions of
Sections 5.1 through 5.6 of the Indenture. 
 “Applicable Premium” means, with respect to any
Note on any Redemption Date, the greater of: 
 (1) 1.0% of the principal amount of such Note; and 

(2) the excess, if any, of: (a) the present value at such Redemption Date of (i) the redemption price of such Note at
June 1, 2016 (such redemption price being set forth in the table appearing above), plus (ii) all required interest payments due on such Note through June 1, 2016 (excluding accrued but unpaid interest to the Redemption Date), computed
using a discount rate equal to the Treasury Rate as of such Redemption Date plus 50 basis points; over (b) the principal amount of such Note. 
 The Issuer shall calculate the Applicable Premium. 
 “Treasury
Rate” means, as of any Redemption Date, the yield to maturity as of such Redemption Date of United States Treasury securities with a constant maturity (as compiled and published in the most recent Federal Reserve Statistical Release H.15
(519) that has become publicly available at least two Business Days prior to the Redemption Date (or, if such Statistical Release is no longer published, any publicly available source of similar market data)) most nearly equal to the period
from the Redemption Date to June 1, 2016; provided, however, that if the period from the redemption date to June 1, 2016 is less than one year, the weekly average yield on actually traded United States Treasury securities adjusted
to a constant maturity of one year shall be used. 
 The Issuer is not required to make mandatory redemption or sinking fund
payments with respect to the Notes. 
 7. Repurchase Provisions 
 If a Change of Control occurs, unless the Issuer has previously or concurrently mailed a redemption notice with respect to all the outstanding Notes as described in Section 5.7 of the
Indenture, each Holder shall have the right to require the Issuer to repurchase from each Holder all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of such Holder’s Notes at a purchase price in cash equal to
101% of the aggregate principal amount thereof plus accrued and unpaid interest, if any, to but excluding the date of purchase, subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest
payment date as provided in, and subject to the terms of, the Indenture. 

  
 A-7

 8. Denominations; Transfer; Exchange 

The Notes shall be issuable only in fully registered form, without coupons, and only in denominations of principal amount of $2,000 and
any integral multiple of $1,000 in excess thereof. A Holder may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements or transfer documents and to pay
a sum sufficient to cover any tax and fees required by law or permitted by the Indenture. The Registrar need not register the transfer of or exchange of any Note (A) for a period beginning (1) 15 days before the mailing of a notice of an offer to
repurchase or redeem Notes and ending at the close of business on the day of such mailing or (2) 15 days before an interest payment date and ending on such interest payment date or (B) called for redemption, except the unredeemed portion of any Note
being redeemed in part. 
 9. Persons Deemed Owners 
 The registered Holder of this Note may be treated as the owner of it for all purposes. 
 10.
Unclaimed Money 
 If money for the payment of principal, premium, if any, or interest remains unclaimed for two years,
the Trustee or Paying Agent shall pay the money back to the Issuer at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Issuer for payment as general
creditors unless an abandoned property law designates another person and not to the Trustee for payment. 
 11. Defeasance 

Subject to certain exceptions and conditions set forth in the Indenture, the Issuer at any time may terminate some or all of its
obligations under the Notes and the Indenture if the Issuer deposits with the Trustee money or U.S. Government Securities for the payment of principal, premium, if any, and interest on the Notes to redemption or maturity, as the case may be.

 12. Amendment, Supplement, Waiver 
 Subject to certain exceptions contained in the Indenture, the Indenture and the Notes may be amended, or default may be waived, with the consent of the Holders of a majority in principal amount of the
outstanding Notes. Without notice to or the consent of any Holder, the Issuer, any Guarantor (with respect to a Guarantee or the Indenture to which it is a party) and the Trustee may amend or supplement the Indenture, any Guarantee and the Notes as
provided in the Indenture. 
 13. Defaults and Remedies 
 If an Event of Default (other than an Event of Default relating to certain events of bankruptcy, insolvency or reorganization of the Issuer or certain Restricted Subsidiaries) occurs and is continuing,
the Trustee by notice to the Issuer, or the Holders of at least 25% in principal amount of the total outstanding Notes by notice to the Issuer and the Trustee, may declare the principal of, premium, if any, and accrued and unpaid interest (including
Additional Interest), if any, and any other monetary obligations on all the Notes to be due and payable. Upon such a declaration, such principal, premium and accrued and unpaid interest (including Additional Interest) and any other monetary
obligations shall be due and payable immediately. If a 

  
 A-8

 
bankruptcy, insolvency or reorganization of the Issuer or certain Restricted Subsidiaries occurs and is continuing, the principal of, premium, if any, and accrued and unpaid interest (including
Additional Interest) and any other monetary obligations on all the Notes shall become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holders. Under certain circumstances, the Holders of a
majority in principal amount of the outstanding Notes may rescind any such acceleration with respect to the Notes and its consequences. 
 14.
Trustee Dealings with the Issuer 
 Subject to certain limitations set forth in the Indenture, The Trustee in its
individual or any other capacity may become the owner or pledgee of Notes and may otherwise deal with the Issuer, Guarantors or their Affiliates with the same rights it would have if it were not Trustee. 

15. No Recourse Against Others 
 An incorporator, director, officer, employee or stockholder of the Issuer or any Guarantor or any of their parent companies, solely by reason of this status, shall not have any liability for any
obligations of the Issuer or any Guarantor under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Note, each Holder waives and releases all such liability. The
waiver and release are a part of the consideration for the issuance of the Notes. 
 16. Authentication 

This Note shall not be valid until an authorized officer of the Trustee (or an authenticating agent acting on its behalf) manually signs
the certificate of authentication on the other side of this Note. 
 17. Abbreviations 

Customary abbreviations may be used in the name of a Holder or an assignee, such as TEN COM (= tenants in common), TEN ENT (= tenants by
the entirety), JT TEN (= joint tenants with rights of survivorship and not as tenants in common), CUST (= custodian) and U/G/M/A (= Uniform Gift to Minors Act). 
 18. CUSIP, Common Code and ISIN Numbers 
 The Issuer has caused CUSIP,
Common Code and ISIN numbers, if applicable, to be printed on the Notes and has directed the Trustee to use CUSIP, Common Code and ISIN numbers, if applicable, in notices of redemption or purchase as a convenience to Holders. No representation is
made as to the accuracy of such numbers either as printed on the Notes or as contained in any notice of redemption or purchase and reliance may be placed only on the other identification numbers placed thereon. 

  
 A-9

 19. Governing Law 
 This Note shall be governed by, and construed in accordance with, the laws of the State of New York. 
 The Issuer shall furnish to any Holder upon written request and without charge to the Holder a copy of the Indenture. Requests may be made to: 

Wolverine Healthcare Analytics, Inc. 
 c/o The Veritas Capital Fund IV, L.P. 
 590 Madison Avenue,
41st Floor 

New York, New York 10022 
 Attention: Ramzi Musallam 
 with a copy to: 

Sullivan & Cromwell LLP 
 125 Broad Street 
 New York, New York 10004 

Attention: John E. Estes 
 Telecopy: (212) 558-4349 
 E-email: estesj@sullcrom.com 

  
 A-10

 ASSIGNMENT FORM 
 To assign this Note, fill in the form below: 
 I or we assign and transfer this
Note to: 
  
  

(Print or type assignee’s name, address and zip code) 

 
  
 (Insert assignee’s social security or tax I.D. No.) 
 and irrevocably appoint
                            agent to transfer this Note on the books of the Issuer. The agent may
substitute another to act for him. 
  
  

 

			
	Date:                             
            	  	Your
Signature:                                       
                                      
	
	Signature Guarantee:                      
                                         
                                         
                                         
                                         
                               

 (Signature must be guaranteed) 

 
  
 Sign exactly as your name appears on the other side of this Note. 
 The signature(s) should be
guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to SEC Rule 17Ad-15. 

The undersigned hereby certifies that it Ÿ  is / • is not an Affiliate of the Issuer and that, to its knowledge, the proposed transferee • is / • is not an Affiliate of the Issuer.

 In connection with any transfer or exchange of any of the Notes evidenced by this certificate occurring prior to the date
that is one year after the later of the date of original issuance of such Notes and the last date, if any, on which such Notes were owned by the Issuer or any Affiliate of the Issuer, the undersigned confirms that such Notes are being: 

CHECK ONE BOX BELOW: 
  

					
	 (1)
	  	 ̈	  	acquired for the undersigned’s own account, without transfer; or
			
	 (2)
	  	 ̈	  	transferred to the Issuer; or
			
	 (3)
	  	 ̈	  	transferred pursuant to and in compliance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”); or
			
	 (4)
	  	 ̈	  	transferred pursuant to an effective registration statement under the Securities Act; or

  
 A-11

					
			
	 (5)
	  	 ̈	  	transferred pursuant to and in compliance with Regulation S under the Securities Act; or
			
	 (6)
	  	 ̈	  	transferred to an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act), that has furnished to the Trustee a
signed letter containing certain representations and agreements (the form of which letter appears as Section 2.8 of the Indenture); or
			
	 (7)
	  	 ̈	  	transferred pursuant to another available exemption from the registration requirements of the Securities Act of 1933, as amended.

 Unless one of the boxes is checked, the Trustee shall refuse to register any of the Notes evidenced by this certificate
in the name of any person other than the registered Holder thereof; provided, however, that if box (5), (6) or (7) is checked, the Issuer may require, prior to registering any such transfer of the Notes, in its sole discretion, such
legal opinions, certifications and other information as the Issuer may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities
Act of 1933, as amended, such as the exemption provided by Rule 144 under such Act. 
  
  

					
	 	 		 	  

	 	 		 	Signature
	Signature Guarantee:	 		 	
	  
	 		 	  

	 (Signature must be guaranteed)
	 		 	Signature

  
  

The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with
membership in an approved signature guarantee medallion program), pursuant to SEC. Rule 17Ad-15. 
 TO BE COMPLETED BY PURCHASER IF BOX
(1) OR (3) ABOVE IS CHECKED. 
 The undersigned represents and warrants that it is purchasing this Note for its own
account or an account with respect to which it exercises sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act of 1933, as amended, and is
aware that the sale to it is being made in reliance on Rule 144A and acknowledges that it has received such information regarding the Issuer as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and
that it is aware that the transferor is relying upon the undersigned’s foregoing representations in order to claim the exemption from registration provided by Rule 144A. 

 

					
	 	 		 	  

	 	 		 	Dated:

  
 A-12

 [TO BE ATTACHED TO GLOBAL NOTES] 

SCHEDULE OF INCREASES OR DECREASES IN GLOBAL NOTES 
 The following increases or decreases in this Global Note have been made: 
  

									
	 Date of

Exchange
	  	 Amount of decrease in Principal
Amount of this Global Note
	  	 Amount of increase in Principal
Amount of this Global Note
	  	
Principal Amount of this Global
Note following such decrease or
increase
	  	 Signature of authorized
signatory of Trustee or Notes
Custodian

  
 A-13

 OPTION OF HOLDER TO ELECT PURCHASE 

If you elect to have this Note purchased by the Issuer pursuant to Section 3.5 or 3.10 of the Indenture, check either box:

  

 ̈       ̈

 3.5   3.10 
 If you want to elect to have only part of this Note purchased by the Issuer pursuant to Section 3.5 or 3.10 of the Indenture, state the amount in principal amount (must be in denominations of $2,000
or an integral multiple of $1,000 in excess thereof): 
 $
                            and specify the denomination or denominations (which shall not be less
than the minimum authorized denomination) of the Notes to be issued to the Holder for the portion of the within Note not being repurchased (in the absence of any such specification, one such Note shall be issued for the portion not being
repurchased): 
 ________________. 
  

					
	Date:                             
	  	Your Signature	  	 
		  		  	(Sign exactly as your name appears on the other side of the Note)
			
	Signature Guarantee:	  	 	  	 
		  		  	(Signature must be guaranteed)

 The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan
associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to SEC Rule 17Ad-15. 

  
 A-14

 EXHIBIT B: Form of Series B Note 

[FORM OF FACE OF SERIES B NOTE] 
 [Depository Legend, if applicable] 
 [OID Legend, if applicable] 

 

					
	No. [      ]	  		  	 Principal Amount $[            ] [as

revised by the Schedule of Increases and

Decreases in Global Note attached hereto]3
 CUSIP NO.
                                         
       
4

 WOLVERINE HEALTHCARE ANALYTICS, INC. 

10.625% Senior Notes due 2020 
 Wolverine Healthcare Analytics, Inc., a Delaware corporation (the “Issuer”), promises to pay to [Cede & Co.]3, or its registered assigns, the principal sum
                         of Dollars, [as revised by the Schedule of Increases and Decreases in Global Note attached
hereto]3, on June 1, 2020. 

Interest Payment Dates: June 1 and December 1, commencing on December 1, 2012 

Record Dates: May 15 and November 15 
 Additional provisions of this Note are set forth on the other side of this Note. 
  

 

	3 	 Insert in Global Notes only 

	4 	 144A – [            ] 

	 	Reg	S – [            ] 

  
 B-1

 IN WITNESS WHEREOF, the Issuer has caused this instrument to be duly executed. 

 

			
	 WOLVERINE HEALTHCARE ANALYTICS, INC.

 

	 By:
	 	  

		 	 Name:

		 	 Title:

  
 C-1

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 
 THE BANK OF NEW YORK MELLON 
 TRUST COMPANY, N.A., as Trustee, 

certifies that this is one of the 
 Notes
referred to in the Indenture. 
  

									
		 		 	
				
	By:	 	 	 		 	Date:
                        
		 	Authorized Officer	 		 		 	

  
 B-2

 [FORM OF REVERSE SIDE OF NOTE] 

WOLVERINE HEALTHCARE ANALYTICS, INC. 
 10.625% Senior Notes due 2020 
 Capitalized terms used herein and not defined
herein have the meanings ascribed thereto in the Indenture. 
 1. Interest 

Wolverine Healthcare Analytics, Inc., a Delaware corporation (such corporation, and its successors and assigns under the Indenture
hereinafter referred to, being herein called the “Issuer”), promises to pay interest on the principal amount of this Note at the rate of 10.625% per annum, which shall accrue from the most recent date to which interest has been paid
or, if no interest has been paid, from June 6, 2012. The Issuer shall pay interest on overdue principal at the rate specified herein, and it shall pay interest on overdue installments of interest (including Additional Interest) at the same rate
to the extent lawful. Interest on the Notes shall be computed on the basis of a 360-day year comprised of twelve 30-day months. 

The Issuer shall make each interest payment in cash semi-annually in arrears on June 1 and December 1 of each year, commencing
on December 1, 2012, or if any such day is not a Business Day, on the next succeeding Business Day (each, an “Interest Payment Date”) to Holders of record of Notes on the immediately preceding May 15 and November 15.

 2. Method of Payment 
 By no later than 11:00 a.m. (New York City time) on the date on which any principal of, premium, if any, or interest on any Note is due and payable, the Issuer shall deposit with the Paying Agent a sum
sufficient in immediately available funds to pay such principal, premium or interest when due. Interest on any Note which is payable, and is timely paid or duly provided for, on any interest payment date shall be paid to the Person in whose name
such Note (or one or more Predecessor Notes) is registered at the close of business on the preceding May 15 and November 15 at the office or agency of the Issuer maintained for such purpose pursuant to Section 2.3 of the
Indenture. The principal of (and premium, if any) and interest on the Notes shall be payable at the office or agency of Paying Agent or Registrar designated by the Issuer maintained for such purpose in the United States or at such other office or
agency of the Issuer as may be maintained for such purpose pursuant to Section 2.3 of the Indenture; provided, however, that, at the option of the Issuer, the principal of (and premium, if any) and interest may be paid by
(i) check mailed to addresses of the Persons entitled thereto as such addresses shall appear on the Notes Register or (ii) wire transfer to an account located in the United States maintained by the payee, subject to the last sentence of
this paragraph. Payments in respect of Notes represented by a Global Note (including principal, premium, if any, and interest) shall be made by wire transfer of immediately available funds to the accounts specified by The Depository Trust Company or
any successor depository. 

  
 B-3

 3. Paying Agent and Registrar 

The Issuer initially appoints The Bank of New York Mellon Trust Company, N.A. (the “Trustee”) as Registrar and Paying
Agent for the Notes. The Issuer may change any Registrar or Paying Agent without prior notice to the Holders. The Issuer or any Guarantor may act as Paying Agent, Registrar or transfer agent. 
 4. Indenture 
 The Issuer issued the Notes under an Indenture dated as of
June 6, 2012 (as it may be amended or supplemented from time to time in accordance with the terms thereof, the “Indenture”), among Wolverine Healthcare Analytics, Inc., VCPH Holding Corp., as guarantor, and the Trustee. The
terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) as in effect on the date of the Indenture (the
“Act”). The Notes are subject to all terms and provisions of the Indenture, and Holders are referred to the Indenture and the Act for a statement of those terms. To the extent any provision of this Note conflicts with the express
provisions of the Indenture, the provisions of the Indenture shall govern and be controlling. 
 The Notes are senior unsecured
obligations of the Issuer. The aggregate principal amount of Notes that may be authenticated and delivered under the Indenture is unlimited. This Note is one of the 10.625% Senior Notes, Series B, due 2020 referred to in the Indenture. The Notes
include (i) $327,150,000 principal amount of the Issuer’s 10.625% Senior Notes, Series A, due 2020 issued under the Indenture on June 6, 2012 (the “Initial Notes”), (ii) if and when issued, additional 10.625%
Senior Notes, Series A, due 2020 or 10.625% Senior Notes, Series B, due 2020 of the Issuer that may be issued from time to time in accordance with the Indenture subsequent to June 6, 2012 (the “Additional Notes”) as provided in
Section 2.1(a) of the Indenture and (iii) if and when issued, the Issuer’s 10.625% Senior Notes, Series B, due 2020 that may be issued from time to time under the Indenture in exchange for Initial Notes or Additional Notes in
an offer registered under the Securities Act as provided in the Registration Rights Agreement (herein called “Exchange Notes”). The Initial Notes, the Additional Notes and the Exchange Notes shall be considered collectively as a
single class for all purposes of the Indenture and any security documents. The Indenture imposes certain limitations on the incurrence of indebtedness and issuance of disqualified stock and preferred stock, the making of restricted payments, the
sale of assets and subsidiary stock, the incurrence of certain liens, the making of payments for consents, the entering into of agreements that restrict distribution from restricted subsidiaries and the consummation of mergers and consolidations.
The Indenture also imposes requirements with respect to the provision of financial information and the provision of guarantees of the Notes by certain subsidiaries. 
 5. Guarantees 
 To guarantee the due and punctual payment of the principal,
premium, if any, and interest (including post-filing or post-petition interest) on the Notes and all other amounts payable by the Issuer under the Indenture and the Notes when and as the same shall be due and payable, whether at maturity, by
acceleration or otherwise, according to the terms of the Notes and the Indenture, the Guarantors have unconditionally guaranteed (and future guarantors, together with the Guarantors, shall unconditionally Guarantee), jointly and severally, such
obligations on a senior unsecured basis pursuant to the terms of the Indenture. 

  
 B-4

 6. Redemption 
 At any time prior to June 1, 2016, the Issuer may redeem all or a part of the Notes upon notice as described under Section 5.3 of the Indenture, at a redemption price equal to 100% of the
principal amount of Notes redeemed, plus the Applicable Premium (as defined below) as of, and accrued and unpaid interest and Additional Interest, if any, to but excluding the date of redemption (the “Redemption Date”), subject to
the rights of Holders of record on the relevant record date to receive interest due on the relevant interest payment date. 

Until June 1, 2015, the Issuer may, at its option, upon notice as described under Section 5.3 of the Indenture, on one or more
occasions redeem up to 35% of the aggregate principal amount of the Notes issued under this Indenture at a redemption price equal to 110.625% of the aggregate principal amount of the Notes, plus accrued and unpaid interest and Additional Interest,
thereon, if any, to but excluding the applicable Redemption Date, subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date, with the net cash proceeds of one or more Equity
Offerings; provided that (a) at least 50% of the sum of the aggregate principal amount of Notes originally issued under the Indenture on the Issue Date and any Additional Notes that are issued under the Indenture after the Issue Date
remains outstanding immediately after the occurrence of each such redemption and (b) each such redemption occurs within 90 days of the date of closing of each such Equity Offering. The Trustee shall select the Notes to be purchased in the
manner described under Sections 5.1 through 5.6 of the Indenture. 
 Except as set forth above, the Notes shall
not be redeemable at the Issuer’s option prior to June 1, 2016. 
 On and after June 1, 2016, the Issuer may
redeem the Notes in whole or in part, upon notice as described under Section 5.3 of the Indenture, at the redemption prices (expressed as percentages of principal amount of the Notes to be redeemed) set forth in the table below, plus accrued
and unpaid interest thereon and Additional Interest, if any, to but excluding the applicable Redemption Date, subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date, if
redeemed during the twelve-month period beginning on June 1, of each of the years indicated in the table below: 
  

					
	 Period
	  	Percentage	 
	 2016
	  	 	105.313	% 
	 2017
	  	 	102.656	% 
	 2018 and thereafter
	  	 	100.000	% 

 Any redemption pursuant to this paragraph 6 shall be made pursuant to the provisions of Sections
5.1 through 5.6 of the Indenture. 

  
 B-5

 “Applicable Premium” means, with respect to any Note on any Redemption
Date, the greater of: 
 (1) 1.0% of the principal amount of such Note; and 

(2) the excess, if any, of: (a) the present value at such Redemption Date of (i) the redemption price of such Note at
June 1, 2016 (such redemption price being set forth in the table above), plus (ii) all required interest payments due on such Note through June 1, 2016 (excluding accrued but unpaid interest to the Redemption Date), computed using a
discount rate equal to the Treasury Rate as of such Redemption Date plus 50 basis points; over (b) the principal amount of such Note. 
 The Issuer shall calculate the Applicable Premium. 
 “Treasury
Rate” means, as of any Redemption Date, the yield to maturity as of such Redemption Date of United States Treasury securities with a constant maturity (as compiled and published in the most recent Federal Reserve Statistical Release H.15
(519) that has become publicly available at least two Business Days prior to the Redemption Date (or, if such Statistical Release is no longer published, any publicly available source of similar market data)) most nearly equal to the period
from the Redemption Date to June 1, 2016; provided, however, that if the period from the redemption date to June 1, 2016 is less than one year, the weekly average yield on actually traded United States Treasury securities adjusted
to a constant maturity of one year shall be used. 
 The Issuer is not required to make mandatory redemption or sinking fund
payments with respect to the Notes. 
 7. Repurchase Provisions 
 If a Change of Control occurs, unless the Issuer has previously or concurrently mailed a redemption notice with respect to all the outstanding Notes as described in Section 5.7 of the
Indenture, each Holder shall have the right to require the Issuer to repurchase from each Holder all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of such Holder’s Notes at a purchase price in cash equal to
101% of the aggregate principal amount thereof plus accrued and unpaid interest, if any, to but excluding the date of purchase, subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest
payment date as provided in, and subject to the terms of, the Indenture. 
 8. Denominations; Transfer; Exchange 

The Notes shall be issuable only in fully registered form, without coupons, and only in denominations of principal amount of $2,000 and
any integral multiple of $1,000 in excess thereof. A Holder may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements or transfer documents and to pay
a sum sufficient to cover any tax and fees required by law or permitted by the Indenture. The Registrar need not register the transfer of or exchange of any Note (A) for a period beginning (1) 15 days before the mailing of a notice of an
offer to repurchase or redeem Notes and ending at the close of business on the day of such mailing or (2) 15 days before an interest payment date and ending on such interest payment date or (B) called for redemption, except the unredeemed
portion of any Note being redeemed in part. 

  
 B-6

 9. Persons Deemed Owners 
 The registered Holder of this Note may be treated as the owner of it for all purposes. 
 10.
Unclaimed Money 
 If money for the payment of principal, premium, if any, or interest remains unclaimed for two years,
the Trustee or Paying Agent shall pay the money back to the Issuer at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Issuer for payment as general
creditors unless an abandoned property law designates another person and not to the Trustee for payment. 
 11. Defeasance 

Subject to certain exceptions and conditions set forth in the Indenture, the Issuer at any time may terminate some or all of its
obligations under the Notes and the Indenture if the Issuer deposits with the Trustee money or U.S. Government Securities for the payment of principal, premium, if any, and interest on the Notes to redemption or maturity, as the case may be.

 12. Amendment, Supplement, Waiver 
 Subject to certain exceptions contained in the Indenture, the Indenture and the Notes may be amended, or default may be waived, with the consent of the Holders of a majority in principal amount of the
outstanding Notes. Without notice to or the consent of any Holder, the Issuer, any Guarantor (with respect to a Guarantee or the Indenture to which it is a party) and the Trustee may amend or supplement the Indenture, any Guarantee and the Notes as
provided in the Indenture. 
  

	13.	Defaults and Remedies 

 If
an Event of Default (other than an Event of Default relating to certain events of bankruptcy, insolvency or reorganization of the Issuer or certain Restricted Subsidiaries) occurs and is continuing, the Trustee by notice to the Issuer, or the
Holders of at least 25% in principal amount of the total outstanding Notes by notice to the Issuer and the Trustee, may declare the principal of, premium, if any, and accrued and unpaid interest (including Additional Interest), if any, and any other
monetary obligations on all the Notes to be due and payable. Upon such a declaration, such principal, premium and accrued and unpaid interest (including Additional Interest) and any other monetary obligations shall be due and payable immediately. If
a bankruptcy, insolvency or reorganization of the Issuer or certain Restricted Subsidiaries occurs and is continuing, the principal of, premium, if any, and accrued and unpaid interest (including Additional Interest) and any other monetary
obligations on all the Notes shall become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holders. Under certain circumstances, the Holders of a majority in principal amount of the
outstanding Notes may rescind any such acceleration with respect to the Notes and its consequences. 

  
 B-7

 14. Trustee Dealings with the Issuer 

Subject to certain limitations set forth in the Indenture, The Trustee in its individual or any other capacity may become the owner or
pledgee of Notes and may otherwise deal with the Issuer, Guarantors or their Affiliates with the same rights it would have if it were not Trustee. 
 15. No Recourse Against Others 
 An incorporator, director, officer,
employee or stockholder of the Issuer or any Guarantor or any of their parent companies, solely by reason of this status, shall not have any liability for any obligations of the Issuer or any Guarantor under the Notes or the Indenture or for any
claim based on, in respect of or by reason of such obligations or their creation. By accepting a Note, each Holder waives and releases all such liability. The waiver and release are a part of the consideration for the issuance of the Notes.

 16. Authentication 
 This Note shall not be valid until an authorized officer of the Trustee (or an authenticating agent acting on its behalf) manually signs the certificate of authentication on the other side of this Note.

  

	17.	Abbreviations 

 Customary
abbreviations may be used in the name of a Holder or an assignee, such as TEN COM (= tenants in common), TEN ENT (= tenants by the entirety), JT TEN (= joint tenants with rights of survivorship and not as tenants in common), CUST (= custodian) and
U/G/M/A (= Uniform Gift to Minors Act). 
 18. CUSIP, Common Code and ISIN Numbers 

The Issuer has caused CUSIP, Common Code and ISIN numbers, if applicable, to be printed on the Notes and has directed the Trustee to use
CUSIP, Common Code and ISIN numbers, if applicable, in notices of redemption or purchase as a convenience to Holders. No representation is made as to the accuracy of such numbers either as printed on the Notes or as contained in any notice of
redemption or purchase and reliance may be placed only on the other identification numbers placed thereon. 
 19. Governing Law

 This Note shall be governed by, and construed in accordance with, the laws of the State of New York. 

  
 B-8

 The Issuer shall furnish to any Holder upon written request and without charge to the Holder
a copy of the Indenture. Requests may be made to: 
 Wolverine Healthcare Analytics, Inc. 

c/o The Veritas Capital Fund IV, L.P. 
 590 Madison Avenue, 41st Floor 
 New York, New York 10022 

Attention: Ramzi Musallam 
 with a copy to: 
 Sullivan & Cromwell LLP 

125 Broad Street 
 New York, New York 10004 
 Attention: John E. Estes 

Telecopy: (212) 558-4349 
 E-email: estesj@sullcrom.com 

  
 B-9

 ASSIGNMENT FORM 
 To assign this Note, fill in the form below: 
 I or we assign and transfer this
Note to: 
  
  

(Print or type assignee’s name, address and zip code) 

 
  
 (Insert assignee’s social security or tax I.D. No.) 
 and irrevocably appoint
                        agent to transfer this Note on the books of the Issuer. The agent may substitute another to act
for him. 
  
  

 

			
	Date:                             
            	  	Your
Signature:                                       
                                      
	
	Signature Guarantee:                      
                                         
                                         
                                         
                                         
                               

 (Signature must be guaranteed) 

 
  
 Sign exactly as your name appears on the other side of this Note. 
 The signature(s) should be
guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to SEC Rule 17Ad-15. 

  
 B-10

 [TO BE ATTACHED TO GLOBAL NOTES] 

SCHEDULE OF INCREASES OR DECREASES IN GLOBAL NOTES 
 The following increases or decreases in this Global Note have been made: 
  

									
	 Date of

Exchange
	  	 Amount of decrease in Principal
Amount of this Global Note
	  	 Amount of increase in Principal
Amount of this Global Note
	  	
Principal Amount of this Global
Note following such decrease or
increase
	  	 Signature of authorized
signatory of Trustee or Notes
Custodian

  
 B-11

 OPTION OF HOLDER TO ELECT PURCHASE 

If you elect to have this Note purchased by the Issuer pursuant to Section 3.5 or 3.10 of the Indenture, check either box:

  

 ̈     ̈ 

3.5   3.10 
 If you want to elect to have only part of this Note purchased by the Issuer pursuant to Section 3.5 or 3.10 of the Indenture, state the amount in principal amount (must be in denominations of $2,000
or an integral multiple of $1,000 in excess thereof): $                             and specify the
denomination or denominations (which shall not be less than the minimum authorized denomination) of the Notes to be issued to the Holder for the portion of the within Note not being repurchased (in the absence of any such specification, one such
Note shall be issued for the portion not being repurchased):
                                         
                       . 
  

					
	Date:                             
	  	Your Signature	  	 
		  		  	(Sign exactly as your name appears on the other side of the Note)
			
	Signature Guarantee:	  	 	  	 
		  		  	(Signature must be guaranteed)

 The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan
associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to SEC Rule 17Ad-15. 

  
 B-12

 EXHIBIT C: Form of Indenture Supplement for Joinder of 

Thomson Reuters (Healthcare) Inc. 
 This Supplemental Indenture (this “Supplemental Indenture”) is entered into as of June 6, 2012 by and among Wolverine Healthcare Analytics, Inc., a Delaware corporation (the
“Issuer”), Thomson Reuters (Healthcare) Inc., a Delaware corporation (“TRHI”), and The Bank of New York Mellon Trust Company, N.A. (the “Trustee”), as Trustee under the Indenture referred to below.

 W I T N E S S E T H: 
 WHEREAS, the Issuer, VCPH Holding Corp., a Delaware corporation, as guarantor, and the Trustee entered into that certain indenture dated as of June 6, 2012 (the “Indenture”) and the
Issuer issued pursuant to the Indenture an aggregate principal amount of $327.15 million of 10.625% Senior Notes due 2020 (the “Notes”); 
 WHEREAS, Section 4.1 of the Indenture provides, among other things, that the Issuer may merge with and into another entity under certain circumstances, provided that, among other things, the
survivor of such merger expressly assumes the obligations of the Issuer under the Indenture and the Notes; 
 WHEREAS,
substantially concurrent with the merger of the Issuer with and into TRHI, TRHI shall execute and deliver this Supplemental Indenture to the Trustee pursuant to which TRHI shall assume all of the Issuer’s Obligations under the Notes and the
Indenture on the terms and conditions set forth herein and under the Indenture; and 
 WHEREAS, each of the Issuer and TRHI have
been authorized by or pursuant to a Board Resolution (or equivalent authorization) to enter into this Supplemental Indenture; and 
 WHEREAS, all acts, conditions, proceedings and requirements necessary to make this Supplemental Indenture a valid, binding and legal agreement enforceable in accordance with its terms for the purposes
expressed herein, in accordance with its terms, have been duly done and performed. 
 NOW, THEREFORE, in consideration of the
premises and the covenants and agreements contained herein, and for other good and valuable consideration the receipt of which is hereby acknowledged, the Issuer, the Guarantors and the Trustee hereby agree as follows: 

ARTICLE I  

DEFINITIONS 
 SECTION 1.1 Capitalized terms used in this Supplemental Indenture and not otherwise defined herein shall have the meanings assigned to such terms in the Indenture. 

  
 C-1

 ARTICLE II 
 REPRESENTATIONS OF ISSUER AND SUCCESSOR 
 SECTION 2.1 Each of the Issuer
and TRHI represents and warrants to the Trustee as follows: 
 (i) It is duly organized, validly existing and in
good standing under the laws of its jurisdiction of organization. 
 (ii) The execution, delivery and performance
by it of this Supplemental Indenture have been authorized and approved by all necessary corporate or limited liability company action on its part. 
 SECTION 2.2 Each of the Issuer and TRHI represents and warrants to the Trustee that upon the filing and acceptance for record of the Certificate of Merger by the Secretary of State of the State of
Delaware (the “Merger Effective Time”), the merger of the Issuer with and into TRHI shall be effective in accordance with applicable law. 
 ARTICLE III  
 AGREEMENT TO BE BOUND 

SECTION 3.1 TRHI hereby becomes a party to the Indenture as the Issuer and as such shall have all of the rights and be subject to all of
the obligations and agreements of the Issuer under the Indenture as if originally named as the “Issuer” therein. TRHI agrees to be bound by all of the provisions of the Indenture applicable to the Issuer and to perform all of the
obligations and agreements of the Issuer under the Indenture. 
 ARTICLE IV  

MISCELLANEOUS 
 SECTION 4.1 Notices. All notices and other communications to TRHI shall be given to Thomson Reuters (Healthcare) Inc., 777 E. Eisenhower Parkway, Ann Arbor, Michigan 48108, Attn: Andra Heller, with
a copy to Sullivan & Cromwell LLP as provided in the Indenture for notices to the Issuer or the Guarantor. 
 SECTION
4.1 Parties. Nothing expressed or mentioned herein is intended or shall be construed to give any Person, firm or corporation, other than the Holders and the Trustee, any legal or equitable right, remedy or claim under or in respect of this
Supplemental Indenture or the Indenture or any provision herein or therein contained. 
 SECTION 4.3 Effectiveness. This
Supplemental Indenture shall become effective as of the Merger Effective Time. 
 SECTION 4.4 Governing Law. This
Supplemental Indenture shall be governed by, and construed in accordance with, the laws of the State of New York. 

  
 B-2

 SECTION 4.5 Severability Clause. In case any provision in this Supplemental Indenture
shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and such provision shall be ineffective only to the extent of such invalidity,
illegality or unenforceability. 
 SECTION 4.6 Ratification of Indenture; Supplemental Indentures Part of Indenture.
Except as expressly amended hereby, the Indenture and the Notes are in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Supplemental Indenture shall form a part of
the Indenture for all purposes, and every Holder of Notes heretofore or hereafter authenticated and delivered shall be bound hereby. The Trustee makes no representation or warranty as to the validity or sufficiency of this Supplemental Indenture or
with respect to the recitals contained herein, all of which recitals are made solely by the other parties hereto. 
 SECTION 4.7
Counterparts. The parties hereto may sign one or more copies of this Supplemental Indenture in counterparts, all of which together shall constitute one and the same agreement. 

SECTION 4.8 Headings. The headings of the Articles and the sections in this Supplemental Indenture are for convenience of
reference only and shall not be deemed to alter or affect the meaning or interpretation of any provisions hereof. 

  
 B-3

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed as of the date first above written. 
  

			
	WOLVERINE HEALTHCARE ANALYTICS, INC.
		
	 By:
	 	  

		 	Name:
		 	Title:
	
	THOMSON REUTERS (HEALTHCARE) INC.
		
	By:	 	  

		 	Name:
		 	Title:
	
	 THE BANK OF NEW YORK MELLON TRUST
 COMPANY, N.A., as Trustee

		
	By:	 	  

		 	Name:
		 	Title:

 EXHIBIT D: Form of Indenture Supplement to Add Future Guarantors 

This Supplemental Indenture is entered into as of
[                    ], 20[    ] (this “Supplemental Indenture”), by and among [NAME OF FUTURE GUARANTOR]
(the “New Guarantor”), a subsidiary of Thomson Reuters (Healthcare) Inc., a Delaware corporation (the “Issuer”), the Issuer, VCPH Holding Corp., as guarantor, and The Bank of New York Mellon Trust Company, N.A., as
Trustee under the Indenture referred to below. 
 W I T N E S S E T H: 

WHEREAS, Wolverine Healthcare Analytics, Inc., as the issuer, VCPH Holding Corp., as the guarantor, and the Trustee have heretofore
executed and delivered an Indenture dated as of June 6, 2012, as supplemented by a supplemental indenture dated as of June 6, 2012, among Wolverine Healthcare Analytics, Inc., Thomson Reuters (Healthcare) Inc. and the Trustee (as
supplemented, waived or otherwise modified, the “Indenture”), providing for the issuance of an aggregate principal amount of $327.15 million of 10.625% Senior Notes due 2020 of the Issuer (the “Notes”); 

WHEREAS, the Indenture provides that under certain circumstances the New Guarantor shall execute and deliver to the Trustee a
supplemental indenture pursuant to which the New Guarantor shall unconditionally guarantee all of the Issuer’s Obligations under the Notes and the Indenture on the terms and conditions set forth herein and under the Indenture (the
“Guarantee”); and 
 WHEREAS, pursuant to Section 9.1 of the Indenture, the Trustee is authorized to
execute and deliver this Supplemental Indenture. 
 WHEREAS, all things have been done to make this Supplemental Indenture a
legal, valid and binding agreement. 
 NOW, THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt of which is hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders as follows: 
 ARTICLE I  
 DEFINITIONS 

SECTION 1.1 Defined Terms. As used in this Supplemental Indenture, terms defined in the Indenture or in the preamble or recital
hereto are used herein as therein defined. The words “herein,” “hereof” and “hereby” and other words of similar import used in this Supplemental Indenture refer to this Supplemental Indenture as a whole and not to any
particular section hereof. 

  
 D-1

 ARTICLE II  
 REPRESENTATIONS; AGREEMENT TO BE BOUND; GUARANTEE 
 SECTION 2.1
Representations. The New Guarantor represents and warrants to the Trustee as follows: 
 (i) It is duly
organized, validly existing and in good standing under the laws of its jurisdiction of organization. 
 (ii) The
execution, delivery and performance by it of this Supplemental Indenture have been authorized and approved by all necessary corporate or limited liability company action on its part. 

SECTION 2.2 Agreement to be Bound. The New Guarantor hereby becomes a party to the Indenture as a Subsidiary Guarantor and as such
shall have all of the rights and be subject to all of the obligations and agreements of a Subsidiary Guarantor under the Indenture. The New Guarantor agrees to be bound by all of the provisions of the Indenture applicable to a Subsidiary Guarantor
and to perform all of the obligations and agreements of a Subsidiary Guarantor under the Indenture. 
 SECTION 2.3
Guarantee. The New Guarantor agrees, on a joint and several basis with all the existing Guarantors, to fully, unconditionally and irrevocably Guarantee to each Holder of the Notes and the Trustee the Guaranteed Obligations pursuant to Article
X of the Indenture on a senior unsecured basis. 
 ARTICLE III  

MISCELLANEOUS 
 SECTION 3.1 Notices. All notices and other communications to the New Guarantor shall be given as provided in the Indenture to the New Guarantor, at its address set forth below, with a copy to the
Issuer as provided in the Indenture for notices to the Issuer. 
 SECTION 3.2 Parties. Nothing expressed or mentioned
herein is intended or shall be construed to give any Person, firm or corporation, other than the Holders and the Trustee, any legal or equitable right, remedy or claim under or in respect of this Supplemental Indenture or the Indenture or any
provision herein or therein contained. 
 SECTION 3.3 Governing Law. This Supplemental Indenture shall be governed by,
and construed in accordance with, the laws of the State of New York. 
 SECTION 3.4 Severability Clause. In case any
provision in this Supplemental Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and such provision shall be ineffective
only to the extent of such invalidity, illegality or unenforceability. 
 SECTION 3.5 Ratification of Indenture; Supplemental
Indentures Part of Indenture. Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Supplemental Indenture
shall form a part of the Indenture for all purposes, and every Holder of Notes heretofore or hereafter authenticated and delivered shall be bound hereby. The Trustee 

  
 D-2

 
makes no representation or warranty as to the validity or sufficiency of this Supplemental Indenture or with respect to the recitals contained herein, all of which recitals are made solely by the
other parties hereto. 
 SECTION 3.6 Counterparts. The parties hereto may sign one or more copies of this Supplemental
Indenture in counterparts, all of which together shall constitute one and the same agreement. 
 SECTION 3.7 Headings.
The headings of the Articles and the sections in this Supplemental Indenture are for convenience of reference only and shall not be deemed to alter or affect the meaning or interpretation of any provisions hereof. 

  
 D-3

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed as of the date first above written. 
  

			
	 [NEW GUARANTOR],
 as a Guarantor

		
	By:	 	  

		 	Name:
		 	Title:
		
		 	[Address]
	
	THOMSON REUTERS (HEALTHCARE) INC., as Issuer
		
	By:	 	  

		 	Name:
		 	Title:
	
	VCPH HOLDING CORP., as Guarantor
		
	By:	 	  

		 	Name:
		 	Title:
	
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	  

		 	Name:
		 	Title:EX-4.2

 Exhibit 4.2 
 EXECUTION VERSION 
 Indenture Supplement for Joinder of Thomson Reuters
(Healthcare) Inc. 
 This Supplemental Indenture (this “Supplemental Indenture”) is entered into as of
June 6, 2012 by and among Wolverine Healthcare Analytics, Inc., a Delaware corporation (the “Issuer”), Thomson Reuters (Healthcare) Inc., a Delaware corporation (“TRHI”), and The Bank of New York Mellon Trust
Company, N.A. (the “Trustee”), as Trustee under the Indenture referred to below. 
 WITNESSETH: 

WHEREAS, the Issuer, VCPH Holding Corp., a Delaware corporation, as guarantor, and the Trustee entered into that certain indenture dated
as of June 6, 2012 (the “Indenture”) and the Issuer issued pursuant to the Indenture an aggregate principal amount of $327.15 million of 10.625% Senior Notes due 2020 (the “Notes”); 

WHEREAS, Section 4.1 of the Indenture provides, among other things, that the Issuer may merge with and into another entity
under certain circumstances, provided that, among other things, the survivor of such merger expressly assumes the obligations of the Issuer under the Indenture and the Notes; 
 WHEREAS, substantially concurrent with the merger of the Issuer with and into TRHI, TRHI shall execute and deliver this Supplemental Indenture to the Trustee pursuant to which TRHI shall assume all of the
Issuer’s Obligations under the Notes and the Indenture on the terms and conditions set forth herein and under the Indenture; and 
 WHEREAS, each of the Issuer and TRHI have been authorized by or pursuant to a Board Resolution (or equivalent authorization) to enter into this Supplemental Indenture; and 

WHEREAS, all acts, conditions, proceedings and requirements necessary to make this Supplemental Indenture a valid, binding and legal
agreement enforceable in accordance with its terms for the purposes expressed herein, in accordance with its terms, have been duly done and performed. 
 NOW, THEREFORE, in consideration of the premises and the covenants and agreements contained herein, and for other good and valuable consideration the receipt of which is hereby acknowledged, the Issuer,
the Guarantors and the Trustee hereby agree as follows: 
 ARTICLE I  

DEFINITIONS 
 SECTION 1.1 Capitalized terms used in this Supplemental Indenture and not otherwise defined herein shall have the meanings assigned to such terms in the Indenture. 

 ARTICLE II 
 REPRESENTATIONS OF ISSUER AND SUCCESSOR 
 SECTION 2.1 Each of the Issuer
and TRHI represents and warrants to the Trustee as follows: 
 (i) It is duly organized, validly existing and in
good standing under the laws of its jurisdiction of organization. 
 (ii) The execution, delivery and performance
by it of this Supplemental Indenture have been authorized and approved by all necessary corporate or limited liability company action on its part. 
 SECTION 2.2 Each of the Issuer and TRHI represents and warrants to the Trustee that upon the filing and acceptance for record of the Certificate of Merger by the Secretary of State of the State of
Delaware (the “Merger Effective Time”), the merger of the Issuer with and into TRHI shall be effective in accordance with applicable law. 
 ARTICLE III  
 AGREEMENT TO BE BOUND 

SECTION 3.1 TRHI hereby becomes a party to the Indenture as the Issuer and as such shall have all of the rights and be subject to all of
the obligations and agreements of the Issuer under the Indenture as if originally named as the “Issuer” therein. TRHI agrees to be bound by all of the provisions of the Indenture applicable to the Issuer and to perform all of the
obligations and agreements of the Issuer under the Indenture. 
 ARTICLE IV  

MISCELLANEOUS 
 SECTION 4.1 Notices. All notices and other communications to TRHI shall be given to Thomson Reuters (Healthcare) Inc., 777 E. Eisenhower Parkway, Ann Arbor, Michigan 48108, Attn: Andra Heller, with
a copy to Sullivan & Cromwell LLP as provided in the Indenture for notices to the Issuer or the Guarantor. 
 SECTION
4.1 Parties. Nothing expressed or mentioned herein is intended or shall be construed to give any Person, firm or corporation, other than the Holders and the Trustee, any legal or equitable right, remedy or claim under or in respect of this
Supplemental Indenture or the Indenture or any provision herein or therein contained. 
 SECTION 4.3 Effectiveness. This
Supplemental Indenture shall become effective as of the Merger Effective Time. 
 SECTION 4.4 Governing Law. This
Supplemental Indenture shall be governed by, and construed in accordance with, the laws of the State of New York. 

 SECTION 4.5 Severability Clause. In case any provision in this Supplemental Indenture
shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and such provision shall be ineffective only to the extent of such invalidity,
illegality or unenforceability. 
 SECTION 4.6 Ratification of Indenture; Supplemental Indentures Part of Indenture.
Except as expressly amended hereby, the Indenture and the Notes are in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Supplemental Indenture shall form a part of
the Indenture for all purposes, and every Holder of Notes heretofore or hereafter authenticated and delivered shall be bound hereby. The Trustee makes no representation or warranty as to the validity or sufficiency of this Supplemental Indenture or
with respect to the recitals contained herein, all of which recitals are made solely by the other parties hereto. 
 SECTION 4.7
Counterparts. The parties hereto may sign one or more copies of this Supplemental Indenture in counterparts, all of which together shall constitute one and the same agreement. 

SECTION 4.8 Headings. The headings of the Articles and the sections in this Supplemental Indenture are for convenience of
reference only and shall not be deemed to alter or affect the meaning or interpretation of any provisions hereof. 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed as of the date first above written. 
  

			
	WOLVERINE HEALTHCARE ANALYTICS, INC.
		
	By:	 	/s/ Ramzi Musallam
		 	Name: Ramzi Musallam
		 	Title: Secretary

 [Signature Page to the Supplemental Indenture] 

 
			
	THOMSON REUTERS (HEALTHCARE) INC. (TO BE RENAMED TRUVEN HEALTH ANALYTICS INC.)
		
	By:	 	/s/ Mike Boswood
		 	Name: Mike Boswood
		 	Title: President and CEO

 [Signature Page to the Supplemental Indenture] 

 
			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	/s/ Lawrence M. Kusch
		 	Name: Lawrence M. Kusch
		 	Title: Vice President

 [Signature Page to the Supplemental Indenture]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}]]